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ABSTRACT 
Malaria is still the most serious tropical disease in the world. It kills at least one 
million people every year, mainly young children in Africa. Malaria transmission is 
increasing due to insecticide resistance of the malaria-carrying mosquito, control 
programme failures, drug resistance of the malaria parasite and perhaps even global 
warming. Therefore, a greater understanding of the genetics and molecular biology of 
the parasite is urgently needed in order to develop novel chemotherapeutic and vaccine 
based control strategies. 
The research aims of this thesis were to study genes and proteins which 
regulate the development of the malaria parasite, Plasmodium falciparum, through its 
intra-erythrocytic life cycle. A Plasmodium falciparum homologue of one of the 
components of a Chromatin-Remodelling Complex which controls binding of 
transcription factors to nucleosome core particles has been cloned and characterised. 
This sequencing effort has been broadened into a genome data bank-based review of 
intons and promotor sequences in Plasmodium falciparum. Immunofluorescence 
microscopy also shows that the PfSNF2L protein is expressed throughout the asexual 
stage of the cell cycle and is localised within nucleus. A proteolytic process and 
granular pattern on the infected red blood cell membrane is revealed by using anti-
PfSNF2L polyclonal antibodies on western blotting and immunoflourescence assay. 
Biological experiments on the cell cycle of malaria parasite have also been 
carried out. Process through the cell cycle has been shown to be retarded by heat 
shock and blocked at certain specific cell stage by drugs known to block certain key 
cell cycle regulatory processes in other cells. The nature of the cell death process in 
cycle arrested cells has also been investigated and its role in apoptosis-like cell death in 
malaria cells has been investigated. 
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1.1 Malaria: the hundred years war 
It is interesting to note that exactly one hundred years ago Patrick Manson 
announced to a meeting in the city of Edinburgh that Major Ronald Ross of the Indian 
Army Medical Service had made the landmark discovery that the vector for the 
transmission of malaria is the Anopheles mosquito. Unfortunately, despite a century of 
research and control efforts, malaria is still the most serious tropical disease in the 
world and is endemic in 99 countries where 2.2 billion people (41% of the world's 
population) are in danger of infection. More than 120 million clinical cases and over 1 
million deaths occur each year, mainly children under the age of five infected with the 
malaria parasite Plasmodiumfalciparum in Africa (WHO, 1992). Malaria also exerts a 
heavy economic burden. The total cost of malaria was estimated to be around $800 
million for tropical Africa in 1987, rising to more than $1800 million in 1995 
(Burgess, 1997). 
By many criteria, the war against malaria is stalemated if not actually being 
lost. Plasmodium parasites, which are the disease causation agents, are resistant to a 
wide range of drugs and the mosquito vectors have also evolved resistance to 
pesticides. Despite decades of research, effective anti-malarial vaccines are not yet 
available although several candidates are now undergoing clinical trials. The existing 
rather short list of effective antimalarial drugs is constantly being threatened by the 
evolution of new resistant malaria strains and the anxiety this provokes in the malaria 
research community does not seem to have increased the rate of development of 
replacement therapies. A better understanding of the molecular mechanisms underlying 
the complex life cycle of the malaria parasite could aid the search for novel anti-malaria 
treatments and this hope underlies much of the work carried out in this thesis. 
1.2 	The life-cycle, genetics and genomics of malaria parasites 
1.2.1 The life-cycle of the malaria parasites 
The obligate protozoan parasites which cause malaria are restricted to the 
family Plasmodiidae within the order Coccidiida, sub-order Haemosporidiidea. There 
are nearly 120 known species of Plasmodia found in vertebrates, namely reptiles, 
birds, rodents, primates and other mammals. Human malaria is caused by four 
species, P. falciparum, P. vivax, P. ovale and P. malariae, all of which are only 
1 
transmitted by female Anopheles mosquitoes. The life cycle of human malaria parasites 
essentially comprises of an exogenous cycle leading from gametic fusion to sporogony 
in the mosquito and an endogenous asexual multiplicative cycle in the vertebrate host. 
The asexual replicative cycle includes the developmental stages in the erythrocytes, 
erythrocytic schizogony, and exo-erythrocytic schizogony in liver hepatocytes. A 
comprehensive life cycle is depicted in Figure 1.1. 
1.2.2 General genetics and genomics of malaria parasites 
The malaria parasite genome is haploid for most of the life cycle, becoming 
diploid only briefly after fertiisation when the zygote is formed. Evidence shows that 
only one allele of each chromosome is found within a single cloned parasite. (Walliker 
et al, 1987). Crossing experiments between clones of the different rodent malaria 
parasites P. berghei and P. chabaudi and P. falciparum have demonstrated that blood 
forms of the parasites are haploid (Walliker et al, 1973; Walliker et al, 1975; Walliker 
et al, 1987). Genetic re-assortment can occur by recombination between chromosomes 
and by crossing-over between genes on homologous chromosomes during meiosis in 
the mosquito cycle (Fenton & Walliker, 1990; Sinnis & Wellems, 1988; Walker-Jonah 
et al, 1992). Intra-genic recombination within the msp-1 gene has been detected in 
some of the progeny of the laboratory crosses referred to above (Kerr et al, 1994). 
Malaria parasites have a nuclear genome and two extranuclear genomes 
(Creasey, 1996). P. falciparum has a haploid genome of around 30 megabases of 
DNA. The haploid genome comprises 14 chromosomes, determined both by 
resolution of chromosomes on pulse-field gel electrophoresis (PFGE) and by counting 
the number of kinetochores in electron micrographs (Kemp et a!, 1987; Prensier & 
Slomianny, 1986; Wellems et a!, 1987). The chromosome sizes range from about 650 
kb (chromosome 1) to over 3 Mb (chromosome 14). In most malaria species and 
particularly P.falciparum the nuclear genome is extremely A+T-rich (82%) 
(McCutchan et al, 1984; Pollack et al, 1982). The mRNA coding strand is more purine 
rich. Overall A+T content in the triplet codon positions increases in the order 1 st-2nd-
3rd position and the codons used in genes are strongly biased towards using the higher 
A+T contents (Weber, 1987). There is no significant difference in codon usage 
between housekeeping and antigen genes (Musto et al, 1995). 
A multi-copy 6kb linear molecule and a lower copy number 35kb circle of 
extrachromosomal DNA have been found in all malaria parasites (Wilson & 
Williamson, 1997; Wilson et a!, 1991). Biochemical and genetic studies have led to the 
conclusion that the 6kb genome is the Plasmodium mitochondrial DNA, usually 
located in the mitochondrial fraction (Wilson et a!, 1992), and having typical 
mitochondrial genes. such as cytochrome b and cytochrome oxidase subunit I and II 
Figure 1.1 Life cycle of Plasmodium falciparum. The sexual cycle culminates in 
the production of sporozoites in mosquitos. Meiosis occurs just after zygote formation. 
Sporozoites infect liver hepatocytes and the parasite then reproduces asexually, in the 
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(Aldritt et at, 1989). It also contains at least 13 fragmentary ribosomal RNA genes 
(Vaidya et al, 1989). 
The 35kb element is in some ways similar to the chloroplast and plastid 
genomes of plants or algae with prokaryote-like features (Gardner et at, 1991). It 
encodes about 60 genes, mainly ribosomal RNAs (rRNAs), transfer RNA (tRNAs), 
ribosomal proteins and the subunits of the RNA polymerase. It has now been 
classified as the malaria plastid-like DNA (Gardner et at, 1991). 
Comparison of homologous chromosomes from different geographic isolates 
indicates that all 14 P. falciparum chromosomes display extensive clone-dependent 
size polymorphisms (of up to 15%) in both field isolates and parasites grown in 
culture (Bigg et at, 1989; Corcoran et at, 1986; Kemp et al, 1985; Van der Ploeg et a!, 
1985). While some genetic variability results from sexual recombination during 
meiosis, the extensive chromosomal polymorphism observed also appears to originate 
spontaneously during mitotic growth in vivo or in vitro (Walliker, 1989). Analysis of 
the chromosome 2 and 4 contig maps has revealed that polymorphisms are mainly 
confined to chromosome ends. The central chromosome regions are more conserved 
and tend to contain 'housekeeping' genes rather than antigen genes (Langsley et at, 
1983; Lanzer et at, 1993; Lanzer et at, 1994; Lanzer et at, 1995; Scherf, 1996). 
An abundant subtelomeric repetitive DNA sequence, termed rep20, has been 
reported by several groups (Aslund et at, 1985; Oquendo et at, 1986; Rao et at, 1986). 
This 21-bp tandemly repeated sequence is AT-rich and is not transcribed in the 
erythrocytic stages of P.fatciparum parasite (Oquendo et at, 1986). This sequence is 
present in all parasite chromosomes and displays significant restriction fragment length 
polymorphism between different isolates of P. falciparum (Oquendo et at, 1986), 
possible as a result of mitotic recombination events. 
1.2.3 General molecular biology of malaria parasites 
Malaria chromosomes are linear and contain telomeric regions similar to other 
lower eukaryotes such as yeast (Dore et at, 1986; Vernick & McCutchan, 1988) The 
nuclear DNA is enclosed within a nuclear envelope, bound to histories and packaged 
into nucleosomes (Cary et at, 1994; Dore et at, 1986; Wunderlich, 1980). However, 
little is known about genome structure and organisational elements such as 
centromeres, replication origins and the structural elements involved in transcription. 
Malaria messenger RNAs (mRNA), like other eukaryotic mRNAs appear to be 
capped at their 5' end (Hyde et at, 1984). Unlike small trypanosome and some 
nematode messages, there is no trans-splicing during malaria mRNA splicing 
(Blumenthal & Spieth, 1996; Blumenthal & Steward, 1996; Vanhamme & Pays, 
1995). The 5-untranslated regions (UTRs) of malaria messages are co-linear with 
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their coding sequences and these are transcribed together from genomic DNA. All of 
the Plasmodium 5'-UTRs characterised to date are much longer than those of most 
eukaryotes, which are usually 100 nucleotides or less. For example, in P. falciparum 
the 5'-UTRs of the PfRan and PfSNF2L genes are at least 679 and 519 bp 
respectively (Ji & Arnot, 1997; Sultan et al, 1994). Multiple potential transcription 
start sites are also often seen in the coding sequences of many malaria genes, although 
their significance is not understood(Ji et al, 1997; Lewis, 1990). The sequences 
flanking the ATG initiation codon in mRNA are believed to play a critical role in the 
initiation of protein translation in higher eukaryotes (Herman, 1988). From earlier 
studies of Plasmodium genes, a 5'-consensus sequence (AAAAATGA) was found 
with the most conserved "A" at position —3 using the definition of Kozak where the 
"A" of ATG codon is position 1 and preceding base is -1 (Kozak, 1984; Kozak, 
1997). This is somewhat different to the consensus sequences ((AIT)A(A/C)A(A/C)A 
ATGT and GCC(A/G)CCATGG) found in yeast and vertebrates (Hamilton et al, 
1987; Kozak, 1987). 
Plasmodium introns are short and extremely AT-rich. However, the sequences 
of their donor and acceptor sites at splice junctions faithfully follow the GT-AG rule 
and closely resemble those of other eukaryotes (Prasartkaew et al, 1996; Vinkenoog et 
al, 1995). The 5'-splice site sequence 'AAGIGTAA(G/A)(AJT)' conforms to the 
consensus 'NAGIGTAAGT' from invertebrate while the 3'-sequence seems a T-rich 
variant of the pyrimidine enriched consensus 'T(T/C)T(T/C)T(TIC)(T/C)(T/C)(TIC) 
(T/C)NCAGIG' with some modifications (Senapathy et al, 1990). Most malaria genes 
described to date have a relatively small number of introns but many have no introns at 
all. Approximately 5% of the total RNA of P. falciparum is polyadenylated, and the 
poly(A) tails have, on average, 100-200 nucleotides (Vaidya et al, 1984). 
Heterogeneous polyadenylation from different sites has been observed at the 3'-end of 
some Plasmodium messages, a feature which has been proposed to play a role in stage 
specific gene expression (Ruvolo et al, 1993). 
1.3 The Plasmodium falciparum life cycle and its relation to the cell 
cycle 
This thesis describes work on the molecular biology of P. falciparum which is 
oriented torwards understanding how key molecular components of the parasite are 
integrated into its life cycle and development. A unifying theme of the work is the 
delineation of signaling pathways and their roles in parasite gene expression. Relevant 
areas of eukaryotic molecular biology are therefore reviewed here and where possible, 
integrated with known features of the parasite's biology. 
1.3.1 Signalling pathways in eukaryotic cells 
In unicellular organisms, such as bacteria, yeast or Plasmodium, growth is 
fundamentally controlled by the availibility of nutrients. Each cell is competing for 
these nutrients with neighbours of either the same or other species. This is different 
from multicellular organisms consisting of differentiated cells which integrate cellular 
activity in all of the basic process of life, eg. movement, metabolic activity, growth and 
ultimately death. However all cells must respond to the surrounding environment and 
control the entry and exit of molecules through the cytoplasmic membrane (Hardie, 
1991). Signals such as growth factors, cytokines or calcium (Ca 2 ), either stimulate 
transmembrane receptors or enter the cell cytoplasm directly and trigger receptors to 
modify or bind intracellular targets and thus trigger a series of signal cascades. 
Information may ultimately be transmitted into the nucleus to initiate gene expression 
(Figure 1.2A). A classic example are steroid hormones which diffuse through the 
plasma membrane into the cytoplasm and bind steroid receptors, before translocating to 
the nucleus to interact with specific promoters which regulate transcription 
(Mangelsdorf et at, 1995). 
Another well-known example is the proto-oncogene c-fos, which is rapidly and 
transiently induced by a multitude of extracellular stimuli. A cascade of events is 
triggered by cell stimulation, as presented in Figure 1.2B. The transcription factor 
known as the serum response factor (SRF) and its accessory protein TCF, (ternary 
complex factor) bind the c-fos SIRE (serum response element, a promoter element) co-
operatively to form a ternary complex to control c-fos transcription (Janknecht et al, 
1995). SRF and TCF, in turn, are tightly regulated by several signal transduction 
pathways, such as extracellular-signal regulated kinase (ERK), phosphatidylinositol 
(Ptdlns) 3-kinase, Ptdlns-specific phospholipase C (PLC)-y, c-raf, trimeric G-protein 
and ras-GAP(see Figure 1.2B for the details) (Cahill et at, 1996)). An increase in c-fos 
protein can then produce a Jun-Fos complex (AP- 1) capable of activating transcription 
of a variety of genes (Cantley et al, 1991). 
Cell cycle control is mediated by a profusion of growth factors acting on 
different messenger pathways (Figure 1.2C). Both G-protein linked receptors and 
tyrosine kinase linked receptors can stimulate proliferation. The inositol (1,4,5)-
triphosphate (InsP3)/calcium signalling pathway is activated by mitogenic stimuli and 
may contribute to changes which culminate in DNA synthesis. Activation of 
transcription factors which then translocate into the nucleus indicates that some of the 
actions of calcium occur in the cytoplasm. Calcium also can activate mitogen-activated 
protein (MAP) II kinase, part of the phosphorylation cascade that culminates in the 
activation of DNA synthesis-promoting factor (Berridge, 1993). 
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Figure 1.2 Signalling pathway networks in eukaryotic cell. (A) A comprehensive 
signal cascade pathway. (B) Intracellular signalling pathways that converge on the c-
fos SRE. ERK activation by Gp y subunits, G1-coupled receptors, voltage-gated 
channels and interferon receptors. Activation of CaMK, leading to SRF activation, is 
also shown. (C) Signalling pathways operating during Gi phase. Growth factors 
generate a number of putative mitogemc messengers which then feed into various 
pathways to control both early events at the G0/G1 boundary and later events which 
culminate in the onset of DNA synthesis. SRE, serum response element; SRF, serum 
response factor; TCF, ternary complex factor; CAM, calmodulin; CaMK, Ca 2 / 
calmodulin-dependent kinase; PLC, phospholipase C; PIP2, phosphatidyl inositol-4,5-
diphosphate; P13, inositol-3 ,4,5-diphosphate; ERK, extracellular-signal regulated 
kinase; SPF,synthesis-promoting factor; GAP, GTPase-activating protein; CN, 
calcineurin; DAG, diacylglycerol; PKC, protein kinase C; shc, src-homology; ras, 
small GTPase; Grb2, adaptor protein; PyK2, protein tyrosine kinase 2; E2F, 
transcription factor E2F; c-fos, proto-oncogene; Ga,,y, trimeric G protein a,1 3,y 
subunits; MAP, mitogen-activated protein; Mek, MAP kinase kinase. (Adapted from 
Cahill et al, 1996; Berridge 1993). 
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1. 3.2 DNA replication and the cell cycle in malaria parasites 
The eukaryotic cell cycle is regulated both temporally and spatially. During 
mitosis, the nucleus, cytoskeleton, and membrane compartments undergo dramatic 
changes which must be tightly coordinated. Similarly, in replicating its genome the cell 
must ensure that each origin fires only once per cell cycle and there appears to be a set 
order in which particular origins initiate DNA synthesis. 
The typical cycle is divided into two fundamental parts: interphase, which 
occupies the majority of the cell cycle and is subdivided into G1 (gap!), S (DNA 
synthesis), G2 (gap2), and mitosis (M). Interphase lasts about 30 minutes in rapidly 
dividing human cells. Two major 'checkpoints' regulating entry into DNA replication 
(the G1/S checkpoint) and into mitosis (the G2/M checkpoint) have been recognised 
(Murray & Hunt, 1993). DNA replication and synthesis of histone proteins occurs 
only in the S phase. Each double-stranded DNA molecule is replicated into two 
identical daughter double-stranded DNAs, and histone and other chromosomal proteins 
bind quickly to the newly synthesized DNA. S phase is preceded and followed by gap 
periods, G1 and G2 respectively, during which there is no net synthesis of DNA, 
although repair to damaged DNA occurs. During M phase, identical DNA molecules 
are condensed and distributed into each of the daughter cells through the classically 
observed prophase, pro-metaphase, metaphase, anaphase and telophase movement 
stages. 
The life cycle of malaria parasites contains several cell cycles and there are at 
least five stages of DNA synthesis within the P. falciparum life cycle. In the mosquito 
there is microgametogenesis, meiosis-associated DNA synthesis and sporogony. 
Within the human there is exo-erythrocytic schizogony in the liver and erythrocytic 
schizogony in the RBCs. Malaria parasites are incapable of de novo synthesis of the 
purines necessary for the synthesis of nucleic acids and other metabolic functions, and 
operate purine salvage pathways (Homewood & Neame, 1980). However de novo 
synthesis of pyrimidines does occur involving the vitamin para-amino-benzoic acid 
(PABA) and folate co-factors. The key biochemical marker of cell cycle progression, 
DNA synthesis, starts in synchronised P. falciparum cultures about 28-31 h after 
merozoite invasion and DNA content then increases for around 8-10 h. A general 
model has been proposed by Arnot and Gull (1998) who interpreted the relationship 
between asexual parasite development and cell cycle as follows: 
(1) The invasive merozoite is in a Go-like  state with condensed chromatin. The 
developing trophozoite is formally similar to the Gi-stage of mammalian cells or yeast 
and the morphologically defined 'rings' and early trophozoites are equivalent to G1. 
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Since DNA synthesis begins in relatively small trophozoites ('late rings') but 
subdivision of the nuclear material (the morphologically defined onset of schizogony) 
does not appear until the trophozoite is much enlarged, growth and DNA synthesis in 
trophozoites must occur concurrently (Hare, 1986). Prior to DNA synthesis 
trophozoites have pre-accumulated high levels of RNA (Hare & Bahler, 1986). The 
steady-state transcripts from both PfPCNA (proliferating cell nuclear antigen) and 
PfDNA polymerase ö have been accumulated by the trophozoite stage (Horrocks et al, 
1996). As parasites progress towards the stage where DNA replication occurs, there is 
a concomitant increase in both topoisomerase H production and activity (Cheesman et 
a!, 1998). During this period, the parasite consumes host cell cytoplasm and grows to 
fill the erythrocyte. 
The S phase occurs during schizogony, but neither microscopy, precursor 
incorporation nor flow cytometry has been able to establish definitively whether G2 
and then M phases occur during progression from the haploid (1C) DNA content to the 
final genome complement of the mature segmentor (-8-30 Q. Thus it is unclear 
whether a brief G2 and M phase occurs after each genome doubling ( 6-8 hours for 4-5 
rounds of mitosis). The mechanism of malaria S phase control during schizogony may 
be similar to the early embryonic development of Drosophila which Drosophila 
embryos undergo rapid rounds of DNA replication and nuclear division. In Drosophila 
embryo the first rapid rounds of replication are tightly regulated by reducing the pre-
accumulated cyclin A and B protein levels (Edgar et al, 1994). Therefore, Leete and 
Rubin (1996) suggested that the overall control of the length of the schizont stage and 
the number of rounds of DNA replication may be controlled by the steady degradation 
of cyclins or some signals during the schizont stage. However, no cyclins have been 
identified to date from P. falciparum and the P. falciparum cdc2 homologues identified 
to date have not been proven encode a functional protein in vivo (Ross-MacDonlad et 
al, 1994; Li et al, 1996). Chromosomes do not condense in the nuclear divisions of P. 
falciparum and the nuclear membrane remains intact throughout genome replication. 
The subsequent mitotic divisions have been assumed to take place within the same 
nuclear envelope (Leete & Rubin, 1997; Read & Hyde, 1997). If mitotic genome 
segregations occur then they are colchicine insensitive and must be very rapid 
(Jacobberger et al, 1992). 
Segmentation occurs as an independent stage at the end of the asexual erythrocytic 
cycle and merozoites are formed then and not during S phase proper. Because the 
transitions from one stage to the next are not clearly separable biochemically or 
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morphologically, the relationship of schizogony to both the DNA synthetic cycle and 
the cell cycle is poorly defined. 
Haploid (1C) merozoites can exit the erythrocytic, asexual replicative cycle and 
differentiate sexually into micro and macro-gametocytes. The gametocytes have 
generally been considered to be arrested in G1 prior to the onset of S phase. However 
in both P. berghei and P. falciparum a considerable excess of DNA over the 1C value 
(almost reaching the 2C value in the latter case) has been measured after Feulgen 
staining and fluorometry (Janse et al, 1988; Janse et al, 1986; Janse et al, 1986; Janse 
et al, 1986). The near diploid amounts of DNA in most gametocytes make it 
impossible to rule out some features of an earlier model, based on the observation of 
gametocyte intranuclear microtubules, that gametocytes have undergone a nuclear 
division (Sinden, 1983; Sinden, 1982). It is, however, clear that microgametocytes 
have not pre-synthesised the 8C DNA compliment necessary to equip the 8 haploid 
microgametes released after microgametogenesis in the mosquito midgut. 
1. 3.3 Signal transduction and the Plasmodium cell and life cycles 
Regulators of cell cycle progression are important targets in the signalling 
pathways that mediate cell growth and differentiation. In model organisms such as 
Schizosaccharomyces pombe, entry into M and S phase is regulated by the cydlin-
dependent-kinase (CDK) CDC2 (Solomon et al, 1990), whereas in higher eukaryotes 
CDC2 homologues such as CDK1, control only entry into M phase, the S phase of the 
cell cycle being controlled by additional CDKs (Lees, 1995). Each phase of the cell 
cycle is initiated by accumulation of the appropriate cyclins above a threshold level, 
leading to activation of a cyclin-CDK complex. In general, each cycin-CDK complex 
represses its predecessor and stimulates the expression of its successor, resulting in 
modulated waves of different cyclin expression (Lees, 1995). CDK activity is also 
regulated by binding of its inhibitors, like cyclin-dependent-kinase inhibitor (CKI), 
and by phosphorylation of regulatory sites on the CDK (Wittenberg & Reed, 1996). 
The relative significance of the three forms of CDK regulation (cycin binding, 
phosphorylation and inhibitor binding) has not been clearly established, but cyclin 
accumulation appears to be the rate-limiting step in many organisms (Lees, 1995). 
A putative CDC2 homologue, PfPK5, has been isolated from P. falciparum 
and can be partially activated in vitro by the same phosphorylation events as yeast 
CDC2 (Graeser et al, 1996; Ross-MacDonald et al, 1994). Studies in two recent 
isolated P. falciparum proteins, Pfmrk (a putative CAK homologue) and Pfcrk (a 
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cdc2-related kinase) also suggest that CDK regulation in malaria parasites may be 
similar to that observed in other eukaryotes (Doerig et al, 1995; Li et al, 1996). 
Initiation of DNA replication in eukaryotes is regulated by 'replication 
licensing' to ensure that DNA replication occurs only once per cycle. Unreplicated 
DNA is in a replication-competent or 'licensed' state. The ability to replicate is lost in S 
phase and regained following passage through mitosis. The minichromosome 
maintenance (MCM) proteins have been indicated in determining this replication 
competence. Therefore, a malarial MCM homologue may be also involved in this 
control (Doeng, 1997; Romanowski & Madine, 1996; White & Kilbey, 1996). Other 
factors which may be involved in malaria cell cycle regulation include a P. falciparum 
homologue of the RanITC4, PfRan, a protein first characterised in this laboratory and 
independently in another group (Dontfraid & Chakrabarti, 1994; Sultan et al, 1994). 
RanJTC4 is a small GTPase mainly responsible for nuclear tranport (this will be further 
discussed in a later part of the introduction). It has also been implicated in transmitting 
a signal that prevents the onset of mitosis before DNA replication is completed (Ren et 
al, 1993). Doerig further suggests that the PfRan may be involved in importing the 
CDKIcyclin complex into the nucleus (Doerig, 1997). 
1.3.4. Signalling pathways in malaria parasites 
A recent review by Doerig (1997) discusses hypotheses for the possible signal 
transduction pathways in malaria parasites. A brief summary of these pathways is 
presented below and in Figure 1.3. 
cAMP -dependent pathways. cAMP is a key messeger of many developmental 
processes and is produced by membrane-bound adenylate cyclase, usually activated by 
heterotrimeric G-proteins (Tang & Gilman, 1991). Protein kinase A (PKA) can be 
activated by binding cAMP in order to phosphorylate a number of substrates including 
transcription factors which modulate gene expression. P. falciparum extracts have been 
shown to contain both adenylate cyclase and PKA activities (Read & Mikkelsen, 1990; 
Read & Mikkelsen, 1990). The addition of high level of cAMP has been proposed as 
the trigger mechanism for gametogenesis in P. falciparum although other groups have 
failed to reproduce this result (Inselburg, 1983; Kaushal et al, 1980). Putative gene 
homologues of adenylate cyclase and PKA have been isolated from different 
Plasmodium species (Doerig, 1997). 
cGMP -dependent pathways. Elements of this pathway appear to be involved 
in gametogenesis in the vector midgut. Both cGMP and guanylate cyclase activators 
stimulate exflagellation in P. falciparuin and P. berghei. A gene encoding a protein 
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Figure 1.3 Signal transduction pathways which may operate in malaria parasites. For the detail, 
please see Introduction 1.3.4. Pf, Plasmodium falciparum; Py, Plasmodium yeolii, TKR, tyrosine 
kinase receptor; AC, adenylate cyclase, PKA, protein kinase A; PKC, protein kinase C; PK, protein 
kinase; KG, protein kinase G; CK, casein kinase; MAP, mitogen activated protein; CAM, calmodulin; 
CDPK, Ca2 /ca1modulin-dependent kinase; CDK, cyclin dependent kinase; CAK, CDK activating 
kinase; CRK, Cdc2 related kinase; mrk, M015 related kinase, CKT, CDK inhibitor; PCNA, proliferative 
cell nuclear antigen. (Adapted from Doerig, 1997). 
MAP kinase pathways. Several MAPKs pathways (mitogen-activated protein 
kinases), also called ERKs (extracellularly-regulated kinases), co-exist in eukaryotic 
cells and mediate responses to a wide variety of signals. MAPK substrates include 
transcription factors, cell cycle control elements, cytoskeleton components and 
downstream protein kinases. MAPK itself can be activated in a variety of ways, such 
as by G-protein coupled receptors via the ras protein, tyrosine kinase receptors, and 
protein kinase C (Cobb & Goldsmith, 1995). A MAPK homologue, Pfmap-1 (also 
called PfMAP or PfMRP) from P. falciparum has been identified and has been 
suggested to play a role in sexual development (Lin et at, 1996). 
Phosphatidylinositol (P1) cycles Surface receptors stimulate phospholipase C 
to hydrolyse phosphatidylinositol 4,5-biphosphate (PIP2) with the subsequent 
generation of the secondary messengers inositol- 1 ,4,5-triphosphate (1P3) and 
diacyiglycerol (DAG) for downstream regulation. Exflagellation of P. falcipa rum 
microgametes is accompanied by the sequential PT degradation. A membrane bound 
merozoite protease can be solubilised through the action of GPI-phospholipase C in P. 
falciparum and P. chabaudi. The activated protease is required for merozoite invasion 
(Braun-Breton et at, 1992). 
Protein phosphatases. Dephosphorylation of regulatory proteins is an 
important way of modulating the output of signal transduction cascades involving 
protein kinases (Hunter, 1995). Recently two different serine/threonine protein 
phosphatases (PP2A-like and PP 1-like) activities have been detected and a putative 
protein phosphatase PP2A gene identified in P. falciparum (Doerig, 1997). 
Calcium signalling. The importance of calcium in signal transduction is well 
known, and its indirect effects on the cell are widespread, including cell cycle arrest, 
regulation of meiosis and regulation of transcription factors. The calcium-binding 
protein, calmodulin, is an important mediator of calcium signalling and required for the 
regulation of a wide variety of Ca2+dependent  enzymes (Clapham, 1995). Calcium 
antagonists inhibit gametogenesis in P. falciparum and P. berghei and prevent both 
normal morphological development and DNA synthesis (Kawamoto et al, 1993). 
Genes encoding a P. falciparum calmodulin homologue (Robson & Jennings, 1991), 
a calcium-binding protein, Pf40 (Rawlings & Kaslow, 1992), and two Ca 2 -
dependent protein kinases, PfCDPK1 and 2 (Zhao et at, 1993), have been isolated. 
PfCDPK1 appears to be associated with the cell surface of the merozoite and is thought 
to play a role in RBC invasion. PfCDPK2 may be associated with a membrane or 
organelle fraction, as it contains a membrane-anchoring motif (Doerig, 1997). 
Missing links between signalling pathways. Heterotnmeric G-proteins play an 
important role in activating many signalling pathways, which either directly contact 
their downstream receptors or act through mediators, such as the ras GTPase (Cobb et 
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al, 1995). There is some evidence that a G protein exists in asexual stage parasites 
(Thelu et a!, 1994) but so far no heterotrimeric G protein gene has been reported (no 
sequences in GenBank and no references in Medline as of June, 1998). Surface 
receptors which can sense extracellular signals and initiate signal transduction cascades 
have not been identified and the precise signals which trigger developmental responses 
such as gametocytogenesis are mostly unknown. Stage-specific transcription factors 
are another essential group of response effectors and represent the target of many 
signalling pathways. Nothing is known about the machinery which regulates stage-
specific transcription in malaria parasites. 
1.4. GTPase mediated signal transduction pathways and nuclear 
transport in P. falciparum 
1.4.1 G proteins and their structures in eukaryotic cells 
Signal transduction is the process by which a receptor interacts with a ligand to 
transmit a signal to trigger a cascade or pathway ending with an effect within the cell. 
In all eukaryotic organisms, a family of heterotrimeric guanosine triphosphate-binding 
proteins (G-proteins) play an essential role in linking many cell surface receptors to 
effector proteins on the plasma membrane (Hepler & Gilman, 1992). G proteins have 
been found to play a central role in a broad array of cellular activities such as mating in 
yeast, chemical induced movement in slime mould, vision, small hormone secretion, 
muscle contraction and cognition in humans. Heterotrimeric G proteins are composed 
of ct, P , and y  chains encoded by distinct genes. Ga subunits have a limited molecular 
weight range between 39 and 52 KDa, and 17 Ga subunits have, to date, been 
identified and subdivided into four main classes termed G, G, G q and G12 (Hepler et 
a!, 1992; Simon et al, 1991; Watson & Arkinstall, 1994). 
The common architectural design shared by all G proteins, and the fact that 
they perform the same biochemical reaction, indicates their probable origin from a 
single progenitor. Most G proteins contain motifs of amino acid sequence that are 
conserved across the entire G protein superfamily. In the primary structure of each G 
protein these motifs appear in the same order, although spacing between them may 
differ. Figure 1.4 schematically depicts a G protein with conserved domains GI to G5. 
Other regions of importance, for example, the 14-carbon myristic acid residues may be 
post-translationally added to the second glycine residue of some G proteins after 
cleavage of the N-terminal methionine to anchor the protein on the under-side of the 
plasma membrane. Cholera Toxin (CT) modifies G proteins by transfering the ADP-
ribose moiety from NAD to the so-called cholera toxin site (CTx) site to block the G 
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Figure 1.4 Schematic representation of generalised Ga  protein showing domains likely to be 
important for interaction with receptor (Rec), effector and 3y dimers. Also indicated are sites for 
myristoylation and ADP-ribosylation by cholera (CTx) and pertussis toxins (PTx). Shown within 
effector region are three zones identified within G as  as particularly important for interaction with 
adenylate cyclase (AC). Conserved regions probably important for binding guanine nucleotides and 
GTPase activity are denoted by 01 to 05. Reproduced and modified from Watson eta!, 1994. 
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protein in an active GTP-bound conformation. Pertussis toxin (PT) on Ga chains 
operates by ADP-ribosylating the Pertussis Toxin site (PTx) site thus uncoupling the 
heterotnmeric G protein from its receptors. Two effector binding sites are important 
for interaction with adenylate cyclase (AC): the C-terminus is important for receptor 
interaction and the N-terminus for interaction with J3y dimers (Bourne, 1993; Watson 
eta!, 1994). A generally accepted model for G protein activation is illustrated in Figure 
1.5. The model is mainly based on studies performed with hormone-stimulated 
adenylate cyclase by Ga s  protein and light-activated retinal rod cyclic GMP-
phosphodiesterase (PDE) by transducin (G at) (Bourne, 1993; Bourne et al, 1991; 
Watson et al, 1994). 
1.4.2 Heterotrimeric G proteins in parasites 
Heterotrimeric G proteins have been detected in a variety of parasites, including 
trypanosomes (Coulter & Hide, 1995; Oz, 1994), Toxoplasma gondii (Halonen et a!, 
1996), trematodes (Mansour & Mansour, 1986; Mansour & Mansour, 1989) and 
filarial nematodes (Grant et a!, 1997). Studies of the liver fluke Fasciola hepatica found 
that activation of fluke adenylate cyclase by serotonin was dependent on GTP and that 
F. hepatica also contained Ga proteins of similar molecular weights which could be 
labelled by bacterial toxin ADP-ribosylation (Mansour et al, 1986). Studies in 
Schistosoma mansoni produced similar findings (Mansour et al, 1989) and a Gas-like 
gene from S. mansoni has been cloned which shows a 65% amino acid match with 
bovine G (Iltzsch, 1992). Stage-specific differences in the level of expression of Ga 
and switches of G protein class have also been revealed by Western blot and RT-PCR 
experiments in Acanthoheilonema viteae (Grant et a!, 1997), Brugia pahangi, 
Onchocerca ochengi and Trypanosoma cruzi. However the G proteins have not been 
linked to a role in regulating the adenylate cyclase signal transduction system in T. 
cruzi so far (Coulter et a!, 1995; Oz, 1994). A recent study of G proteins in T. gondii, 
indicated the binding of radiolabelled GTP to molecules corresponding in molecular 
weight to Ga and the cholera toxin-induced ADP-ribosylation of a molecule of —45 
kDa (Halonen et al, 1996). Similar, unpublished experiments done in this laboratary 
indicate that heterotrimeric G-proteins may also exist in P. falciparum (Arnot and 
Shah, unpublished). 
1.4.3 Other members of the GTPase family which are not part of 
membrane-associated complexes. 
Evidence from the 3-D structure of guanine nucleotide binding domains of ras 
p21 and EF-Tu have indicated that the five stretches of amino acid sequences which 
define the GTPase superfamily form part of the guanine nucleotide binding pocket of 
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Figure 1.5 	The G protein cycle, coupling hormone receptor (R) to its 
effector (E). Binding of hormone (H) to its receptor causes the G protein to 
exchange GDP for the GTP, which activates the G protein. The G protein then 
dissociates, after which the GTP-bound Ga (a) diffuses through and 'along' 
the membrane and binds to an effector thus activating it. The switch is on. 
Later, the Ga hydrolyses GTP to GDP and inorganic phosphate (Pi), thereby 
inactivating itself. The Ga will then reassemble with the Gfr1 (f,y)complex. 
The switch is then off. The Gay complex then returns to resting state 
associated with the plasma membrane. 
GTPase (Neer & Smith, 1996; Valencia et al, 1991). Although structural features of 
the basic switch are highly conserved, individual members of the superfamily 
communicate with specific proteins which may regulate the cycle and/or respond to 
regulation by different conformations of GTPase itself (Table 1.1). Within the families 
of G proteins, defined by amino acid sequence homology, the individual G proteins 
turn out to perform similar or closely related functions (Bourne, 1993; Hall, 1990). 
Structurally, members of each family resemble one another much more closely than 
they resemble members of other families. Thus the Ga proteins transduce signals 
between ligand-regulated receptors and effectors. The elongation and initiation factors 
(EFs & ifs) of ribosomal protein synthesis use their G protein cycle in a different way 
to catalyse and monitor assembly of complex macromolecular structure. The signal 
recognition particle family are components of the machinery that translocates 
polypeptides into the endoplasmic reticulum. The tubulin and cytoskeletal motor G 
proteins trigger the a and P tubulin polymerisation to form microtubules. 
The small, monomeric subclass of G proteins are all structurally related to 
proteins encoded by Ras proto-oncogenes. This group has been subdivided into at 
least five families—Ras, Rab, Rho, Ran and the ADP-ribosylation factors (ARFs). 
They control a wide variety of cellular processes, serving to monitor and control much 
of the information flow in eukaryotic cells. Some members of this group also play an 
important part in control of the function of the cytoskeleton and are central to the 
regulation of traffic between various membrane-bound compartments in the cell. The 
GTP-GDP cycling is controlled by three different classes of effectors (guanine 
nucleotide exchange factors, GEFs, which switch the GTPase on; GTPase activating 
proteins, GAPs which switch it off, guanine nucleotide dissociation stimulators or 
inhibitors, GDS  or GDIs, which protect it from switching). A P. falciparum RanJTC4 
and its possible GEF, RCC1 have recently been studied in this laboratary (Ji et al, 
1998; Sultan et al, 1994). Experiments on their biochemical and cellular functions in P. 
falciparum will be discussed in this thesis. 
1.5 The control of gene expression in P. falciparum 
Since this thesis is concerned with the genes and proteins involved in the 
control of malaria parasite development and cell cycle, it is necessary to review current 
knowledge on the activation of specific gene transcription in higher eukaryotic systems 
with a view to integrating what is known about P. falciparum gene activation into this 
body of knowledge. 
1.5. 1 General mechanisms of eukaryotic transcriptional activation 
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Table 1.1 GTPase families 
Family 	 Example(s) 
Heterotrimeric 0-proteins 
(hormonal and sensory signalling) 
Initiation and elongation factors 
(ribosomalsynthesis) 
the stimulatory regulator of adenylate cyclase. 
Gt (transducin) mediates retinal phototransduction. 
the inhibitory regulator of adenylate cyclase and the 
activator of phospholipases. 
EF-Tu proof-reads association between the TURNA protein 
codon and the anticodon of aa-tRNA. 
SRP/SR family (translocates polypeptides SRP54, a GTPase component of the SRP. 
into the ER) 
Tubulins and cytoskeletal motor GTPases cc and f3 tubulin polymerise to form microtubules. 
Monomeric (ras-related) small GTPases 
Ras family (proliferation, differentiation) ras p2!, oncogenic in many cells. 
Rab family (vesicle traffic) 	 Sec4 regulates late stage of secretion in S. cerevisiae. 
ARF family (vesicle traffic) 	 Sari regulates budding from the ER. 
Ran family (protein and mRNA transport) Ran/TC4 regulates protein and mRNA nuclear import and 
export. 
Rho family (assembly and function of 	Rho-A stimulates formation of actin stress fibres. 
actin cytoskeleton) 
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Activation of transcription requires a complex interplay between enhancer 
sequence-binding factors and components of the general transcription machinery. 
None of the genes discussed here have yet been identified in P. falciparum but it is 
likely that many functionally homologous genes exist and that the projected complete 
sequence of the P. falciparum genome will allow rapid progress to be made in this 
area. Co-factors are required for relaying specific activation signals to the RNA 
polymerase II transcription complex in order to achieve enhanced levels of mRNA 
synthesis. Two distinct types of DNA elements, core promoter sequences and arrayed 
enhancers are also important. The core promoter specifies the accurate initiation site of 
transcription whereas enhancers appear to direct the spatial and temporal patterns of 
gene-selective transcription. The core promoter is also thought to serve as an anchor 
point for tethering the general transcription machinery, a multiprotein complex 
comprising the basal transcription factors TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
TFIIH and RNA Polli (reviewed in Roeder, 1996). 
Three distinct classes of cofactors, upstream stimulatory activity factor (USA), 
mediator, and TBP-associated factors (TAF5), are required to potentiate gene-specific 
transcription directed by enhancer-binding factors. USA, which has the ability to bind 
DNA, was first identified as stimulating activator-dependent transcription in vitro and 
then subsequently found to either repress basal levels or potentiate activated levels of 
transcription. For instance, PC4 is able to bind single stranded DNA and repress basal 
transcription and enhance activated levels of transcription (Kaiser et al, 1995; 
Kretzschmar et at, 1994). The mediator is a multiprotein complex associated with 
RNA Polymerase H (RNAP II) which is able to potentiate transcriptional activation by 
certain activators in vitro, such as Lupressors of RNA polymerase B (SRBs), GAL  1 
and 51N4 (Chao et at, 1996; Maldonado et at, 1996). Interaction of GAL l 1 protein 
with the DNA-binding domain of the yeast activator GALA is able to stimulate 
transcription in yeast, by recruiting the mediator/RNA polyll complex to its promotor 
(Barberis et at, 1995; Farrell et at, 1996). But it is still unclear what mechanism allows 
the mediator to stimulate transcription. 
In contrast to USA and mediators, TAFs are generally required only for 
activator-dependent transcription. They have been shown to directly interact with 
activators. In vitro reconstitution of TFILD complexes from recombinant TAF subunits 
helped to establish the functional relevance of this TAF/activator interaction. Several 
different classes of activators have been shown to support activation of transcription in 
vitro only in the presence of the TAFs targeted by these activators. The simultaneous 
interaction of different activators with distinct TAFs contributes to synergistic 
activation of transcription (Sauer et at, 1995; Sauer et al, 1995). Thus, TAFs do not 
work as generalized cofactors but rather as activation-domain-specific coactivators. 
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Interestingly, the SNF/SWI (ucrose non-fermenting I mating typeswitch) complex 
which is responsible for chromatin remodelling has also been found as a component of 
the mediator (Wilson et al, 1996). The SWIJSNF complex is highly conserved among 
different organisms and is itself comprised of more than 11 distinct polypeptides. The 
SNF2/SWI2 protein is one of the key components in the complex and appears to serve 
as its energy motor. A P. falciparum homolgue of SNF2/SWI2 has been cloned and 
characterised and is reported in this thesis. It constitutes one of the first tools to initiate 
studies in the control of P. falciparum transcription. 
1.5.2 The role of chromatin in the control of transcription 
In the 25 years since the discovery of nucleosomes (Kornberg, 1974) it has 
become clear that nucleosomes organised into chromatin, play the central role in 
transcriptional regulation (Lewin, 1994; Paranjape et al, 1994). In eukaryotes the 
nucleosome consists of 146 base pairs of DNA wrapped twice around an octamer of 
core histones. Although the nucleosomal organisation of chromatin is generally 
considered universal in eukaryotes, there is at least one report of a lower eukaryote, the 
dinoflagellate Gyrodinium cohnii, lacking nucleosomes (Bodansky et al, 1979). In 
Entamoeba histolytica and Trypanosoma brucei, nuclesome-like filaments have been 
reported. Significant structural differences may exist between the chromatin of these 
protozoan parasites and that of higher eukaryotes (Bender et al, 1992; Torres-Guerrero 
eta!, 1991). 
Little is known about the organisation of nuclear DNA structure in malaria 
parasites. Electron micrographs of chromatin prepared from Plasmodium knowlesi 
show a beaded fibre structure suggesting the presence of nucleosome filaments similar 
to higher eukaryotes (Wunderlich, 1980). However, these data are not entirely 
conclusive, since structures that appear similar to nucleosomes in electron micrographs 
can be detected even in the absence of histones (Sinha et al, 1982). Cary and collegues 
(1994) demonstrated that micrococcal nuclease digestion of chromatin in isolated P. 
falciparum nuclei yielded a ladder of DNA fragments characteristic of nucleosomal 
organisation. In addition, they identified a set of major proteins from P. falciparum 
nuclei that are similar in size and charge to histones of other eukaryotic cells. 
Furthermore, the histone H2A, 112B and H3 genes have been identified in P. 
falciparum (Bennett et al, 1995; Creedon et al, 1992). These histone genes of P. 
falciparum are closely related to histones of other lower eukaryotes such as yeast. A 
chromatin-associated protein also has been isloated from P. berghei and is thought to 
be involved in the dynamics of chromatin packaging (Birago et al, 1996). 
In higher eukaryotic cell, the histone octamer is organised as a central tetramer 
of histones H3 and H4 flanked by two heterodimers of histories H2A and H2B. In 
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vivo and in vitro studies indicate that nucleosomes repress transcription by blocking 
the access of both the general transcription machinery and regulatory factors to their 
DNA sites. For example, one face of the DNA helix is completely concealed upon 
association with the histone core and the structure of DNA is changed dramaticly upon 
wrapping around the histone proteins. Several trans-acting factors, such as the yeast 
positive regulator PH04, have been shown to be blocked from binding their preferred 
sequences when presented in a nucleosomal context. 
There appear to be both replication-dependent and replication-independent 
pathways to cope with the nucleosome-mediated repression of transcription (Quinn & 
Peterson, 1997). In the replication-dependent mechanism transcription factors bind to 
the DNA template immediately following passage of the replication fork and prior to 
the assembly of the freshly replicated DNA into chromatin, thus preventing the 
formation of repressive chromatin structures. In the replication-independent pathway 
promoter regions are assembled into organised nucleosomal arrays following 
replication. Such repressive chromatin structures must then be directly disrupted and 
there is now evidence that a distinct class of transcriptional co-activators exist, whose 
primary role is to reconfigure chromatin structure (see below). Thus, the RNA 
polymerase transcription complex, associated activating factors, and chromatin are part 
of a single system for regulating eukaryotic gene expression. 
1.5.3 Alleviating chromatin-mediated repression of transcription 
A fundamental question in molecular biology is how the transcriptional 
machinery competes with the chromatin structure of eukaryotic DNA to activate gene 
expression. The specific binding of transcriptional activators disrupts nucleosomal 
arrays, suggesting that the primary steps leading to transcriptional initiation involve 
interaction between activators and chromatin. The affinity of transcription factors for 
nucleosomal DNA is determined by the location of recognition sequences with 
nucleosomes, and by the cooperative interactions of multiple proteins targeting binding 
sites contained within the same nucleosomes. Therefore, a network of linkages 
between chromatin and transcription have been proposed (Hampsey, 1997; Kadonaga, 
1998) as depicted in Figure 1.6. 
1.5.4 Chromatin remodeling machines 
Except for the work reported in this thesis, none of the genes and proteins 
involved in chromatin remodelling have yet been identified in malaria parasites. 
However, although this literature is large and complex, it forms part of the background 
to the experimental work of this thesis and since it will ultimately need to be 
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Figure 1.6 	Schematic diagram of potential linkages between 
chromatin and chromatin modifying machines. 
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assimilated into our understanding of P. falciparum molecular biology, it is reviewed 
here in some detail. 
Experiments in flies, yeast and human cells have uncovered a set of multi-
protein chromatin remodeling machines, which are good candidates for promoter 
restructuring factors. These complexes include the yeast SWJJSNF complex, yeast 
RSC complex, Drosophila nucleosome remodelling factor (NURF), Drosophila 
chromatin assembly complex (CHRAC), Drosophila assembly chromatin factor 
(ACF), Drosophila braham (BRM) complex, as well as mammalian brm-related gene 
1(BRG1) protein or the hbrm-associated complex (Cairns, 1998; Cairns et al, 1996; 
Cote et al, 1994; Ito et al, 1997; Kadonaga, 1998; Tsukiyama & Wu, 1995; Varga-
Weisz et al, 1997; Wang et al, 1996). Each contain a subunit homologous to DNA-
dependent ATPases (SWI2/SNF2 in the yeast SWIJSNF complex, STH1 in yeast 
RSC, ISWI in Drosophila NURF, CHRAC, and ACF, Drosophila BRM and 
mammalian BRG1 or hbrm). All complexes tested demonstrate ATP-dependent 
chromatin perturbation. The presence of this ATP-dependent subunit in the different 
factors suggests that it may carry out a related biochemical function in each complex. It 
has been postulated that the ATP-binding subunit might act as an ATP driven DNA-
translocating motor that disrupts histone-DNA interactions. For instance, the purified 
yeast SWIJSNF complex was found to be able to induce perturbation of histone-DNA 
interactions in a mononucleosome and to facilitate binding of GAL4-AH to a 
mononucleosome. These transcription activating chromatin remodeling machines form 
part of the subject of this thesis and will be discussed further. 
The RNA polymerase II (RNA pol II) holoenzyme composition controversy 
As discussed previously, the RNA pol II holoenzyme has been considered to 
be an RNA p01 II - SRB - mediator complex. An intriguing connection between this 
holoenzyme and the SWIJSNF complex was suggested by studies in which the 
SWIISNF complex was found to be an integral and equimolar component of the 
holoenzyme complex (Kingston et al, 1996; Struhl, 1996; Wilson et al, 1996). But 
there are some arguments about this conclusion, because components of SWIISNF 
complexes were not found in other preparations of mediator or holoenzyme (Cairns et 
al, 1996; Pan et a!, 1997). In these experiments, binding of the yeast mediator/ 
holoenzyme to a promoter with a GALl 1-PHO42 fusion protein was observed to 
induce nucleosome remodeling in vivo either in the presence or the absence of 
functionally active SWJJSNF complex (Gaudreau et al, 1997). In a recent report, an 
Escherichia co/i SW12ISNF2 homologue, RapA, has been identified which copurified 
with RNA pol II holoenzyme as a 1:1 complex. RapA forms a stable complex with 
RNA pol II and has ATPase activity which is stimulated by binding to RNA p01 H 
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(Sukhodolets & Jin, 1998). These data indicate that the nature of the interaction 
between the RNA p01 II holoenzyme and the SWIJSNF complex requires further 
clarification. The P. falciparum homologue of the RNA polymerase II has been cloned 
and characterised, could be used to further study interactions with P. falciparum 
SNF2/SWI2 homologue complexes. 
Histone acetyltransferases (HATs) and deacetylases (HDAs) 
The core histones, particularly H3 and 114, can be acetylated at the lysine 
residues in the N-terminal tails that extend outwardly from the globular core of the 
histone octamer. The function of this acetylation is not yet clear but it may be important 
on activating transcription. One theory is that charge neutralisation of the lysine 
residues reduces the interaction of the N-terminal tails with DNA and with nonhistone 
repressor proteins (Turner et al, 1992). A second is that the acetyl groups act as a 
signal for interaction of histone with other proteins, resulting in disruption of 
nucleosomes. 
Recently, there has been progress in the identification of histone 
acetyltransferases (HATs) and histone deacetylases (HDAs) that can catalyze the 
acetylation and deacetylation of histone (reviewed in Grant et a!, 1998; Hampsey, 
1997; Kadonaga, 1998). Nuclear HATs include a basal transcription factor 
(TAFII250) and transcriptional co-activators (GCN5, p300/CBP, P/CAF, and SRC 1). 
In addition, the RPD3-related HDAs appear to participate in transcriptional repression 
(Grunstein, 1997; Pazin & Kadonaga, 1997). These findings suggest that the HAT 
and HDA activities are an important component of transcriptional regulation. It remains 
to be determined whether it is the acetylation and deacetylation of core histone and/or 
other proteins that is responsible for the transcriptional effects. 
The yeast GCN5 protein has been found in at least two distinct, multiprotein 
complexes that possess HAT function. For example, a 1.8 MDa complex, termed 
SAGA (PT-DA-CN5-cetyltransferase), appears to contain SPT3, SPT7, SPT8, 
SPT20/ADA5, ADA2 ADA3 and GCN5. A combination between mutations in 
components of the SAGA complex and mutations in components of SWIJSNF 
complex is severely deleterious in yeast (Roberts & Winston, 1997). However, none 
of the known components of the SWJJSNF or SAGA complexes are essential for 
mitotic growth in yeast which implies that the complexes may function in a cooperative 
manner. None of these genes have yet been identified from P. falciparum. 
Chromatin assembly factors 
Chromatin assembly is a fundamental biological process that is required for the 
duplication and the maintenance of the genome (Ito et a!, 1997; Kaufman, 1996; Roth 
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& Allis, 1996). In actively dividing cells, chromatin assembly is required to package 
the newly synthesised DNA into chromatin, whereas in long-lived quiesent cells such 
as mammalian neurons, chromatin assembly is needed to maintain the integrity of the 
genome upon turnover of the histones. The core chromatin assembly machinery that is 
required for the ATP-dependent assembly of periodic nucleosome arrays appears to 
comprise a protein complex termed ACF (ATP-utilising  hromatin assembly and 
remodeling factor) (Ito et al, 1997). ACF was purified from Drosophila embryos and 
found to be a multiprotein factor that contains ISWI, a protein that is a member of the 
SW12/SNF2 family. The finding that ACF contains an ISWI subunit and can function 
as a chromatin remodeling factor suggests links between chromatin assembly, 
chromatin remodeling, histone acetylation and deacetylation and transcription (Figure 
1.7). A small subunit of CAF-1, a histone chaperone for chromatin assembly, has also 
been found to be identical to a protein that is associated wth a histone deacetylase and 
closely related to a protein that is associated with the HAT1 histone acetyltransferase 
(Kaufman et al, 1997). None have been identified in P. falciparum. 
1.5.5 SNF/SWI complex and its related complexes 
It could be argued that none of the above information is relevant to the malaria 
parasite which may organise its gene expression quite differently. However, data 
presented in the experimental chapters of this thesis indicates that this is unlikely to be 
the case. A P. falciparum homologue of one of the key components of a chromatin 
remodelling complex has been clearly identified (ii et al, 1997). This protein is an 
ATPase associated with the SNF/SWI type chromatin remodelling complex. 
The SWI/SNF complex is a macromolecular complex of _2 MDa which is 
composed of at least 11 subunits (Cairns et al, 1994; Peterson et a!, 1994). Several 
members of yeast SWJJSNF complex were identified for the purpose of identifying 
important regulators of RNA polymerase II in genetic experiments (Neigeborn & 
Carlson, 1984). Mutations in the SWIISNF genes are supressed by mutations in genes 
coding for the nucleosome core histones and HMG1-like protein, SIN 1ISPT2 (Kruger 
et a!, 1995). Chromatin remodelling does not occur at SWIJSNF-dependent promoters 
in yeast swi/snf mutants (Hirshhom et al, 1992). Purified yeast SWL/SNF complex 
mediates ATP-dependent chromatin restructuring in vitro (Cote et al, 1994). The 
human SWI/SNF complexes display biochemical activities similar to their yeast 
counterparts in vitro and have been linked to both transcriptional activation and cell 
cycle control (Kingston et al, 1996). In addition, a related complex from Drosophila 
has been identified which is important in the regulation of homeotic gene transcription. 
Furthermore, an abundant yeast complex RSC (Lemodels the structure ofchromatin) 
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Figure 1.7 The SNF2-like family of proteins. (Adapted and modified from 
Kadonaga. et a!, 1997). 
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components of SWIJSNF (Cairns et al, 1996; Treich & Carlson, 1997). Unlike 
SWI/SNF, RSC is essential for mitotic growth and although its genetic targets remain 
unidentified, the greater abundance of RSC (10-10 molecules/cell) suggests that this 
complex may be required for activities such as transcription or replication which 
involve the remodelling of large numbers of nucleosomes (Cairns et al, 1996; Treich et 
al, 1997). 
There are three different remodelling complexes in Drosophila, NURF, 
CHRAC and ACF, that each contain an ISWI subunit. NURF can facilitate the ATP-
dependent binding of transcription factors, e.g. GAGA factor and GAL4, to chromatin 
templates (Pazin et al, 1994; Tsukiyama et a!, 1995). Purified NURF is composed of 
just four subunits and requires ATPase hydrolysis to function. Unlike SWIJSNF, the 
ATPase activity of NURF is stimulated more significantly by the presence of 
nucleosomes than by free DNA or core histones alone, suggesting that NURF is 
capable of detecting some unique feature of nucleosome organisation (Tsukiyama et al, 
1994; Tsukiyama et al, 1995). CHRAC was identified on the basis of its ability to 
mobilise nucleosomes in a manner that allows enhanced access of a restriction enzyme 
to DNA packaged into chromatin. Extensive fractionation yielded CHRAC, a complex 
of five proteins. Unlike other known chromatin remodeling factors, CHRAC can also 
function during chromatin assembly. It uses ATP to convert irregular chromatin into a 
regular array of nucleosomes with even spacing. CHRAC combines enzymes that 
modulate nucleosome structure and DNA topology (Varga-Weisz et al, 1997). As 
mentioned previously ACF uses ATP to assemble properly spaced arrays and to 
facilitate activator binding to chromatin. It can mediate promoter-specific nucleosome 
reconfiguration by Ga14-VP16 in an ATP-dependent manner. These results suggest 
that ACF acts catalytically both in chromatin assembly and in the remodeling of 
nucleosomes that occurs during transcriptional activation (Ito et al, 1997). 
Surprisingly, NURF, CHRAC and ACF all contain the ISWI (initiation SWI2) 
ATPase (Tsukiyama et al, 1995), which was originally isolated by homology to SWI2 
and encodes the ATPase component of the yeast SWJJSNF complex. ISWI and SWI2 
are both members of the SWI2/SNF2 family of DNA-dependent ATPase. 
Interestingly, several large complexes each containing the ISWI subfamily member 
hSNF2L have been found in human cells (Wang et al, 1996; Wang et al, 1996). They 
could represent human counterparts of NURF, CHRAC and ACF and it is possible 
that all these large intra-nuclear complexes exist within the nucleus of all eukaryotic 
cells including P. falciparum. 
1.5.6 SNF2/SWI2 and related proteins 
MI 
SWI2/SNF2 proteins are a gene family whose members probably have 
different functions (Table 1.2). The SWI2/SNF2 proteins contain the seven conserved 
motifs, which could bind the nucleotide triphosphate (NTP), similar to those found in 
many DNA or RNA helicase protein families (Bork & Koonin, 1993). Comparative 
amino acid sequence analysis revealed that this group of helicases and related proteins 
comprises at least three superfamilies, which in turn can be further divided into 
families and subfamilies (Bork et al, 1993; Eisen et al, 1995; Gorbalenya & Koonin, 
1993). The SNF2 family has been assigned to helicase superfamily 2, which also 
includes the ERCC3, RAD3, PRIA, eIF4A and PRP16 protein families. The 
conserved structure of these proteins may reflect a similar mechanism of action (Eisen 
et al, 1995). 
Members of the SNF2-like family exhibit considerable range of biological 
functions. These activities include gene-specific transcriptional regulation (SNF2 
subfamily), transcriptional repression (MOT1 subfamily), destabilisation of 
recomposed nucleosomes (SNF2 and SNF2L subfamilies), transcription-coupled 
repair (ERCC6 subfamily), nucleotide excision repair of non-transcribed regions of the 
genome (RAD16 subfamily), recombination repair (RAD54 subfamily), chromatin 
modification and negative regulation of cellular growth (CHD1 subfamily), 
developmental regulation and UV protection (ETL1 subfamily) and chromosome 
segregation (lodestar) (Eisen et at, 1995). In spite of the presence of the conserved 
helicase-like motif in these proteins, however, helicase activity has not yet been 
detected in any SNF2-like family member. The sequences within the proposed 
subfamilies are more related to each other than to any other characterised proteins, 
including other members of the SNF2-like family (Eisen et at, 1995). SNF2-like 
family members are also involved in many human diseases (Ellis, 1997). Human 
ERCC6/CSB mutations result in Cockayne's syndrome, which is characterised by 
growth deficiency, skeletal abnormalities, photosensitivity, mental degeneration, 
characteristic facies, cataracts and dental cavities (Troelstra et at, 1992). In addition, 
mutations in the human ATR-X gene, assigned in the RAD54 subfamily, cause a 
combined c-thalassemia, mental retardation syndrome, developmental delay and 
genital abnormalities (Gibbons et at, 1995). 
The available evidence on SWI2/SNF2, STH1, NOT1 and ISWI suggest, as 
proposed earlier, that these factors may function as ATP-driven motors that translocate 
along DNA and destabilise protein-DNA interactions. The movement of these proteins 
along DNA is likely to be similar to the ATP-dependent translocation of helicases 
along nucleic acids. A model proposed by Pazin and Kadonaga (Pazin & Kadonaga, 
1997) suggests that a DNA-translocating protein uses the energy derived from 
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Table 1.2 SNF2 Families 
Proposed protein 	No. of 	Species 	Possible functions/comments 
subfamily 	 amino acid 
S.cerevisiae 	Transcription activation. DNA-dependent ATPase. Alters 
chromatin structure 
S.cerevisiae 	Cell cycle control. Required for normal growth 
D.melanogaster Transcription activation of homeotic genes 
Mouse 	 Binds retinoblastoma protein 
Human Transcription co-activation with hormone receptors 
Human 	 Transcription co-activation with hormone receptors 
P.falciparum 	? 
Human 	 ? 
D.melanogaster DNA remodeling 
C.elegans 	? 
S.cerevisiae 	? 
Human 	 Causes ATR-X syndrome. Interacts with EZH2 protein 
Mouse 	 Binds DNA, modify chromatin structure 
S.cerevisiae 	? 
S. pombe 	A negative regulator of cellular growth 
Mouse 	 Expressed very early in development. Concentrated 
in CNS and epithelium 
S.cerevisiae 	Mutants have increased UV resistance 
S.cerevisiae 	Transcription repression. Removes TBP from DNA 
Human 	 Transcription repression. Removes TSP from DNA 
S. cerevisiae 	Transcription-coupled repair 
Human 	 Transcription-coupled repair. Defective in Cockaynes 
syndrome group B 




Mouse 	 ? 
S.cerevi Si am 	Nucleotide excision repair of silent genes 
S.cerevisiae Post-replication repair. GT repeats more stable in 
mutants 
S.pombe 	Mutants have increased sensitivity to UV and gamma 
irradiation 
Human 	 DNA-dependent ATPase. Binds HIV and SPH motifs of SV40 
enhancer. Aberrantly regulated in malignant cells 
Mouse 	 Activates the transcrition of the PAl-i gene specificly 
A. californica Viral encoded protein 
D.melanogaster Mutants have excessive chromosome breakage and tangling 
in mitosis 
None 	HepA 	968 	 E.coli 	 Induced by DNA damage 
None 	RapA 	990 	 E.coli 	 Associated with RNA Pol 
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a partial disruption of the nucleosome at any particular point. This sort of process 
could account for the ATP-dependent destabilisation of nucleosome structure and 
facilitated transcription factor binding that has been shown in vitro with SWIJSNF 
complex, RSC, ACF, or NURF (Pazin et al, 1994; Tsukiyama et at, 1995; Varga-
Weisz et at, 1997). Also, the translocation of these proteins could facilitate changes in 
nucleosome positioning, as seen with nucleosome arrays in vitro. Hence, this ATP-
driven DNA translocation mechanism seems to be consistent with the available data on 
the properties of the SNF2-like family members. 
1.6 The aims of the research presented in this thesis 
The interest of this laboratory in signal transduction pathways led to a series of 
preliminary experiments to study the possible role of the heterotrimeric G protein 
signalling pathways which are involved in the regulation of the cell cycle of the malaria 
parasite Plasmodium falciparum. The first task was attempt to isolate a Ga protein 
gene in order to initiate the study. At the same time, other work to complete the 
cloning of the malaria RCC 1-like gene and further characterise its cellular functions 
was carried out. 
In the course of experiments to clone genes for the Ga protein a gene for a P. 
falciparum SNF2-like protein, a putative global transcriptional regulator involved in the 
chromatin remodelling was identified, termed PfSNF2L. These transcription factors 
play a very important role in the regulation of cell cycle and are linked with many 
signalling pathways. Many reports recently published also indicate that the SNF2-like 
family members play a key role in the regulation of transcription and are involved in 
many cellular activities. Therefore, the primary aims of the project moved towards the 
cloning and characterise the PJSNF2L gene at the molecular and biochemical level. In 
order to provide a more biological and less purely gene-oriented basis for studying P. 
falciparum cell cycle regulation, experiments studying the effects of heat shock and 
drug inhibition on cell cycle progression were carried out. Finally, some computational 
analysis of P. falciparum regulating sequences was carried out, a by-product of the 
work on transcription and gene activation. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Parasite, erythrocyte and bacterial sources 
Plasmodium falciparum strains 3D7A, Dd2, Ki and HB3B were used in this 
work. These clones are kept in the WHO Registry of Standard Strains of Malaria 
Parasites in the Centre for Parasite Biology, ICAPB, University of Edinburgh. 
Fresh human whole blood, group 0, Rh+,  in citrate phosphate dextrose-
adenine pack used for the parasite culture was supplied from Edinburgh and South-
East Scotland Blood Transfusion Service. The blood was washed and centrifuged at 
1500g three times in incomplete RPMI medium to remove leukocytes and the 
preservatives. The 'buffy coat' of the white blood cells was removed from the red 
blood cell (RBC) pellet. The RBCs were resuspended in complete medium to a final 
50% haematocrit and kept at 4°C for up to one week (Hyde, 1993). 
The bacterial strains used in this study are listed in Table 2.1 
Table 2.1 Bacterial strains 
Strain 	 Genotype 	 Remark 
BL21 	E. co/i B V dcm ompThsdS (rB, mB) gal 	For high-level expression of genes cloned into 
expression vectors. (Studier and Moffatt, 1986). 
BL21 	E. co/i B V dcm ompT hsdS (rB , MB -) gal 
(DE3) (DE3) 
DH5a 	supE44 4/acU 169 (080 /acZtxM15) 
hsdRl7 recAl endAl gyrA96 thi-1 re/Al 
INVaF F endAl recAl hsdRl7 (rl( ,mk)supE 44 
thi -1 gyrA96 re/Al (080 /acZEM15) 
A(/acZYA-argF)U 169 deoR 2- 
For high-level expression of genes cloned into 
expression vectors containing bacteriophage 
T7 promoter. (Studier and Moffatt, 1986). 
For the recombinant DNA manipulation with 
blue/white screening on X-gal-IPTG plate. 
(Hanahan, 1983). 
For the recombinant DNA manipulation with 
blue/white screening on X-gal plate. 
(Invitrogen Co.). 
XL1-Blue supE44 hsdRl7 recAl endAl gyrA46 thi re/Al For the recombinant DNA manipulation with 
lac F [proAB 1aclqlacZb.MI5T nI0(tett)] 	blue/white screening on X-gal-IPTG plate. 
(Bullock et a/, 1987). 
2.2 eDNA libraries 
The Plasmodium falciparum asexual cDNA library used in this work were 
made from rings and late trophozoites in plasmid pJEF14 (a gift from Dr. A. Craig, 
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Oxford university). The RNA was prepared from ring and trophozoite stage of line 
ff04 parasites. 
2.3 	Oligonucleotide primers used in this study 
Oligonucleotide primers used in this study were synthesised by the Oswel 
DNA Service, Department of Chemistry, University of Southampton. The sequence of 
the primers are given in Table 2.2. 
Table 2.2 Oligonucleotide primers used in this course of studies 
Name 	 Sequence 
Sequencing primers 
-40M13, (+)a 5'GccAGAcC3 
M13 reverse,(-) 5'-CAGGAAACAGCTATGAC-3' 
pJFE-14, (+) 5 -TCTAGAGATCCCTCGACCTC-3' 
pJFE-14, (-) 5 -CGCGGCGTCCAGCGCCGGC-3 
T7 promoter 5 -TAATACGACTCACTATAGGG-3 
PGEX, (+) 5 -GGGCT3GCAAGCCACGT'I'TGGTG-3 
PGEX, (-) 5' -CCGGGlGCTGCATGTGTCAGA3G-3 
G-protein 	degenerate 	primers 
gpl, (+) 5'-AA(A/G)TGGAT(A/C/T)CA(C/T)TG(C/T)Tr-3 
(-) 5-(A/G)TC(A/G/T)AT(C/T)Pr(A/G)Tr(A/G/T/C)AA(A/G)AA-3 
(-) 5-(A/G)T(A/G/T)AT(C/T)rr(A/G)r(T/C)AA(A/G)A-3' 
gifi, (+) 5-GG(A/T)GC(A/T/C)GG(A/T)GA(G/A)TC(A/T/C)GG(A/T)A-3 
g1f2, (+) 5-GG(A/T)GC(A/T/C)GG(A/T)GA(G/A)AG(T/C)GG(A/T)AA-3' 
g3fl, (+) 5-GP(T/C)G(T/C) (A/T/C)GG(A/T)GG(A/T)CA(A/G) (A/C)G-3 
g3rl, (-) 5'-C(T/G) (T/C)TG(A/T)CC(A/T)CC(A/T/G) (AIG)C(AIG)TC-3 
g4rl,(-) 5'-(A/G)TC(T/C)rT(T/C)'rr(A/G)T'r(T/C)AA(A/G)AA-3' 
g4r2, (-) 5'-(A/G)TC(T/C)Tr(T/C)r(A/G)Tr(A/G/T)AG(A/G)AA-3' 
g5rl, (-) 5'-(G/A/T/C)GT(A/G)TC(G/A/T/C)GT(A/T/G)GC(A/G)CA(G/A/T/C)GT 3 
PfSNF2L primers 
S6161, (+) 5 • -ArrC'rrcTGCrrGTGG'rTAGG-3 
S6162,(+) 5 -CGAAGTMAGCAATCM1ACCACC-3' 
S6163,(-) 5' -GC' rCATCTrCPCNITrGCATCC-3 
S6164,(-) 5 -GCTCGATCCA'r'rGCTPGTATATCC-3' 
S6165, (-) 5-Cc rCTAA1TAGrTCTrCCCC-3' 
S6166, (+) 5 -GGTATACAAGCAATGGATCGGC-3 
T0499,(+) 5 -GGGGAGAAACrATPrI1GAAGG-3 
T0500,(-) 5 -GGTGGTAA3ATTGCTCTACTrCG-3 
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T5777,(-) 5 -GTGCTPCTAPrAGTACATIG-3 
T5778,(-) 5-ACCTAACCACAAGCAGAAGAA-3 
T6118,(+) 5 -CAATGTACTAATAGAAGCAC-3 
V1425,(+) 5 -GTGCAAAAGAAGATGAAG-3 
V1426,(+) 5' -AA'rrGTTACACACAGTAcC-3 
V1427,(-) 5' -TGCTITrATATC'rI'CCATCG-3' 
V4436,(+) 5' -AACAGAAGAGGTGAAAACTG-3' 
V4437,(+) 5' -ATrGAATATCGATGTAGG-3' 
V4438,(-) 5' -AACCTACATCGATATI'CAAC-3' 
V4439,(-) 5 -ATrrGGTACAAAGPPATCAG-3 
PfSNF2L fusion protein primers 
V8616, (+) 5' -CGTGGATCCCTCTCAGAAGGAGTTGATAG-3' 
V8617,(-) 5' -CGCTCGAGCTAAGGGATAAAGTCTrGTG-3 
W7289,(+) 5' -AATTGTAGAGAGAGCAGCAAAGAAG-3' 
W7290,(-) 5' -CTTCTAAAATAGTrrCTTCCCCTGA-3' 
W7291,(+) 5' -ATGGAGAGCTGAAGCTAGAGGTGGT-3' 
W7292,(-) 5'- 	 -3 - 
W7293,(+) 5' -TGTAGAAAAGGATATAGCTAGTGTA-3' 
W7294,(-) 5' -CATATCTCAAAPTTGATGGTAGPTG-3 
DDRT-PCR PRIMERS 
M4854, (-) 5'-TrITTTrrrTrAG-3 
M4855,(-) 5'-rrPrrITrrrrAT-3 
M4856,(-) 5'- 	 -3 - 
M4857,(-) 5'-TTrrrrrrrrTCC-3' 
M4858,(-) 5'- 	 -3 - 
M4859,(-) 5'- 	 -3 - 
M4860,(-) 5.- 	 -3- 
M4861,(-) 5'- 	 AA-3' 
M4862,(-) 5'- 	 -3 - 
M4863,(-) 5'- 	 -3 - 






a. (+): sense strand; , (-): anti-sense strand 
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2.4 Chemicals and equipments 
Analytical grade standard laboratory chemicals and solvents were purchased 
from British Drug House (BDH) plc., and Sigma Chemical Co. Ltd., UK. 
Radioactive nucleotides were obtained by Amersham International plc. The sources of 
other materials are given in the text. 
Centrifugation was either carried out in a bench top centrifuge Biofuge 13 
(Heraeus, Germany) or Centrifuge 5410 (Eppendorf, Germany). Higher speed 
centrifugations were performed in Sorvall-RC5C-refrigerated centrifuge (DuPont, 
USA). The models and brands of other equipment are given in the text. 
2.5 General stock solutions, buffers and media 
All aqueous solutions were prepared in de-ionised glass-distilled water. pH 
values of solutions were measured with a pH meter model PW 9410 (Philips). 
Denhart's solution 	1% w/v Ficoll, 1% w/v BSA fraction V, 1% w/v 
(50x) 	 polyvinylpyrrolidone. 
DNA Loading Buffer 50 mM Na2 EDTA, 0.25% bromophenol blue, 0.25% xylene 
cyanol, 40% (w/v) sucrose in H20 and stored a small aliquots 
at 4°C. 
IPTG 	 Stock solution (0. 1M): dissolving 0.238 g IPTG in 10 ml 
dH20, filter sterilised and stored in imi aliquots at -20°C. 
Luna-Bertani 	1% Bacto-tryptone, 0.5% Bacto-yeast extract, 1% NaCl 
medium (LB) adjusted to pH 7.2 with 10 N NaOH in dH20. 
LB agar 	 LB medium with 1.5% agar 
LB-amp. 	 LB supplemented with ampicillin to 50 tg/m1 
M9 medium 	5x M9 salts (per litre): 2.5 g NaCl, 64 g Na2HP047H20, 15 
g KH2PO4, 5 g NH4C1 in dH20 to 1 litre and sterilised by 
filtration through 0.22 j.tM Nalgene filter. Working medium: 
200 ml 5x M9 salts, 20 ml 20% glucose and 780 ml sterile 
dH20 with or without 15 g bacto-agar. 
MOPS 	 lOx stock solution: 0.2 M 3-[N-Morpholino]- propane- 
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suiphonic acid, 0.5 M Na acetate pH7.0, 0.01 M Na2EDTA, 
H20 to 1 litre. lx working solution: (0.02 M morpholino-
suiphonic acid, 0.05M Na acetate, 0.001M EDTA) 
PBS 	 1 O stock solution: 80 g NaCl, 2g KC1, 11.5 g Na2HPO4 
7H20, 2 g KH2PO4 to 1 litre, working solution: 137 mM 
NaCl, 2.7mM KC1, 4.3mM Na2HP047H20, 1.4 mM 
KH2PO4, pH-7.3. 
Protease inhibitors 	Leupeptin 50 p.g/ml (in dH20), Chymostatin 10 jig/ml (in 
acetic acid), Pepstatin 10 p.g/ml in methanol, PMSF 200 mM in 
propanol, idoactamide 20 j.tg/ml in dH20, EDTA 500 mM, 
EGTA 500 mM. 
RPMI medium 	10.4 g of RPMI 1640, 5.94 g of HEPES, dissolved in 960 ml 
(incomplete) of distil dH20. Filtered through 0.22 p.M Nalgene filter and 
stored at 40C for up to four weeks. 
RPMI medium 	Was prepared by addition of 42 ml of Sodium bicarbonate, 
(complete) 	50 mg/nil gentamycin, and 40 ml heat inactivated human serum 
to 600 ml of incomplete RPMI medium. 
SDS 	 10% stock solution: 100 g is dissolved in 900 ml H20,  heated 
to 68°C and the pH was adjusted to p117.2 by HC1, and made 
up to 1 litre with dH20. 
2x SDS-loading 	Core buffer: 125 mM Tris pH6.8, 4% SDS, 20% glycerol, 
buffer (Studier 0.004% bromophenol blue in H20. Before use, 800 p.1 of core 
buffer) 	 buffer was mixed with 200 p.1 of 1 M Dithiothreitol 
SOC medium 	2% Bacto-tryptone, 0.5% bacto-yeast extract, 10 mM NaCl, 
2.5 mM KCI, 10 MM M920, 10  MM  M92SO4, 20 mM 
glucose in 1 litre dH20. 
SSC 	 20x stock solution: 175g NaCl, 88 g Na3 citrate2H20, 
adjusted to pH 7.0 and made up to 1 litre with dH20. 
working solution: (0.3 M NaCl, 0.03 M Na3Citrate2H20). 
TAE 	 50x stock solution: 242 g Tris base, 37.2 g Na2EDTA2H2O 
57.1 ml glacial acetic acid, dH20 to 1 litre. This solution was 
diluted 50 times to give lx working solution: 40mM tris 
acetate, 2mM EDTA. 
TBE 	 lOx stock solution: 108g Tris base, 55g boric acid, 40m1 
0.5M EDTA pH 8.0, dH20 to 1 litre. This solution was diluted 
10 times to give lx working solution: 89mM Tris base, 89mM 
boric acid, 2mM EDTA. 
TE buffer (lx) 	10 mM Tris-HC1 pH 8.0, 1 mM EDTA pH 8.0 
Transformation 	30 mM potassium acetate (30 ml of a 1M stock pH7.5), 100 
Buffer I (TFB I) mM RbC1 (12 g), 50 mM MnC1 2 2H20 (9.9 g), 10 mlvi 
(amounts/litre) 	CaC122H20 (1.5 g), 15% w/v glycerol (150 g), pH adjusted 
to 5.8 with 0.2 M acetic acid , Solution sterilised by filtration. 
Transformation 	10 mlvi MOPS (20 ml of a 0.5 M stock pH6.8), 10 mM RbCl 
Buffer II (TBF II) (1.2 g), 75 mM CaC1 2 2H20 (11 9), 15% (w/v) glycerol, 
adjusted with KOH to pH6.8 and sterilised by filtration. 
X-Gal 	 Fresh dry LB-amp. plates, spread with 25jil X-Gal (40mg/ml 
stock solution in dimethyl-formamide) 
Percoll gradient: 
Solution for gradient layers of 52.5%, 45% and 30% Percoll were made up in 
incomplete RPTvH medium as follows: volume of lOx conc. RPIvH medium was added 
to 9 volumes of stock Percoll (Sigma) to make an isotonic 90% Percoll solution. 
Then:- 
to 2 volumes of 90% Percoll, 1 volume of 1xRPMI was added to make 60% 
Percoll. 
to 1 volume of 60% Percoll, 1 volume of 1xRPMT was added to make 30% Percoll. 
to 1 volume of 60% Percoll, 1 volume of the 30% Percoll was added to make 45% 
Percoll gradient. 
to 1 volume of 60% Percoll, 1 volume of 45% Percoll was added to make 52.5% 
Percoll gradient. 
2.6 In vitro culture of P. falciparum. 
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2.6.1 Culture of asexual parasites 
P. falciparum parasites were grown under standard conditions (Hyde, 1993; 
Trager & Jensen, 1976; Zoig et al, 1982). Parasites were maintained in 5 ml complete 
RPM! medium (Sigma) containing washed 0 red blood cells (RBCs) at 5% 
hematocrit in 75 ml culture flasks. Cultures were typically initiated at a parasitaemia of 
0.5%. The cultures were gassed with a mixture of 1% 02,  3% CO2. and 96% N2 and 
incubated at 37°C. The medium was replaced with fresh pre-warmed medium daily. A 
drop of blood was taken by a Pasteur pipette and smeared on a slide. The smear was 
air dried, fixed by 100% methanol, stained with 5% Giemsa's solution (in Sorensen's 
buffer, pH7.2) for 40-45 min and the parasitaemia measured by microscopic 
examination. The cultures were diluted with fresh RBCs, when the parasitaemia 
arrived at 10-15%. 
2.6.2 Synchronisation of the parasites 
Three main techniques are available to obtain synchrony of different parasite 
stages: 1. treatment with sorbitol (Lambros & Vanderberg, 1979). 2. density gradient 
separation (Aley et al, 1986; Dulzewski et al, 1984). 3. exposure to high temperature 
(Kwiatkowski, 1989). In this study, synchronised cultures were obtained using the 
sorbitol treatment to destroy large parasites (trophozoites and schizonts) in 
erythrocytes, resulting in a synchronously growing population, starting from the 
remaining ring-forms. 
Cultures with low parasitaemia (about 1%) and a high proportion of ring-forms were 
used as starting material. Cultures were centrifuged in IEC Centra-MP4R rotor 215 at 
1000x g for 5 minutes, and the supernatant was discarded. The cells were then 
resuspended in 5% sorbitol solution in dH20 (10% [v/v]), and allowed to stand at room 
temperature for 5 minutes. The mixture was then centrifuged as above and the cells 
resuspended in complete RPMI medium. The centrifugation was repeated once more, to 
remove any residual sorbitol, and the cells were finally resuspended in RPMII medium at 
5% hematocrit (method 2.6.1). After 24 hours of culture, a blood smear was examined 
by Giemsa staining and microscopy. The culture should not contain ring-forms at this 
stage, but mainly trophozoites and maturing schizonts. Six hours later, another blood 
smear was examined and if a new generation of small rings was seen, a second sorbitol 
treatment was carried out as above to remove remaining trophozoites/schizonts. The 
culture was then monitored over 48 hours to ensure that it was synchronous. If not, more 
sorbitol treatments were carried out at times when the only ring-forms present were small. 
When cultures were fully synchronous, they were harvested for the desired experiments. 
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The sorbitol synchronised parasites could be further synchronised by percoll 
gradient. 5% mature schizonts (segmented) in 4 ml lx incomplete RPIVH medium was 










rings, trophozoits & uRBC 
The schizont layer was collected and washed 3 times with lx incomplete RPIvH 
medium then precipitated again. The mature schizont infected RBCs were resuspended 
in complete RPMI medium with fresh RBC to 2.5% hematocrit and done smear and 
giemsa stain again immediately. Another sorbitol treatment could be undertaken at this 
point to improve synchronisation of the parasites. 
2.6.3 Gametocyte culture 
Cultures were set up in 15 ml complete RPMI medium at 6% haematocrit and 
started at 0.5 to 0.7% parasitaemia in 75 mls flasks (Hyde, 1993; Ifediba & 
Vandenberg, 1981). Parasitised RBCs from asexual stock cultures at parasitaemia 
about 4% to 6% were used to ensure a high rate of commitment to sexual 
development. Cultures were gassed and maintained at 37°C. The medium was 
replaced daily with 15 ml of 37°C pre-warmed complete medium. 4 to 5 days after the 
start of each culturing, when a high parasitaemia had been reached, samples of the 
parasites were smeared, stained, and examined microscopically for morphological 
changes associated with gametocyte development, such as slightly triangular ring 
forms and early trophozoites in shape. When such signs were observed, the hematocrit 
was reduced to 3.6% by substituting with 25 ml of complete RPMT medium instead of 
15 ml. The gametocyte cultures were then maintained with daily medium changes of 
25 ml until the desired stage of maturity was reached, according to the Hawking et al 
classification (Hawking et al, 1971). Mature gametocytes were usually harvested 10 to 
17 days after the starting of the cultures. 
2.6.4 Purification of gametocytes 
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A high level gametocyte producing line, such as 3D7A, grown manually in 75 
ml culture flask ( as described in Methods 2.6.3), will produce 2-5 x 107 stage IV or V 
gametocytes. Gametocyte cultures were harvested by centrifugation at 2,300 rpm for 7 
mm. The cells were resuspended to a final haematocrit of about 20% in incomplete 
RPMI medium. Percoll gradients were prepared from the bottom up in 15 ml Corex 
tube (First 3 ml of 30% percoll, then 3 ml of 45% percoll, then 3 ml of 52.5% percoll, 
as described Methods 2.5). Finally 5 ml of harvested cells were overlaid on the top of 
the percoll gradient. The tube was then spun at 10,000 rpm in a 22°C Sorval 
centrifuge (RC's) for 10 mm. Mostly mature gametocytes were recovered from the 
interface between the 30% and 45% percoll layers, and immature gametocytes from the 
interface between the 45% and 52.5% layers. The recovered cells from each interface 
were resuspended in at least 5 volumes incomplete RPMI medium and washed once to 
move percoll. The cells were condensed in 1 ml incomplete RPMT for counting 
gametocyte numbers and for further total RNA isolation and Immunoflourescence 
assay (IFA). 
2.7 Preparation of parasite DNA, RNA and plasminds 
Unless otherwise noted, the molecular cloning techniques used were carried 
out as described in Sambrook et al. (1989). 
2.7.1 Preparation of P. falciparum genomic DNA 
5 ml of asexual stage culture at 5-10% parasitaemia were normally used for the 
genomic DNA preparation. Parasitised erythrocytes were pelleted by centrifugation at 
4,000 rpm for 10 minutes. The erythrocyte pellet was resuspended in 1 ml of 0.1% 
saponin in phosphate-buffered saline (PBS), and incubated at room temperature for 5 
minutes. The erythrocyte lysate was then transferred to a microcentrifuge tube and 
spun in a microcentnfuge for 5 minutes (10,000 rpm). The parasite pellet was 
collected and washed four times with 1 ml of ice-cold PBS to remove the residual 
ghosts of RBCs. The parasite pellet was then lysed by addition of 600 il of 10mM 
Tris-HC1 pH 7.6, 50mM EDTA pH 8.0, 0.1% SDS, lmg/ml proteinase K and 
incubated overnight at 50°C. The lysate was extracted twice with phenol/chloroform, 
then once with chloroform. DNA was then precipitated by adding 0.1 volume of SM 
sodium Acetate and 1 volume of isopropanol, and left to stand at room temperature for 
15 minutes. DNA was then collected by centrifugation, washed with 70% ethanol, 
dried and resuspended in 100 .tl of Tris buffer (10mM Tris-HC1, pH8.0). 
2.7.2 Plasmid DNA preparations 
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Mini-preparation of plasmid DNA: 
Plasmid DNA was prepared either by the SDS-Alkaline Extraction method as 
described by Sambrook et al. (1989) or QIAGEN Plasmid Mini Kit or QlAprep Spin 
Miniprep Kit (QIAGEN Inc.), according manufacturer's instructions. 
For automated sequencing, all the plasmid DNAs were isolated from E. co/i 
XL1-Blue host by using the QIAGEN Plasmid Mini Kit (QIAGEN Inc.) with the 
following modifications. Single colony was inoculated into 5 ml of LB broth 
containing 50 pg/ml ampicillin and grown overnight at 37°C with shaking. The 
bacteria from 3-5 ml of the overnight culture were collected by centrifugation at 13,000 
rpm for 2 minutes and resuspended in 300 j.il of Buffer P1 (10 mM EDTA, 50 mlvi 
Tris-Cl pH 8.0, 100 Jig/ml RNase A, pH 8.0). The cells were then lysed by the 
addition of 300 j.tl of Buffer P2 (0.2N NaOH, 1% SDS) and mixed gently by 
inversion of the tube several times. This was neutralised with 300 j.tl of chilled Buffer 
P3 (3.0 M potassium acetate pH 5.5), mixed immediately, and incubated on ice for 10 
mm. In order to pellet precipitated bacterial debris, the solution was centrifuged at 
13,000 rpm for 15 minutes. The supernatant was then transferred to a QIAGEN-tip 20 
pre-equilibrated by Buffer QBT and it was allowed to flow out by gravity. The 
QIAGEN-tip 20 was washed with 4 x 1 ml of Buffer QC. Then DNA was eluted with 
800 pJ Of Buffer QF. The eluted DNA was precipitated with 0.7 volumes of 
isopropanol and centrifugated immediately at 13,000 rpm for 30 mm. The DNA pellet 
was then washed with 70% ethanol once, air dried, resuspended in 15 .Ll of ddH20, 
and stored at -20°C. 
Maxi-prep of plasmid DNA: 
Large scale preparations of plasmid DNA were prepared using QlAfiter 
Plasmid Midi Kit, following the manufacturer's instructions. A single colony was 
picked into 250 ml of LB-amp broth and grown overnight at 37°C with vigorous 
shaking. The bacteria were harvested by centrifugation at 3000 rpm for 10 minutes at 
4°C and the pellet resuspended in 10 ml of Buffer P1(100 pg/ml RNase A, 50 mM 
Tris-HCL, 10 mM EDTA, pH 8.0). The cells were lysed by adding 10 ml of Buffer 
P2 (200 mM NaOH, 1% SDS). The lysate was mixed gently and incubated at room 
temperature for 5 minutes. After the addition of 10 ml of Buffer P3 (3 M potassium 
acetate pH 5.5) and mixing, the solution was then poured into the barrel of the 
QIAGEN Cartridge, incubated at room temperature for 10 mm. During this time, a 
QIAGEN-tip 500 was equilibrated by applying 10 ml of Buffer QBT and the column 
was allowed to empty by gravity flow. The cap was removed from the QlAfilter outlet 
nozzle, the plunger was gently inserted into the QlAfilter Maxi Cartridge, and the cell 
lysate was filtered into the previously equilibrated QIAGEN-tip 500. The cleared lysate 
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was allowed to enter the resin by gravity flow, and then the QIAGEN-tip was washed 
with 2 x 30 ml of Buffer QC. The DNA was eluted with 15 ml of Buffer QF, 
precipitated by 10.5 ml of isopropanol, and centrifuged immediately at 15,000 x g 
(SS-34 Sorvall rotor) for 30 minutes at 4°C. The DNA pellet was then washed with 5 
ml of 70% ethanol, air dried, resuspended in 0.25 ml of Tris buffer (10 MM Tris-Ci, 
pH 8.5), and stored in -20°C. 
2.7.3 Purification of DNA fragments from agarose gels 
DNA fragments obtained after PCR amplification and restriction digestion were 
purified by one of the following methods: 
Phenol/chloroform extraction: 
After PCR amplification and restriction digestion, the DNA was 
electrophoresed using the appropriate percentage low melting temperature (LMP) 
agarose-TAE gel and excised under long wave UV light (366 nm, 1131) in a minimum 
volume. The gel slice was then transferred into a 1.5 ml of Eppendorf tube and 
smashed to small pieces. An equal volume of phenol/chloroform was added to the 
mixture, vortexed for a few seconds, and kept in -70°C for 10 mm. The frozen 
mixture was then microcentrifuged for 5 mm. The aqueous upper phase was removed 
to a new 1.5 ml tube and extracted once with same volume of phenol/chloroform/ 3- 
methyl- 1 -butanol (50:48 :2) and once with same volume of chloroform. The DNA was 
precipitated by addition of 0.1 volume of 3M sodium acetate and 2 volumes of 
absolute ethanol, and dissolved in an appropriate volume of 10 mM Tris buffer, pH 
8.0. 
Magic PCR PrepsrM  DNA purification system: 
DNA contained in LMP agarose gel slices was also purified by using Magic 
PCR PrepSTM purification Kit ( Promega), according to the manufacturers protocol. 
The gel slice was incubated in a 1.5 ml Eppendorf tube at 70°C until the agarose was 
compete melted. lml of Resin was added to the melted agarose and mixed 
immediately. The mix was pipetted into a syringe barrel attached to a mini column. 
Then the syringe plunger was inserted slowly to push the slurry flowing through the 
mini column. The mini column was washed with 2m1 of 80% isopropanol and 
centrifuged for 20 seconds at 13,000rpm in a microcentrifuge to dry the resin. The 
mini column was then transferred to a new microcentrifuge tube. 50 pJ of ddH20 was 
applied to the column and left 3 minute. The microcentrifuge tube with the minicolunm 
was centrifuged for 1 minute at 13,000 rpm to elute the bound DNA fragments. The 
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mini column was removed and discarded. Purified DNA was stored 200C  until 
required. 
2.7.4 Preparation of total RNA from parasite culture 
Total RNA was prepared from asexual P. falciparum parasites using the RNA 
Isolator Kit (containing guanidimum thiocynate, N-lauryl sarcosine and EDTA; 
Genosys Biotechnologies, Inc). Cultures were centrifuged at 4,000 rpm for 5 minutes 
to collect the parasites. Then the parasites were released from the RBCs by lysis in 
0.1% saponin in 1xPBS, centrifuged and collected prior to extraction following the 
manufacture's instructions. The RNA pellet was resuspended in 20 ml DEPC-treated 
H20 and incubate at 55-60°C for 10 mm. The total RNA was either used immediately 
or stored frozen at -70°C until use. 
2.7.5 DNA quantification 
The concentration of DNA in solution was estimated by measuring its 
absorbence at 260nm in spectrophotometer. It was assumed that an 0D260 of 1.0 is 
equivalent to a concentration of 50 p.g/ml for double stranded DNA and 35 gg/ml for 
oligonucleotides. 
2.7.6 Restriction 	endonuclease 	digestion, 	electrophoresis 	and 
photography 
Restriction endonuclease enzymes were obtained from Boehringer Mannheim 
Chemical Company and New England Biolabs. Restriction enzyme digestions were 
performed in the appropriate buffer supplied by the manufacturer. The reactions were 
carried out at 37°C for 3-6 hours (unless otherwise indicated) and 4-12 units of 
restriction endonuclease were used per gg of DNA. Reactions were terminated by 
addition of 1/10 volume of 50mM Na2EDTA, 40% w/v sucrose, containing 0.25% 
bromophenol blue, 0.25% xylene cyanol. 
Agarose gels were used to check the integrity of DNA, to analyse PCR 
products and restriction enzyme digests. 1% - 2% agarose (lET) was dissolved in 
appropriate volume of lx TAE buffer by boiling. After the solution had cooled to 
around 45°C, ethidium bromide (EtBr) was added at concentration of 0.5 jig/mI, mixed 
and the gel was poured onto a pre-levelled electrophoresis gel plate (lET) and left to 
polymerise at room temperature. The appropriate amount of DNA was mixed with 0.1 
volumes of gel loading buffer (40% w/v sucrose , 50mM EDTA pH 8.0, 0.25% 
bromophenol blue, 0.25% xylene cyanol) and loaded into the submerged gel. 
Electrophoresis was carried out in 1xTAE at 100 volts for the appropriate time 
depending on the size of the fragment being separated. Fluorescence from DNA 
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bound-ethidium bromide was visualised by short wave-length UV light and 
photographed. 
In order to estimate the size of DNA fragments 2j.tg of DNA markers were 
loaded adjacent to the DNA samples on agarose gels. The standards, pBR328 Bgl 
I+Hinf I digest (Boehringer Mannheim) consisted of the following sized fragments 
2176, 1766, 1230, 1033, 653, 517, 453, 394, 298, 234, 220, and 154 base pairs 
(bp), and Hind ifi digest of bacteriophage X C1857 (Boehringer Mannheim) consisted 
of the following sized fragments (bp): 23130, 9416, 6562, 4368, 2322, 2027, 564 
and 125. 
After electrophoresis the agarose gels were stained with 10 pjg/mi ethidium 
bromide and photographed under UV transilluminator (ff1) using short wave-length. 
A photograph of the gel was taken by the Polaroid camera with 667 professional film 
or the gel video documentation system (Video Copy Processor, Mitsubishi TM). 
2.8 Polymerase Chain Reaction Techniques 
2.8.1 Polymerase Chain Reaction (PCR) 
The PCR is used for enzymatic synthesis of specific DNA sequences (Saiki et 
al, 1988). The single or double stranded DNA is first denatured, then annealed with 
specific primers corresponding to each end of the target sequence, and the sequence 
extended. This cycle is repeated as much as 20-40 times and has the potential of 
amplifying the target sequence as much as 107-109  times. Due to the high temperature 
required for the denaturation step, the thermostable DNA polymerase, so-called Taq 
DNA polymerase was normally used in the thermal reactions. However, the pfu and 
Deep Vent DNA polymerase could be instead of Taq to improve the PCR accuracy. 
PCR was performed in 0.5 ml Eppendorf tubes. Each reaction contained 1 p.l of each 
primer at 10 jIM, 1 p.1 of dNTP solution (contained each dGTP, dATP, dTTP, dCTP) 
at 750 jiM, 2jtl of lOxTaq polymerase buffer (500 mM KC1, 100 mM Tris-HC1 pH 
8.3, 20 mM MgCl2,  0.02% gelatin), dH20 to a total reaction volume of 20 p.1 and 1 p.1 
(0.25 units) of Taq polymerase (Perkin Elmer Cetus Corp.). The reaction mixture was 
overlaid with 20 p.1 of mineral oil and PCR was performed using HybaidTM Omnigene 
thermal reactor. The temperature have to be varied to accomodate differences in oligo 
composition. The products of the PCR reactions were analysed by electrophoresis on 
1.5%- 2% agarose gels and ethidium bromide staining. 
2.8.2 Inverse Polymerase Chain Reaction (IPCR) 
This technique is used to rapidly in vitro amplify the DNA sequences that flank 
a region of known sequence. The technique used a pair of primers oriented in the 
reverse direction of the usual orientation in known region. The template for the reverse 
primers is a restriction fragment that has been ligated upon itself to form a circle 
(Triglia et al, 1988). In such experiments, 1 jig of P. falciparum genomic DNA was 
digested to completion with EcoR!. The reaction was heat inactivated if possible, but 
otherwise it was phenol/chloroform extracted and alcohol precipitated. Then the DNA 
was resuspended in an appropriate volume of TE buffer. The product of the digestion 
was ligated and inverse PCR was carried out in 50 jil PCR reaction using 2 p1 of the 
ligation mix as template DNA. 
2.8.3 Reverse transcriptase (RT)- PCR 
Single-stranded cDNA was reverse transcribed from total RNA of asexual or 
gametocytic parasites of P. falciparum. Each reaction contained 2 ng total RNA, 4 p.1 
5x MrMuLV reverse transcriptase buffer, 2 p.10. 1M DT!', 3 p1 750p.M dNTP mixture, 
1 p.1 20 mM degenerate oligoprimer [Ti 1MN] (M=G,A or C, N=G,A,T or C) and H20 
to give 19 p1 total volume in a 0.5 ml microcentrifuge tube. Then incubate the tubes at 
65°C for 5 min to denature the mRNA secondary structure and incubate 10 min at 
37°C to allow primer annealing. Add 1 p.1 200 U/mi MrMuLV reverse transcriptase 
(BRL) to each tubes, mix well, and incubate at 37°C for 1.5 hours. After that, 
incubate at 95°C for 5 min to inactivate the reverse transcriptase and spin briefly to 
collect condensation. Place the tubes on ice for immediate PCR amplification or store 
at -200C for later use. The PCR conditions set up as described above. The amplified 
PCR products were analysed by 1.5% agarose gel electrophoresis and ethidium 
bromide staining. 
2.9 Recombinant DNA techniques 
2.9.1 Subcloning and ligation of DNA 
For subcloning, vector DNA (SOng) and insert DNA were cut with suitable 
restriction enzyme endonucleases. In order to prevent the self-ligation of the 
compatible ends of digested plasmid, linearised DNA was treated with 1 unit of calf 
intestine alkaline phosphatase (CIP) (New England BioLabs) at 37°C for 1 h which 
removes the 5'-phosphatase residues from DNA. Then 0.1 volume of 250 mM EDTA 
pH 8.0 was added and the solution incubated at 75°C for 10 minutes to inactivate the 
enzyme. Ligation of the insert to vector was titred at molar ratios of approximately 3:1, 
5:1 and 10:1. To the mixture of vector and insert DNA was added 1p1 of lOx ligase 
buffer (500 mM Tris-HC1 pH 7.5, 100 MM M902, 100 mM DT!', 100 mM ATP), 1 
unit of T4 DNA ligase (Invitrogen Inc.) and the total reaction volume made up to lOjil 
with dH20. The reaction was incubated at 16°C overnight and then used to transform 
47 
the competent E. coli cells. The pBluescript KS plasmid (see Appendix D) was used 
in the lab for daily subclomng works. 
2.9.2 Subcloning of PCR products into pCR2.1 plasmid vector 
The TA CloningTM System (see Appendix A) from Invitrogen Inc. was used 
routinely during this study to provide a one-step cloning strategy for direct insertion of 
PCR product into a plasmid vector (Mead et al, 1991). The system takes advantage of 
the non-template dependent activity of the thermostable polymerases used in PCR that 
add single deoxynucleotides to the 3' end of all duplex molecules. These A-overhangs 
are used to insert the PCR product into specifically designed vectors providing single 
37-overhangs ready for the insertion site. 
The ligation and transformation were carried out following the manufacturer's 
instructions. Briefly, the appropriate amount of PCR sample was transferred to a new 
0.5 ml eppendoff tube and avoid the contamination of the mineral oil. The ligations 
with the pCRTm vector (3.9 kb) were set up as 1:1 to 1:3 molar ratio of vector: PCR 
insert. For each ligation reaction, 2 il (50 ng) of vector, 1 tl (12.5 ng) of PCR 
product, 1 p.1 lOx ligation buffer (0.5 M Tris pH 7.4, 0.1 M MgC12, 0.1 M 
dithiothreitol, 10 mM spermidine, 10 mM ATP, 1 mg/ml BSA), 10 of T4 DNA ligase 
and 6 p.1 of dH20. The ligation mix was incubated overnight at 14-16°C. 
2.9.3 Preparation of competent bacterial cells 
The method used was modified after Hanahan (1983). Cells of the appropriate 
E. coli strain from a -70°C stored master stock were plated on LB agar overnight at 
37°C. Two-three colonies were picked and grown in 5 ml LB broth overnight at 37°C 
with shaking. The following morning the culture was diluted 50-fold in LB broth and 
incubation with shaking for approximately 2-4 hours until the cell density was 4-7 x 
10 viable cells/ml (0D600 of 0.4-0.6). At the same time, a 100 ml of 80 mM CaC12/ 
15% glycerol solution or transformation buffer I (ThI) was prepared and sterilised by 
filtering through a 0.22 p.m filter and kept on ice bath. The culture was then chilled on 
ice for 15 minutes. The bacterial pellet was then collected by centrifugation at 4,500 
rpm for 5 minutes at 4°C, and resuspended in the ice-cold CaC12/glycerol solution or 
TBI at 1/2 of the original culture volume. The cells were then incubated on ice for 5 
minutes, collected again by centrifugation as above. The pellet was then resuspended 
in 1/2 of the original culture volume ice-cold CaC12/glycerol solution or transformation 
buffer II, and incubated on ice for 30 minutes. The cells were collected again and 
resuspended in 1/10 of the original culture volume of ice-cold CaC12/glycerol solution 
or transformation buffer II. The cells could then be stored at -70°C in small aliquots 
(100-200 p.1), or could be used the same directly. 
2.9.4 Transformation of E. Coli 
Competent cells (50-100 pi)  were mixed with either 5 Rl  of a ligation reaction 
or 20 ng of uncut plasmid DNA. The cells were then incubated on ice for 30 minutes, 
heat-shocked at 42°C for 90 seconds and incubated on ice for 2 minutes. To each 
transformation mixture, Then 400-450 jil of pre-warmed LB or SOC medium was 
added and the mixture was incubated at 37°C, with gentle shaking, for 1 hour. 25-100 
p.1 of from each transformation were plated out on appropriate selective LB agarose 
plates and incubated overnight at 37°C. 
2.9.5 Transformation by Electroporation 
A overnight culture was set up in 10 ml of LB broth. The following morning 
the lOml of overnight culture was inoculated into 1 litre of LB broth and incubated 
until 0D600 to 0.5- 1.0 with shaking (about 2.5 hrs). The culture was chilled on ice 
for 15- 30 min and pelleted in a cold rotor at 4000g for 15 mm. The pellet was 
collected and resuspended in 1 litre of cold water. The pellet was washed with 0.5 
litre of cold water. The pellet was collected by centrifugation as above conditions and 
resuspended in 20 ml of cold 10% glycerol. The pellet was collected again and 
resuspended in 2- 3 ml of cold 10% glycerol. Cells were frozen in aliquots on dry ice, 
and store at -70°C for up to 6 months. 
For transformation, competent cells kept at -70°C were thawed on ice and 35-
40 p.1 of competent cells (for each reaction) were added to a 1 ng ligation mixture in a 
1.5 ml tube (The DNA should be made salt- free, by placing onto a filter is floating on 
water to dialyse the salts out). Then the transformation mixture was placed into an 
electroporation cuvette (on ice), electroporated at 2.25 kV, 25mf, 200W and 
immediately added to lml of ice-cold LB broth. Different amounts of mixture were 
then plated out on LB agar plate with appropriate antibiotics and incubated overnight at 
37°C. 
2.10 DNA sequencing 
2.10.1 Manual sequencing 
Sequencing reaction 
Sequencing of plasmid DNA was performed by the dideoxy chain termination 
method (Saiki et al, 1988), using the Sequenase version 2.0 Kit based on T7 DNA 
polymerase (USB), following a modification of protocol of Winship (Winship, 
1989). In this protocol, 10% culture grade DMSO was added in the sequencing 
reactions to enhance the intensity of the signal, to reduce background and to prevent 
formation of secondary structure when sequencing double-stranded DNA fragments. 
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For sequencing plasmid and double-stranded DNA, the templates were 
denatured by an alkaline method. Approximately 5 tg of double stranded DNA in 10 
1.il of TE buffer was incubated with 1 111 of a solution of 2N NaOH and 2mM EDTA 
for 30 minutes at 37°C. After incubation, 1 jd of 3N Na acetate (pH5.5) and 100 gI of 
absolute ethanol were added and incubated at -70°C for 30 minutes. The DNA was 
collected by centrifugation at 13,000 rpm for 15 minutes. The pellet was washed with 
500 il 70% ethanol and air-dried. The denatured template was mixed with 2 p.1 of 5x 
reaction buffer (200mM Tris-HC1 pH 7.5, 100mM MgC12, 250mM NaCl), lp.l of 
sequencing primer (lng/p.l), 1 j.d of 10% DMSO and 7 p.1 of 1120, then boiled for 5 
minutes and then placed on ice. To this mixture was added 1 p.1 of 0. 1M DTT, 1 p.1 of 
1:5 diluted labelling mix (1.5 p.M each of dCTP, dGTP, dTTP), 1 p.1 of [a 35S] dATP 
(1000ci mM, 10 p.Ci-1; Amersham SJ246), and 1 p.1 (2 units) Sequenase (diluted in 
enzyme dilution buffer of 10 mM Tris-Cl pH 7.5, 5mM DTT and 0.5mg/mi BSA) and 
incubated at room temperature for 5 minutes. Then 3.5 p.1 of the solution was aliquoted 
into 2.5 p.1 appropriate pre-warmed (37°C) termination mix (80 p.M dNTP [dGTP, 
dATP, dCTP, dTTP]; 8 p.M ddNTP [ddGTP, ddATP, ddCTP, CIdTTP, respectively]; 
50 mM NaC1) and 0.5 p.110% DMSO and incubated at 37°C for 5 minutes. The 
reactions were terminated by adding 4 p.1 of stop solution (95% formamide, 20 mlvi 
EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol FF). Samples were boiled 
3 minutes prior to loading (3 jil per well). 
Sequence reactions were separated on a 380 mm x 0.3 mm, 6% 
polyacrylamide gel (8 M Urea, 6% acrylamide, 0.16% bis-acrylamide, 0.08% 
ammonium persuiphate in lx TBE pH 8.8). Electrophoresis was then carried at 55 W 
constant power. Following electrophoresis, the gel was fixed in 7% acetic acid and 7% 
methanol for 30 minutes. Gel were dried under vacuum on a gel dryer (Model 583 Gel 
Dryer, BlO-RAD) for 2 hours at 80°C, and exposed to X-ray film (Kodak XAR-5 or 
AGFA CURIX) in a cassette for about 16-24 hours. Films were developed in an 
automatic X-ray film processor (X-ograph Xl). 
2.10.2 Automatic sequencing 
Automated sequencing of plasmid DNA was carried out using dye terminators 
with the PRISMTM cycle sequencing kit (Applied Biosystems Inc.) and the 377 
automated sequencer (ABI). Protocols were achieved as described by the manufacturer 
(ABI PRISM dye Terminator protocol, P/N 402078). For each reaction, the reagents 
were aliquoted into a 0.5 ml PCR tube as follows: 8 p.1 Terminator Ready Reaction 
Premix, 5 p.1 dsDNA Template (0.2 p.g/ml), 2 p.1 sequencing primer (1.6 pmollml), 3 
p.1 H20 with total volume 20 p.1. Cycle sequencings were performed on the HYBAID 
DNA thermal cycler (OmniGene) by following condition: 25 cycles (96°C for 30 sec, 
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50°C for 20 sec, 60°C for 4 mm, respectively), then keep on 4°C. After reaction, 
PCR products were precipitated, washed and resuspended in 5 pd deionized formamide 
and 1 p1 of 50 gg/ml Blue dextran in 25 mM EDTA, pH8.0. Each sample was then 
heated at 90°C for 5 min and 1.8 .tl of each sample was loaded. 6% Denaturing gels 
were run at 50 W for 7 h. Chromatograms were viewed and data were edited using the 
SeqedTM program (ABI). 
2.11 Computing analysis 
Sequence analysis was performed using the GCG software package (Devereux 
et al, 1984) or through World Wide Web browsers. The cDNA sequences and 
translated amino acid sequences of the SNF2L gene were compared with the EMBL 
and GenBank database using the BLAST algorithm (Altschul et a!, 1990; Altschul et 
al, 1997) as implemented in the GCG package. Local alignments of multiple sequences 
were constructed using these algorithms under varying parameters on individual 
sequence pairs, followed by manual optimisation of the alignments. The RNASPL 
(Solovyev et al, 1994) and POLYAH (Brondel et a!, 1992) programs were used to 
predict intron-exon junctions and potential poly(A) sites. PSORT version 6.3 (WWW) 
was used to predict protein localisation sites from cDNA sequences. Statistical analysis 
of protein sequences was carried out using the SAPS program (Brondel et a!, 1992). 
DNA and protein sequences were collected using Entrez programme in NCBI web 
service. Analyses of phylogenetic trees were performed using PAUP phylogenesis 
software package. 
2.12 Pulsed field gradient gel electrophoresis 
Pulsed field gradient electrophoresis (PFGE) analysis has been a important tool 
for fundamental genetic studies of P. falciparum (Foote & Kemp, 1989; Hinterberg et 
a!, 1994; Schwartz & Cantor, 1984). Southern blots of PFGE separations readily 
serve to assign genetic markers to chromosomes. On a practical level, important 
features of PFGE methods include embedding cells in agarose blocks and removing 
protein so that the DNA remains intact but free within the gel matrix. The movement of 
the large chromosomal DNA molecules through the gel was by switching direction of 
the applied electric field at fixed time intervals. 
2.12.1 Preparation of parasite DNA in agarose blocks 
For preparation of chromosomal DNA in agarose blocks, parasites were first 
grown in 5m1 asynchronous culture at 5% haematocrit to a 10% parasitaemia. 
Parasitised red blood cells were pelleted by centrifugation at 4000 rpm for 5 minutes at 
4°C. Parasites were released from the Parasitised RBC pellet by lysis with an equal 
volume of 0.1% saponinllxPBS (made up fresh). After incubation at room 
temperature for 10 minutes the parasites were pelleted by centrifugation as above. The 
parasite pellet was washed twice in excess of ice-cold lx PBS and resuspended in 2 
volumes of 1xPBS at room temperature. The suspension was fixed by addition of an 
equal volume of 1.5% low-melting point agarose (IBI)/1xPBS at 42°C, mixed gently 
and quickly pipetted into a pre-warmed mould (Bio-Rad) before the agarose had set. 
The mould was then placed at 4°C for 20 minutes to allow the gel to set. The agarose 
blocks were transferred from the mould into lysis solution (1% sarkosyl, 0.5M EDTA 
pH 8.0, 0.01M Tris pH 8.0, 1 mg/ml proteinase K), approximately 0.5m1 per block, 
and incubated for 48 hours at 50°C with one change of the lysis solution. The blocks 
were stored in the lysis solution, without proteinase K, at 4°C until they were used. 
Blocks can last for many months if properly made and stored. 
2.12.2 Electrophoresis conditions 
Chromosome separations were performed in 0.8% PFGE-grade agarose/0.5x 
TBE buffer. Molten agarose was poured about 60°C. The gel was allowed to set at 
room temperature for about 30 minutes. After that the comb was removed and the 
slices of parasite DNA blocks were inserted into the wells. The blocks were sealed 
into the wells with low-melting agarose/1xPBS, avoiding trapped air bubbles in the 
wells. The temperature of the buffer was maintained at 14°C by circulating it through 
a cooling system. DNA separation was performed on a Bio-Rad CHEF DRII system. 
Table 2.1 shows the conditions used for separating DNA of various sizes using Bio-
Rad CHEF DR11 system. Switch time was ramped from 90 to 300 s for 22 h at 95 V 
followed by switch time ramped from 300 to 720 s for 30 h at 90 V. 
2.13 Southern hybridisation 
2.13.1 Southern blotting 
Southern blotting was carried out by a modification of the method of Southern 
(1975). The agarose gel containing fractionated DNA was soaked in 0.25M HCl for 
20 minutes to partially depurinate the DNA. The gel was then rinsed in dH20 for 5 
minutes before being soaked in 0.4 M NaOH three times for 15 minutes each. The gel 
was then placed onto blotting paper pads. The DNA was alkaline transfered to Hybond 
N+ membrane (Amersham) with 0.4 N NaOH. After overnight transfer the membrane 
was removed and neutralised in 0.5M Tris-HC1 for 5 minutes, air dried, short wave 
UV linked and wrapped in Saran wrap, (Dow Chemical Company), until it was 
required for the hybridisation reaction. 
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For transfer of DNA from mini-gels onto HybondN+ membrane (Amersham) 
prior to probing the following method was used: After depurination, the gel was 
soaked in denaturation solution (0.5M NaOH, 1.5M NaCl) for 20 minutes and then 
transferred into neutralisation solution (1.5M NaCl, 0.5M Tns pH 7.5) for 30 
minutes. The gel was then placed on a glass plate and overlaid with a piece of Hybond 
N+ membrane and 3 sheets of blotting paper all pre-wetted in lOx SSC. Onto this 
were placed 3 sheets of dry blotting paper, a stack of paper towels, a glass plate and a 
weight. After transfer for 4-8 hours, the membrane was removed, rinsed in 2x SSC 
and air-dried. The membrane was then ready for prehybridisation and probing. 
2.13.2 Probe synthesis 
For maximum sensitivity in filter hybridisation, phosphorus-32 (32P) is the 
most widely used radiolabel as it is available at high specific activity and can be 
detected with efficiency. Several methods are available for making probes. End-
labelling with polynucleotide kinase is employed with short oligonucleotides, whereas 
longer DNA fragments are generally labelled by random priming labelling methods. 
In this work, random primer labelling method was used which was first 
described by Feinberg and Vogeistein (Feinberg & Vogelstein, 1983). The approach 
utilises Klenow enzyme which has 5'-3'polymerase activity but lacks the 5'-3' 
exonuclease activity. The absence of the 5'-3' exonuclease also ensures that 
incorporated nucleotides are not subsequently removed as monophosphates. A mixture 
of random DNA hexanucleotides is used to prime the DNA and synthesise the 
radiolabelled complementary strand DNA from the 3'-OH termini of the primers. In 
this work, the Random Primed DNA Labelling Kit (Boehringer Mannheim), was used 
to synthesise radioactive probes for hybridisation reactions. The DNA template (25-50 
ng in TE buffer) was first denatured by boiling for 10 minutes and chilled on ice to 
prevent reannealing. A mixture of 2 jtl hexanucleotide mixture in lOx reaction buffer 
[900 mM HEPES, adjusted to pH 6.6 with 4 N NaOH, 100 HIM  MgC121, 1 .tl [0.5 
mlvi] each of dCTP, dGTP, dTTP, 5 p.1 [50 pCi, 1.85MBq] of [a- 32P] dATP 
(Amersham International Plc.), and 1 p.! (2 units) of Kienow enzyme were then added 
to the denatured DNA template and incubated at 37°C for 30-60 minutes. The reaction 
was stopped by addition of 0.5mM EDTA. This procedure can routinely be used to 
obtain probes with specific activity as high as 1.8x 10 9 dpm/p.g. 
In general, the denatured labelled DNA can be used directly as a hybridisation 
probe without stopping the reaction or removing unincorporated label. Removal of 
unincorporated nucleotides was performed by passing the labelling reaction through a 
Sephadex G-50 column. A 1.5 ml Eppendorf tube was punctured by a No.26 needle, 
plugged by glasswool and then packed with 1 ml Sephadex G-50 prepared/FE buffer 
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(10mM Tris-HC1 pH 8.0, 1 mM EDTA pH 8.0). The column was placed on the top 
of a new Eppendorf tube and spun at 700x g for 5 minutes to remove excess TE 
buffer. After the radiolabelling reaction was completed, 5 j.tl of gel loading buffer was 
added to the DNA sample. The DNA sample was applied to the top of the column. The 
column was then placed on the top of another new Eppendorf tube and spun at 700x g 
for 5 minutes again to recover radiolabelled fractions. The radioactive fractions in the 
leading peak pooled and stored at -20°C until needed. The probe was boiled for 10 
minutes before it was added to hybridisation solution. 
2.13.3 DNA hybridisation 
All hybridisations were performed in a Hybridisation oven (Hybaid). In the 
course of this study all Southern blots, Northern blots and filters were probed for 
homologous DNA sequences and therefore hybridisation was carried out under 
stringent conditions throughout. In general, to maximise the rate of annealing of the 
probe with its target, hybridisations were usually carried out in the presence of 10% 
dextran sulphate in a solution of high ionic strength at a temperature that was 20-25°C 
below the melting temperature (T m) (Sambrook et al, 1989). 
The probe was added with sonicated salmon or herring sperm DNA boiled for 
10 minutes before it was added to hybridisation solution. Blots were prehybridised at 
65°C for 4 h using a prehybridisation buffer which was made by addition of 10 g of 
dextran sulphate [MW-500,000], lOml of 10% SDS, 5.8g NaCl and 5 ml of 50x 
Denhart's solution to 85 ml of dH20 and heated at 65°C for 30 minutes. For 
hybridisation, the prehybridisation buffer was reduced to 50 j.tl of hybridisation buffer 
per cm2 of membrane. Just before hybridization was carried out, the probe was added 
0.1 ml of 5 mg/ml sonicated herring sperm DNA and 0.9 ml of dH20 and boiled to 
denature the DNAs. The boiled, denatured probe was then added and hybridisation 
continued overnight at 56-65°C. Non-specifically bound nucleotides were removed by 
washing the membrane twice with excess 2xSSC at room temperature for 10 minutes. 
The membrane was washed stringently with two washes in 0.5xSSC, 0.1% SDS at 
56°C for 30 minutes and then two washes in 0. lx SSC for 30 minutes. Filters were 
then placed between two layers of Saran Wrap and autoradiographed. 
2.13.4 Stripping probes from DNA blots 
Blots were stripped before being used in new hybridisation reactions. DNA 
blots were incubated at 45°C for 30 minutes in 0.4N NaOH and then in neutralisation 
solution (0.1xSSC, 0.1% SDS, 0.2M Tris-Ci pH 7.5) for 30 minutes. Alternatively, 
blots could be boiled in 0. lx SDS for 10 minutes. The blots were then exposed to X-
ray films and autordiographed to check for removal of the probe. 
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2.13.5 Autoradiography 
This was performed using X-ray film (Kodak XAR-5 or AGFA Curix) for 32p 
probed filters, in a cassette containing intensifying screens. The cassette containing 
32p probed filters were stored at -70°C while those containing 35S labelled gels were 
stored at room temperature. Film was developed using a X-O'GRAPH X  automatic 
X-ray film processor. 
2.14 Colony hybridisation 
The procedure used was that described by Hanahan and Meselson (1983) and 
Buluwela et a! (1989) in which colony lysis, DNA denaturation and DNA fixation to 
the membrane are carried out in a single step. 
A sterile HybondN+ filter was laid on a surface of a day-old LB agar plate 
containing ampicillm using sterile, blunt-ended forceps (Millipore). When the filter 
was thoroughly wet, the bacterial colonies were directly replicated from the plate onto 
the surface of filter. The filters were then oriented by making a series of holes in them 
with an 18-gauge needle and before being peeled apart. The filters were then peeled off 
the plate and laid, colony side up, on 3MM paper to dry. The plate was then inverted 
and incubated overnight at 37°C for about 4-8 hours to allow colonies grow back. 
The replica filters were removed and placed for 3 minutes, colony side up, 
onto filter paper pre-wetted with 10% SDS solution. The filters were then placed for 5 
minutes onto a second sheet of 3MIM paper that had been saturated with denaturing 
solution (0.5M NaOH, 1.5M NaCl). After that, filters were placed for 5 minutes onto 
a third sheet of 3MM paper that had been saturated with neutralising solution (1.5M 
NaCl, 0.5M Tris.Cl pH 8.0). Finally, the filters were rinsed briefly in 2xSSC 
solution and dried at room temperature for 30-60 minutes. The DNA was fixed on the 
filters by baking at 80°C for 2 h or cross-linking with UV for 5 minutes. The filters 
were either used immediately in hybridisation reactions or wrapped loosely in 
aluminium foil and stored under vacuum at room temperature. Positive signals were 
then identified and the appropriate colony on the master plate picked for further 
analysis. 
2.15 Northern hybridisation 
2.15.1 Formaldehyde gel electrophoresis 
RNA was run in 1.2% w/v agarose gel, lx MOPS buffer (20mM MOPS, 
5mM NaAc pH 7.0, 1mM EDTA, pH 7.0) , 3% formaldehyde. 4.5 jil of RNA in 
solution was mixed with 2 Rl  of lOx MOPS buffer, 10 il of formamide and 3.5 p1 of 
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37% formaldehyde to final volume 20 jil and heated to 65°C for 10 minutes then 
immediately cooled on ice. After addition of 0.25 volumes of sample buffer (0.25% 
bromophenol blue, 0.25% xylene cyanol, 30% glycerol) the sample and an aliquot of 
RNA molecular weight marker (Boehringer Mannheim RNA marker II consisted of the 
following bands (kb) 7.4, 5.3, 1.9, 1.6, 1.0, 0.6, 0.4, and 0.3) were loaded. The gel 
was run at 70V for 1-2 hours. After the electrophoresis was complete the gel was 
stained and photographed. 
2.15.2 Northern blotting 
The RNA gels were first rinsed in 1xSSC for 10 minutes to remove 
formaldehyde from gels and then denatured by soaking the gels for 10 minutes in 
1xSSC, 50mM NaOH solution for 10 minutes. The gels were blotted overnight onto 
HybondN+ membrane using 1OxSSC. After overnight transfer the membrane was 
removed and rinsed in 2xSCC. The blot was then ready for hybridisation. 
2.15.3 RNA hybridisation 
Membranes were prehybridised at 65°C for 4 hours in 8 ml prehybridisation 
buffer (50 jil I cm2 membrane) as above. The buffer was changed once after 8 hours. 
The probe was random-primer labelled. Hybridisation was carried out at 56°C 
overnight using 3 ml of the same solution overnight. Filters were washed in 2xSSC, 
0.1% SDS, then in 0.1xSSC, 0.1% SDS for 30 minutes twice before exposure to X-
ray films. 
2.15.4 Stripping of Northern blots 
When necessary Northern blots were first stripped prior to probing. A solution 
of boiling 0.1% (wlv) SDS was poured over the blot and allowed to cool to room 
temperature. The filter was then autoradiographed to check for complete removal of the 
probe. 
2.16 Preparation of fusion proteins 
2.16.1 Construction and expression of the recombinant glutathione S - 
transferase (GST) fusion proteins 
pGEX-4T- 1 vectors were used to express polypeptides fused with glutathione-
S-transferase (OST) in E. coli BL21 host. The basic protocol used for expressing, 
purifying and cleaving fusion proteins was that described by Smith & Corcoran 
(1990). For this work, the PCR fragment GST1 was amplified from the P. falciparum 
PfSNF2L clone with a BamHI site at both ends and subcloned into the BamHI site of 
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the pGEX-4T-1 vector to produce a GST N-terminal fused fusion protein. BL21 cells 
were used for transformation and the cells were grown on LB-amp agar plates 
overnight at 37°C. Positive clones were identified by restriction enzyme digestion of 
purified plasmid and then further confirmed by DNA sequencing. 
Single colonies were picked and put into 5 ml of LB-amp and grown overnight 
at 37°C with shaking. The following day the culture was diluted 1:10 in LB-amp and 
grown at 37°C with shaking to an 0D600 of 0.6-0.8 (about one hour). imi of culture 
was removed as a control before induction, and to the remaining culture 100mM IPTG 
was added to a final concentration of 0.1mM in order to induce fusion protein 
expression. Cells were then grown for a further 2-3 hours. Cells were collected by 
centrifugation, at 5,500 rpm (Sorvall) for 10 minutes at 4°C. They were then 
resuspended in 1 ml of ice-cold lx PBS. In order to check expression of the fusion 
protein 10 pJ of the resuspension was added with lOmi of 2x loading buffer and 
checked by SDS-PAGE and Coomassie staining. 
2.16.2 Purification of GST fusion proteins 
Bacterial cells with the induced fusion protein were lysed by sonication with a 
5mm diameter probe. 10% Triton X-100 was added to the lysed cell suspension to a 
final concentration of 1%, in order to minimise any association of fusion proteins with 
bacterial proteins. An aliquot of the lysed bacterial extract was then spun and a sample 
of both the supernatant and pellet analysed by SDS-PAGE and Coomassie staining to 
indicate the solubility of the GST fusion protein. 
For large scale purification of a soluble fusion protein, a colony of a pGEX 
transformant was inoculated into lOOmi LB-amp and grown overnight at 37°C with 
shaking. This culture was then diluted 1:10 into 500m1 fresh LB-amp and grown at 
37°C continuously to an 0D600 of 0.6-0.8. The culture was induced by addition of 
100 mM WIG to a final concentration of 0.1 mM and continued the incubation was 
continued for an additional 3 hours. The culture was centrifuged for 10 minutes in a 
Beckman rotor at 5000 rpm and the supernatant discarded. The pellet was resuspended 
in 10 ml ice-cold lx PBS and the cells were lysed by sonication. After sonication, 
10% Triton X-100 was added to give a final concentration of 1%. This was mixed 
and centrifuged for 5 minutes at 10000rpm at 4°C. The supernatant was collected and 
1 ml of a 50% slurry of pre-swelled S-linkage glutathione-agarose beads in PBS 
(Pharmacia) was added and this mixed was gently for 1 hour at room temperature. The 
beads were washed three times with 1xPBS. The pellet was resuspended in imi of ice-
cold PBS and then transferred to an Eppendorf tube. The fusion protein was eluted by 
addition of lml of 50mM Iris-Cl (pH 8.0)15 mM reduced glutathione. An aliquot of 
induced proteins were run in parallel to non-induced ones on SDS-PAGE. 
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2.16.3 Construction and expression of the recombinant histidine 
tagged (His-tag) fusion protein 
pET29 TA vectors were used to express polypeptides fused with His6-tag in 
E. coli BL21 (DE3) host. The basic protocol used for expressing, purifying and 
cleaving fusion proteins was that described by Studier et al (Studier & Moffatt, 1986). 
For this work, the PCR fragment FP 1, FP2 and FP3 were amplified from the P. 
falciparum PfSNF2L clone and subcloned into the A-protruding site site of the pET29 
TA vector to express a His6-tag C-terminal fused fusion proetin. BL21 (DE3) cells 
were used for transformation and the cells were grown on LB-kam agar plates 
overnight at 37°C. Positive clones were identified by restriction enzyme digestion of 
purified plasmid and then further confirmed by DNA sequencing. 
Single colonies were picked and put into into 5 ml of LB-amp and grown 
overnight at 37°C with shaking. The following day the culture was diluted 1:10 in LB-
amp and grown at 37°C with shaking to an 0D600 of 0.6-0.8 (about one hour). lml of 
culture was removed as a control before induction, and to the remaining culture 
100mM JPTG was added to a final concentration of 0. 1 m in order to induce fusion 
protein expression. Cells were then grown for a further 2-3 hours. Cells were 
collected by centrifugation at 5,500 rpm (Sorvall) for 10 minutes at 4°C. They were 
then resuspended in 1 ml of ice-cold lx PBS. The cells were lysed by sonication on 
ice and spun by microcentrifuge. A sample of both the supernatant and pellet was 
analysed by SDS-PAGE and Coomassie staining to indicate the solubility of the His-
tag fusion protein. 
2.16.4 Purification of His tagged fusion proteins 
A. Protein purification under non-denaturing conditions 
The cells were harvested from 5 ml induced culture by centrifugation at 4500 
rpm on 4°C for 5mm. After decanting the supernatant, the cell pellet was resuspended 
in 0.2 ml of lx ice-cold Binding Buffer. NP-40 can be added to 0.1% to reduce non-
specific binding. With the sample in a tube on ice bath, the sample was sonicated until 
no longer viscous. The DNA was sheared to avoid clogging of the resin. The cell 
lysate was then centrifuged at 13,000 rpm for 30 min to remove debris. The post-
centrifugation supernatant was filtered by passing through a 0.45 gm filter to reduce 
clogging of the resin (for soluble protein purification) and kept on ice before further 
purification. 
His-Bind resin was gently mixed until completely suspended. Each 2.5 ml of 
settled resin can be used to purify up to 20mg of target protein. 0.1 25m1 of settled 
resin (0.24 ml suspension) was aliquoted into 1.5m1 tube and spun for lrnin at 900 
M. 
rpm. After decanting supernatant, the resin was used the following sequence of 
washes to charge and equilibrate (where 1 volume is equivalent to the settled bed 
volume): 3 vol sterile deionized water, 5 vol lx Charge Buffer, 3 vol lx Binding 
Buffer, respectively. 
The charged resin was spun down and separated from the supernatant. The 
filtered cell extract was added into the resin tube and gently mixed to resuspend the 
resin, and shaken continuously for 1 hr to allow His-Tag bound to Ni2+ charged 
resin. The supernatant was removed after centrifugation and the resin was washed 
with 1.25 ml of lx Binding Buffer, 0.75 ml of lx Wash Buffer, respectively. The 
bound proteins were eluted with 0.75 ml of lx Elute Buffer. 
Eluted proteins were dialysed in the 1X PBS. A gradual removal of the 
imidazole is recommended for refolding the desired protein. After dialysis, the sample 
can be concentrated by sprinkling solid PEG 15,000-20,000 or Sephadex G50 on the 
dialysis tubing (Using dialysis tubing < 6,000 MW) or by vacuum dessication. 
B. Protein purification under denaturing conditions 
The cells were harvested from 5ml induced culture by centrifugation at 
4500rpm for 5mm. The cell pellet was then resuspended, sonicated and centrifuged as 
described above. The pellet was washed with imi of lx Binding Buffer (without 
denaturant) three times to release trapped proteins. Finally, the pellet was resuspended 
in 0.25m1 1X Binding Buffer containing 6M urea and incubated on ice for 1 hr to 
completely dissolve the protein. Any remaining insoluble material was removed by 
centrifugation at 13,000rpm for 30mm. The post-centrifugation supernatant was 
filtered by passing through a 0.45 gm filter to prevent clogging of the resin. 
The resin is prepared as described above, except that Binding Buffer plus 6M urea 
should be used in the final equilibration step. The charged resin was spun down and 
separated from the supernatant. The filtered cell extract was added into the resin tube 
and gently mixed to resuspend the resin, then shaken continuously for 1 hr to allow 
the His-Tag to bind to the Ni2+  charged resin. The supernatant was removed after 
centrifugation and the resin was washed with 1.25 ml of lx Binding Buffer, 0.75 ml 
of 20 mM iniidazole buffer (combine 1 imi of iX Binding Buffer with 4. lml of 1X 
Wash Buffer). The bound protein was eluted with 0.75m1 of lx Elute Buffer. Most 
proteins will elute with 300 mM imidazole under denaturing condition. 
Eluted proteins were dialysed in the 1X PBS. A gradual removal of 6M Urea is 
recommended for refolding the desired protein. After dialysis, the sample may be 
concentrated by sprinkling solid PEG 15,000-20,000 or Sephadex G50 on the dialysis 
tubing (Using dialysis tubing < 6,000 MW) or vacuum pump. 
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2.17 Protein electrophoresis 
2.17.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein extracts prepared from bacteria and parasites were fractionated by SDS-
PAGE (Laemmli, 1970) with a discontinuous buffer system. Mini-gels (80mm x 70mm 
x 0.75mm) (Hoefer) were used in the course of this study. Protein samples were 
prepared by the addition of an equal volume of 2x sample loading buffer and then 
boiled for 5 minutes prior to loading. Gels were run in an electrode buffer (25mM Tris, 
190mM glycine, 1%SDS) at 40 mA. Separated proteins were then either stained with 
Coomassie blue stain or electrophoretically transferred onto a PVDF membrane for 
Western blotting. 
2.17.2 Coomassie blue staining of protein gels 
Protein gels were stained with 0.1% Coomassie brilliant blue R-250 in order to 
visualise fractionated protein. The stain was prepared in water: methanol: glacial acetic 
acid 4:5:1 for 20 min to 1 h at room temperature with gentle agitation. Excess stain was 
removed by destaining the gel in water: methanol: glacial acetic acid 8:1:1 until the 
background was clear. Coomassie staining can detect approximately 0.5-1 pg of protein 
per band. 
2.17.3 Protein molecular weight markers 
Color markers (Sigma, C4337) contained Myosin (205,000; blue), 3-
Galactosidase (116,000; turquoise), BSA (66,000; pink), Ovalbumin (45,000; yellow), 
Carbonic anhydrase (29,000 orange), Trypsin inhibitor (20,100; green), cc-Lysozyme 
(14,200; purple) and Aprotinin (6,500; blue) was used routinely in this study. The 
marker was prepared in 2x loading buffer and boiled for 5 minutes before being loaded. 
For mini-gels 2 jig of each marker protein was loaded per well, and for large gels 10 jig 
per lane was loaded. The gel was then dried under vacuum. 
2.18 Mouse immunisation and serum preparation 
Five ME! mice were used to raise antibodies against each PfSNF2L fusion 
protein. Approximately 500 pg of protein was emulsified in lml of complete Freund's 
adjuvant. Each mouse was intraperitoneally (i.p.) injected 200 p1 of the mixture. Prior 
to the first immunisation a 0.25 ml tail bleed was taken from each mouse as a sample of 
'pre-inimune' sera. Four weeks later the animals were boosted with protein prepared in 
incomplete Freund's adjuvant. Again 0.2 ml was i.p. injected into each mouse. Mice 
were boosted again 4 weeks later following an identical procedure. Two weeks after 
each boost a 0.5 ml eye bleed was taken. 
To separate the serum from whole blood the blood sample was left for 1 hour at 
37°C, incubated at 4°C overnight and the serum decanted into a fresh tube. In order to 
remove any remaining traces of blood clot the serum was centrifuged for 10 minutes at 
2000 rpm. The clarified serum was then removed, aliquoted into Eppendorfs and stored 
at -20°C. The sera were tested by western blotting and IFA. 
2.19 Western blotting 
2.19.1 Preparation of total proteins from P. falciparum 
Parasites were released from infected RBCs by saponin lysis and washed in 
1xPBS as described in Method 2.7.1. The parasites were pelleted by centrifugation at 
4,000 rpm for 10 minutes, washed in PBS and resuspended in SDS-PAGE loading 
buffer, 100 jil per ml of original infected blood. Samples were boiled for 5 minutes 
prior to loading, 10-15 j.tl per lane. lx PBS with 25 mM EDTA, 5 mM EGTA and 
protease inhibitor cocktail (Boehringer Mannheim) was used instead of normal lx PBS 
in order to prevent protein degradation during the sample preparation. Parasite pellets 
were also sometimes resuspended in 100 p.1 of lx NETTIL (0.15 M NaCl, 5 MM 
EDTA, 50 mM Tris-HC1 (pH 7.5), 0.5% Triton X-100, 0.01% Na azide, 20% 
glycerol, 0.004% bromophenol blue, pH7.5) and 10 p.l resuspension was run in a 
native gel. 
2.19.2 Protein blotting 
Proteins separated by SDS-PAGE were transferred onto PVDF (Sigma) or 
Hybond-C nitrocellulose (Amersham) membrane by the electrophoretic transfer method 
(Renart et al, 1979; Towbin et al, 1979). 
The following gel 'sandwich' was assembled from the bottom anode electrode 
of semi-dry blotting apparatus (Pharmacia LKB) and presoaked in transfer buffer 
(48mM Tris-base, 39mM glycine, 0.037% SDS, 20% methanol): four pieces of 3MM 
papers cut to the size of the gel, a piece of PVDF or nitrocellulose filter cut to the size, 
the gel, another four pieces of 3MM papers. To make sure no bubbles were trapped 
between each layers, a pipette was used to gently roll over each additional layer. After 
excess transfer buffer was removed, the upper cathode electrode was placed on the top 
of the stack and connected the electrodes. Transfer was conducted at 100V for 1.5 
hours. Filters were then ready to be probed for bound antigen. The marker proteins can 
be visualised by (1) 10 min amido black stain in 0.1% amido black 10-B/45% 
methanol! 10% acetic acid, and destain in 90% methanol! 2% acetic acid! 8% water; (2) 
india ink stain ( i. wash blot in 0.4% Tween 20/PBS, 2x 100 ml for 5 min each; ii. 
Place blot in 100 p.1 irikJlOO ml of 0.3% Tween 20/ PBS at RI!' for 2 hr; iii. Destain 
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with several times PBS washings); (3) Ponceau S reversible stain (0.1% Ponceau S 
(w/v)I 5% acetic acid (vlv), Sigma P7170). 
2.19.3 Antibody binding to Western blots 
After the Western transfer was completed the following method was used to 
detect antigens bound to PVDF or nitrocellulose filters. The filters were first incubated 
in blocking solution (5% fat free dried milk, 50 mM Tris pH7.5, 150 mM NaCl, 0.05% 
Tween 20) for 2 hour and washed with 1xPBS, 0.05% Tween 20, twice. The filters 
were then incubated in an antiserum in blocking solution with gentle shaking at room 
temperature for 2 hours. The polyclonal mouse serum was used at several dilutions. 
The filters were washed three times, 5-10 minutes per wash in TBST (50 MM Thris 
pH7.5, 150 mM NaCl, 0.05% Tween 20). The filters were then incubated for 2 hours 
in anti-mouse Horse Radish Peroxidase conjugated anti-IgG (Sigma) diluted 115000 in 
blocking solution. The filters were washed as before and the bound second antibody 
detected using Diaminobenzidine/metal ion enhancement (DAB/Metal) buffer. For 10 ml 
of detection solution, 9 ml of 50 mM Tris pH7.5, 1 ml of 0.3% w/v CoC12 and 10 p.l of 
Hydrogen Peroxide were added to 6 mg of 3,3'-Diaminobenzidine tetrahydrochionde 
and the solution used immediately. Colour development was continued until the desired 
intensity was achieved. Filters were then rinsed in d1420 and dried. All incubations and 
washings were performed at room temperature with shaking. 
2.20 Indirect immunofluorescence assay (IFA) 
2.20.1 Preparation of slides 
In order to prepare slides from different developmental stages of P. falciparum, 
cultures were first synchronised according to the Method 2.6.2, and examined regularly 
by thin blood film, until parasitaemias of 5%-10% were obtained. Then the cultures 
were centrifuged at 4,000 rpm for 5 minutes, and the cells were washed three times in 
Ix PBS with or without 25 mM EDTA, 5 mM EGTA and protease inhibitor cocktail. 
The pellet was then resuspended at 30% hematocrit in lx PBS. Then on a clean slide 
(Hendly, Essex, UK), 5 .tl was used to make a thin smear and allowed to dry at room 
temperature. The slides were either used immediately or stored with desiccant (silica 
gel) at -20°C. 
2.20.2 Staining of slides 
Slides were fixed in ice-cold acetone for 5 minutes, allowed to air dry and then 
grided into 12 squares using nail varnish. Each square was pre-blocked with 20 j.il of 
Ix PBS with 1% BSA and 0.02% sodium azide at room temperature for 30 minutes. 
The solution in each square was removed by water suction and replaced with 20 pJ 
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appropriately diluted antibody, in PBS with 1% BSA and 0.05% sodium azide. Slides 
were incubated in a moist chamber at room temperature for 60 minutes, before the 
antibodies were then aspirated off, and washed three times in ice-cold lx PBS, 
allowing 5 minutes per wash. Slides were then incubated with 20 jiJ of the 
manufacturer's recommended dilution of the second conjugated antibody per square. 
This was either a fluorescein isothiocyanate (FITC) conjugated anti-mouse 
immunoglobulin (Sigma) or a rhodamine isothiocynate (RITC) conjugate of anti-rabbit 
immunoglobulin (Sigma). In addition, parasite nuclei were counter-stained with DAPI 
(4;6 diamidino-2-phenyl-indole, Sigma). In order to do this DAPI was included in the 
second antibody solution at 1:40 dilution in PBS/azide (final concentration of 5 i.tg/ml). 
Slides were then incubated and washed as before, and mounted in mounting solution 
(90% glycerol, 100 mM Tris, pH8.0 and 2.5 mg/ml 1,4-diazabicyclo-[2,2,2] octane 
(DABCO) (Sigma)) to prevent fading. The slides were then examined by fluorescence 
microscopy (Leitz, Germany). 
2.21 Differential display reverse transcriptase-PCR (DDRT-PCR) 
2.21.1 Reverse transcription of P. falciparum RNA 
This reaction was performed in 0.5 ml Eppendorf tubes. Each reaction 
contained 4 j.tl of 5X MrMuLV reverse transcriptase buffer, 2 j.tl of 0.1 M DTT, 1.6 pJ 
250 gM dNTP, 2 p.1 of 10 p.M oligo(dT)primer: [Ti 1GA], 0.2 p.g total RNA from 
asexual or gametocyte stages of P. falciparum (obtained as described previously) and 
H20 to a total volume of 19 p.1. Two different stage mouse embryo total RNAs were 
used as control. The tubes was incubated at 65°C for 5 min to denature the mRNA 
secondary structure and incubate at 37°C for 10 min to allow primer annealling. Add 1 
p.1200 U/mi MrMuLV reverse transcriptase (BRL) to each tube, mix well, and incubate 
at 37°C for 1.5 hours. After that, incubate at 95°C for 5 min to inactivate the reverse 
transcriptase and spin briefly to collect condensation. Place the tubes on ice for 
immediate PCR amplification or store at -20°C for later use. 
2.21.2 Performing of PCR amplification 
Set up a 20 .t1 of reaction mixture in a 0.5 ml Eppendorf tube as follows: 8.2 p.1 
of H20,  2 p.1 of each cDNA (as prepared above), 2 p.l of lOX PCR buffer (100 mM 
Tris-HC1 pH8.3, 500 mM KC1, 0.01% (w/v) gelatin), 1 p.1 of 15 mM MgC1 2, 1.6 p.1 
of 25 p.M dNTP (Boehringer Mannheim), 1 p.1 of 10 mCi/ml [a 35S]dATP, 2 p.1 of 2 
p.M arbitrary decamer: [AATGGATGTG], 2 p.1 of 10 p.M oligo(dT) primer: [T1 1GA] 
and 1 U AmpliTaq (Perkin-Elmer). The reaction mixture was mixed well and overlaid 
with 20 ml of mineral oil. Then PCR was performed using the following conditions: 
40 cycles 94°C for 30 sec, 40°C for 2 mm, 72°C for 30 sec, an additional one cycle 
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extension period at 72°C for 10 mm. 3.5 ml PCR product was mixed with 2 gI of 
formamide loading buffer and incubated 2 min at 80°C to denature the template. The 
sample was loaded onto a 6% denaturing polyacrylamide gel and the gel run at 60W 
for about 3 hr until the Xylene cyanol ran to within 10 cm of the bottom. 
2.21.3 Recovery of differential displayed amplified DNA bands 
Gels were transferred to a piece of Whatman 3MM filter paper and dried by gel 
drier for 1 hr at 80°C. Dried gels were marked by radioactive ink to orient their 
position, and the film exposed for 24 to 48 hrs at room temperature. DNA bands of 
interest which are differentially displayed in different lanes were marked on the gel 
with a clean pencil and cut from the gel with a razor blade. The excised gel was placed 
in a 0.5 ml microcentrifuge tube and 100 .tl of H20 was added to (incubated for 10 
min at room temperature) before boiling for 15 mm. Spin for 2 min at 13,000rpm to 
pellet gel slice and paper debris. The supernatant was decanted into a clean tube and 
added to 10 j.tl of NaOAc, 5 pA of 10 mg/ ml glycogen (as a carrier) and 400 pA of 
100% Ethanol. The tube was incubated at -70°C for 30 min and spin for 10 min at 
13,000 rpm. The pellet was rinsed with 500 pA of 85% Ethanol, air dried and the DNA 
pellet was dissolved in 10 j.tl of H20. 
2.21.4 Reamplification of the recovered DNA 
4 ml of the recovered DNA was reamplified using the same oligo(dT) primer: 
[T GA] and pCR condition described as above; except 1.6 p1 of 250 PM dNTP was 
used instead of 1.6 pA of 25 j.LM dNTP. The reamplified PCR products were analysed 
by 1.5% agarose gel electrophoresis and ethidium bromide staining. Because DNA 
bands are not visible after the first reamplification, 4 pA 1/100 dilution of the first 
reamplification sample was used for a second 40 cycles of amplification to enable 
visualisation of the DNA bands of interest. 
2.22 Administation of heat shock to synchronous P. falciparum 
cultures 
Cultures were first synchronised according to the method 2.7.2 at ring stage 
and examined regularly by thin blood film, until a parasitaemia of 5%-10% was 
obtained. Then three flasks of 5 ml cultures were set up in 5% hematocrit, 1% 
parasitaemia and gased. One bottle was incubated at 40 0C for 3 hours and then moved 
to 37°C, the other two flasks were continuously incubated at 37°C. Thin blood smears 
were taken from these three bottle every 12 hours. One bottle was treated at 40°C after 
12 hours culture (about trophozoit stage) for 3 hours as well as another bottle was 
treated after 24 hour culture (about schizont stage) for 3 hours. The smears were 
stained with Giemsa solution and cells were counted at least 5 microscopic fields. 
2.23 The effects of inhibitors and drugs on progression through the 
P. falciparum cell cycle 
In order to work with synchronised developmental stages of P. falciparum 
parasites, cultures were first sorbitol treated according to the method 2.7.2 at ring stage 
and examined regularly by thin blood film, until parasitaemia of 5%-10% was 
obtained. 5 ml of synchronised cultures were set up in 5% hematocrit, 1% 
parasitaemia. Different inhibitors or drugs (2.5 pg/ml aphidicolin, 2.5 ng/ml 
pyrimethamine, 0.1 jig/ml coichicine, 30 jiM verapamil and 100 ng/ml HC-toxin) were 
continuously added a each change of culture medium. Thin blood smears were taken 
fron those cultures every 12 hours, stained with Giemsa solution and counted. 
2.24 Apoptosis assay with the P. falciparum cultures 
2.24.1 DNA fragmentation assay (DNA ladder assay) 
The DNA fragmentation assay was carried out using the method of Herrmann et al 
(1994) (Herrmann et al, 1994). After treatment, the parasitised RBCs were lysed in 0.1% 
w/v saponinlPBS. The parasites were pelleted, washed with lx PBS and then lysed with 
400 jil of Apoptosis buffer D (100 mM Tris-HCI pH 8.0, 5 mM EDTA pH 8.0, 0.2 M 
NaCl, 0.42 mg/ ml proteinase K, 0.2 % SDS pH 8.0) at 550C for 1 hr. Another 100 jil 
of Apoptosis Buffer D was added to the mixture and incubated at 37°C for at least 2 h. 
After incubation, 215 p1 of 5 M NaCl was added to final concentration 1.5 M in the 
mixture. The mixture was then spun at 6,000 rpm, RT for 5 mm. The supernatant was 
transferred to a new 1.5 ml tube and an equal volume of 100% v/v ethanol was added, 
and kept on ice for 10 min to precipitate the DNA. DNA pellets were washed with 70% 
ethanol once and then resuspended in 40 p1 Apoptosis buffer E (10 MM Tris-HC1 pH 
7.5, 1 mM EDTA pH 8.0, 200 jig/ ml DNase free RNase A) and incubate in 37 0C for 2 
h to digest RNA. The samples were run in 1.5% agarose gel. 
2.24.2 Terminal deoxynucleotidyl transferase mediated dUTP nick-end-
labeling (TUNEL) assay 
The ApoAlert DNA fragmentation assay kit (Clontech) based on the TUNEL assay 
(Piqueras et al, 1996) (Piqueras et al, 1996) was used in these assays. After treatment, 
parasitised RBCs were collected by centrifugation, washed and resuspended in lx 
PBS to 30% hematocrit. On a clean slide (Hendly, Essex, UK), 5 p.1 of the cell 
suspension was used to make a thin smear and allowed to dry at room temperature. To 
fix the cells, the slides were immersed in a Coplin jar containing fresh 4% 
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formaldehyde/PBS at 4°C for 25 minutes and washed with lx PBS, twice. To 
permeabilise the cells, the slides were immersed in a Coplin jar containing prechilled 
0.2% Triton X-100/PBS on ice for 25 minutes and twice washed with lx PBS for 5 
minutes each at each wash. Excess liquid was removed from the slides. The cells were 
covered in 100 tl of equilibration buffer (200 mM K cacodylate pH6.6, 25 mM Tris 
pH6.6, 0.2 mM DTT, 0.25 mg/ml BSA and 2 MM  CoC12) and equilibrated at room 
temperature for 10 minutes. Terminal deoxynucleotidyl transferase (TdT) incubation 
buffer was prepared for the experimental samples, positive controls and negative 
controls and added to the cells. Then the slides were placed at 37°C for 1 hour and 
washed in 2x SSC at room temperature for 15 minutes. The slides were washed again 
in lx PBS for 5 minutes three times. The cells were then stained with 0.5 .tg/m1 
propidium iodide (P1)/PBS at room temperature for 10 minutes and washed in dH20 
twice. Slides were mounted in mounting solution (90% glycerol, 100 MM Tris, pH8.0 
and 2.5 mg/ml 1,4-diazabicyclo - [2,2,2] octane (DABCO) (Sigma)) to prevent fading. 
The slides were then examined by fluorescence microscopy. 
2.25 Methods for the analysis of gene organisation 
The release of the GenBank (Benson et al, 1998), dated February 3, 1998, was 
used in this study. In order to analyse the intron number, size, position, splicing and 
initiation pattern, the sequences from Plasmodiums and T. gondii were first chosen 
which have complete coding sequences. The genes from small organelle genomes were 
not chosen for this study since they may be different splicing pattern to those genes 
from nuclear genome. Then by eliminating the open reading frames (ORFs) that 
contain partial sequences and are repeat chosen (redundant) from different isolates, we 
obtained 53 genes with 100 introns, 58 gene without introns and 34 mRNA form P. 
falciparum, 19 gene with 46 introns, 37 gene without intron and 8 mRNA from other 
Plasmodiums and 15 gene with 60 introns from T. gondii. For each sequences in 
GenBank, the splice sites and initiation codons were located using the information in 
the annotation preceding the sequence, a FEATURES line being followed by multiple 
lines indicating different features present in the gene. As a consequence, there are 
many errors in the database: many sequence entries are either mislabelled, 
contaminated, incompletely or erroneously annotated, or contain sequencing errors. 
Each sequences was checked and corrected manually for this analysis. 
To identify a consensus sequence, the criterion was that a single base at each 
location should represent at least 40% of the total. But the second highest nucleotide 
may also be chosen if it exceeds 30% or is at least twice as large as the third highest 
(Long et al, 1997; Senapathy et a!, 1990). A quantitative measure of conservation is 
the information content at the i'th site, Rs(i), which ranges from zero to two for 
maximum information: 
Rs(i) = 2 + f1,1og2(f) - e(n), 
where fb and e(n) are the frequency of nucleotides and a correction term for sample 
size (n) (Long et al, 1997; Rogers et al, 1995). 
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CHAPTER 3 
STUDIES ON GTPASE MEDIATED PATHWAYS IN PLASMODIUM 
FALCIPAR UM 
3.1 Introduction 
Ran is the most abundant and best conserved small GTPase in eukaryotes 
(Bischoff & Ponstingi, 1991; Drivas et al, 1990). It is also the only known member of 
the Ras superfamily found in the nucleus. Ran has been implicated in a variety of 
nuclear functions including: chromosome decondensation, assembly of a functional 
nucleus, initiation of S phase and import of protein with nuclear localisation signals, 
pre-mRNA processing, export of proteins and mRNA, and cell cycle coordination. 
Like all regulatory GTPases, Ran functions as a molecular switch cycling between 
GTP-bound "on" and GDP-bound "off'. It plays an essential role in protein import 
into the nucleus (Moore & Blobel, 1993) and its GTP loading and hydrolysis cycle 
may be the major energy source for nuclear localisation signal (NLS) mediated 
translocation through nuclear pore complexes (Gorlich et at, 1996). Ran has been 
shown to abundantly expressed in the dividing blood stages of Plasmodium falciparum 
(Dontfraid & Chakrabarti, 1994; Sultan et at, 1994). 
Several Ran homologues have been cloned from Saccharomyces cerevisiae 
(GSPJ/CNRJ and GSP21CNR2), Schizosaccharomyces pombe (Spi), and humans 
(Ran). The human Ran protein is a 25 Kda molecule, abundant in the nucleus, 
(Bischoff & Ponstingl, 1991). Determination of the crystal structure of Ran-
GDP.Mg2+ has shown that the G-domain is similar to Ras but the region involved in 
GDP and Mg2+ coordination is distinct. The N-terminus and the acidic tail are flexible 
in the crystal structure, suggesting that a major conformational change may occur on 
GTP binding (Scheffzek et at, 1995). Unlike other Ras family proteins, Ran lacks the 
C-terminal lipid modification motif for cell membrane anchoring but possesses an 
unusually acidic tall (DEDDDL) (Drivas et at, 1990), which stabilises GDP binding to 
Ran and is required for stable interaction with RanBP1 (Richards et at, 1995). 
The guanidine nucleotide exchange factor (GEF) for Ran is known as RCC1 (for 
regulator of chromosome condensation) (Ohtsubo et at, 1989), a chromatin protein 
which stimulates guanine nucleotide loading and thus generates Ran GTP within the 
nucleus. Ran GTP-Ran GDP hydrolysis is catalysed by the GTPase activating protein 
Ran GAP 1, which is located exclusively in the cell cytoplasm (Bischoff & Ponstingle, 
1995). A cytoplasmic activator of GTP hydrolysis is thus separated by the nuclear 
membrane from a nuclear GTP generator regulating nuclear protein import by the Ran 
cycle. Ran GDP-associated NLS-marked protein complexes destined for nuclear 
import form in the cytoplasm and dissociate in the nucleus along a steep trans- 
membrane Ran GTP gradient (Gorlich et al, 1996). Exchange of GDP for GTP on 
intra-nuclear RCC 1/Ran complexes causes dissociation of the complex and Ran GTP 
export to the cytoplasm. There, Ran-GAP 1 catalyses re-conversion to Ran GDP which 
can then once more bind and chaperone NLS-proteins to nuclear pore complexes and 
the nucleus. The rate of guanine nucleotide exchange on Ran is very low, but the 
exchange factor, RCC 1, specifically stimulates the rate by about 10 5-fold (Kiebe et al, 
1995). The intrinsic rate of GTP hydrolysis by Ran is also low and requires a GTPase 
activating protein (RanGAP). Human RanGAP1 stimulates Ran-GTP hydrolysis by 
about 105-fold (Kiebe et al, 1995). 
RCC1 was first found as a chromatin-associated protein (Ohtsubo et al, 1989). 
RCC1 homologues are identified in Drosophila (BJ1) (Frasch, 1991), Saccharomyces 
cerevisiae (SRM1/ PRP20/TMR1) (Clark & Sprague, 1989), Schizosaccharomyces 
pombe (Pim-Di) (Matsumoto & Beach, 1991), and human (RCC1 and RCC1-1) 
(Miyabashira et al, 1994). All RCC1 family members have seven glycine-rich tandem 
repeats, 50-60 amino acids in length, an N-terminal extension which in at least one 
case, functions as a NLS, and a C-terminal extension whose length varies (Clark et al, 
1989; Dasso, 1993; Frasch, 1991; Matsumoto et al, 1991; Nishitani et al, 1990; 
Ohtsubo et al, 1989). Although there are considerable sequence differences between 
members of this family, the conservation of key glycine residues among the repeats, 
both within a single species and between species is striking. RCC1 and its homologues 
have also been implicated in diverse cellular processes, such as the formation of nuclei, 
the initiation and termination of transcription and pre-mRNA splicing, and Y-end 
formation (Dasso, 1993). 
If Ran mediated nuclear protein import functions in intra-erythrocytic malaria 
parasites then a protein homologous to the Ran-GEF RCC 1 must exist. The aim of the 
work reported in this chapter was to further analyse of a putative RCC 1 gene 
tentatively identified in this laboratory. 
3.2 Partial sequencing and structural analysis of the P. falciparum 
RCCI gene 
A 3 kb cDNA fragment encoding an P.falciparum RCC 1-like molecule was 
previously identified in an asexual erythrocytic stage cDNA library in this laboratory 
(Sultan, 1994). Two PCR probes were amplified and used to isolate three more cDNA 
clones (Figure 3.1). These three clones were completely sequenced. The DNA 
sequence of the original 3 kb cDNA clone was confirmed and the new clones further 
extended the sequence on the 5' and 3' sides for additional 1.1 kb. Several sequencing 
errors in the original sequence have been corrected. A total of 4,161 bp of cDNA have 
been sequenced, encoding a single continuous reading frame without stop codons 
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Figure 3.1 Schematic restriction map of the partial PfRCC1 gene 
compared to the localisation of clones A7, C2-3, C3-1, fusion protein, 
and 5'-and 3-probes. Clone CIO was previously cloned by Sultan, 
1994. 
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which has been primed from a short dA-rich 3' end sequence (Figure 3.2). This 
sequence has been demonstrated to be a single copy gene on chromosome 5 by 
restriction mapping and Southern blotting experiments (Sultan, 1994). Northern 
blotting experiments with RNA from synchronised cultures has also indicated that 
relatively low-level transcription of a single -8 kb RNA occurs in the trophozoites and 
to a lesser extent in the schizonts (Sultan, 1994). This clone has been named PfRCC1 
(GenBank accession number AF048836) and its size and structure compared to other 
RCC1 proteins are shown in Figure 3.3. 
The Swissprot data base was used to compare PfRCC1 with other RCC1 
proteins and the p619 Giant Protein. The human p619 giant protein has 4861 amino 
acid residues that contains two regions of seven internal RCC 1-type repeats and other 
additional regions (Rosa et al, 1996). The alignments around the RCC 1-type repeats 
are depicted using the Pileup programme (Figure 3.4). The alignments of the seven 
RCC 1-type repeats from the human RCC1 protein, the S.cerevisiae RCC1 homologue 
(SRM1), and the two sets of repeats from the p619 protein confirm that PfRCC1 is a 
member of this family of GEFs. Internal homology of the repeats to each other is low 
in all of these proteins. Outside the repeat blocks there is no sequence conservation. 
Sequence insertions, a common feature of P.falciparum proteins, occur in two of the 
seven repeats and in repeat IV, the insertion is 140 amino acids long. Amino acid 
identity between each sequence in the seven RCC1 repeats is only between 11-15% 
although similarity in the short sequence motifs themselves rises to around 60%. The 
single longest block of amino acid identity between the P. falciparum sequence and any 
other is a sequence around the third tandem repeat where 11/18 amino acids (61 %) are 
shared with the p619 Giant Protein. This observation, together with the large size of 
the PfRCC1 and its slightly higher homology with p619 raises the possibility that the 
P.falciparum sequence is actually a homologue of this cytoplasmic GEF rather than of 
the intra-nuclear RCC 1 proteins. However, the extensive partial sequence obtained 
does not appear to leave coding space in the 8kb PfRCC 1 mRNA for the additional set 
of RCC1 repeats that occur in p619 (encoded by a 15kb mRNA (Rosa et al, 1996)). 
Low stringency Southern blotting experiments also indicated only one copy of the 
PfRCC1 repeats exists in the P.falciparum genome (Sultan, 1994). Taken together, 
these experiments indicate that a RCC 1-like homologue does exist in the P. falciparum 
parasites and its predicted molecular weight indicates a size in between conventional 
RCC1 proteins and the p619 proteins. 
3.3 Further characterisation of the P. falciparum RCC1 protein 
To establish the intra-cellular location of PfRCC 1, a DNA fragment encoding 
139 amino acids (comprising the whole of the first and most of the second RCC1 
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Figure 3.2 The partial sequence of the PfRCC 1 gene and its encoded protein. 
The amino acids contained within the shadowed boxes are those of the conserved 
RCC1-like domains. The clone contains a single contiguous reading frame of 
4161 nucleotides encoding a 1387 amino acid protein and the GenBank accession 
number is AF048836. 
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Figure 3.3 Schematic diagram of the size and structure of the PfRCC 1 predicted 
protein compared to the human p619 Giant Protein and the yeast and human RCCI 
proteins. Each block indicates the seven tandem repeated RCCI motifs. 
-.4 
250 aa 
Figure 3.4 Alignment of the conserved sequence motifs in the RCC 1-type repeats. 
p619 is the human p619 Giant Protein (Rosa et al, 1996), RCC1 is the human RCC1 
protein (Ohtsubo et a!, 1989) and SRM1 is the yeast homologue of RCC1 (Clark & 
Sprague, 1989). Regions highlighted in black indicate sequence identity, those in grey 
indicate conservative amino acid substitutions. The seven conserved blocks are 
numbered and P. falciparuin specific insertions are shown below Block I and IV. The 
consensus motif is shown below, q indicating hydrophobic residue. 
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repeat) was cloned into the pET29b bacterial expression vector. The hexahistidine-
tagged fusion protein was induced in E. coli BL2 1 (DE3) and purified by affinity 
chromatography (Yasukawa et al, 1995). The purified protein was injected into rabbits 
with Titremax adjuvant to raise a specific antiserum against the recombinant protein. 
Immuno-fluoresence micrographs comparing the localisation of antibodies to PfRCC 1 
protein in isolated P. falciparum nuclei, with nuclear staining with the DNA binding 
dye DAPI are shown in Figure 3.5. Panels a, c, and e, show the DAPI stained 
isolated parasite nuclei. Panels b, d and f show the corresponding parasite nuclei 
stained with fluor labelled pre-immune sera, mouse antiserum against the PfSNF2L 
chromatin remodelling ATPase (Ji & Arnot, 1997) and the rabbit anti-PfRCC1 
antiserum respectively. While the pre-immune sera does not react with the isolated 
nuclei, antibodies against both the intra-nuclear PfSNF2L and the PfRCC 1 react with 
these parasite nuclei. 
To locate PfRCC1 in intact parasites, immuno-fluorescence micrographs with 
the ring, trophozoite/schizont and segmenting schizont stages of sorbitol synchronised 
cultures are shown in Figure 3.6. Although the resolution of internal structures within 
the erythrocytic parasite is at the limits of that obtainable with fluorescence 
microscopy, it is clear that the fluor-labelled antibody co-localises with segmented 
schizont nuclei stained with DAPI (panels (g) and (h)) and also with the small DAPI 
stained nuclei of the early ring stages (panels (c) and (d)) and the larger, probably 
dividing nuclei present in the late trophozoite/early schizont stages (panels (e) and (f)). 
Western blots prepared from asexual stage total parsite extract were incubated 
with the polyclonal anti-PfRCC 1 rabbit serum in order to identify the PfRCC 1 protein 
from the total protein. However, this anti-serum did not cross-react strongly with any 
band on the Western blots. Multiple very faint bands were shown on the blots (data not 
shown). It was concluded that the polyclonal rabbit anti-sera was not of sufficient 
quality to use in Western blotting although it does appear to give specific nuclear 
staining in IFA experiments. It is possible that the major epitopes being recognised are 
conformational ones which are not conserved in the more denaturing Western blotting 
conditions. 
3.4 	Discussion 
The conclusion drawn from these experiments is that we have identified a P. 
falciparum RCC 1-type guanidine exchange factor and that antibody localisation studies 
indicate that PfRCC1 is located in the parasite nucleus. It is therefore likely that this 
gene encodes the intra-nuclear GEF involved in the Ran mediated nuclear protein 
import cycle. The seven RCC 1-type repeats have also been found in one other protein 
which also appears to act as a GEF, but in this case for the small G protein ADP - 
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Figure 3.5 Staining of isolated P. falciparum nuclei with antibodies against a 
characterised intra-nuclear protein (PfSNF2L) and PfRCC 1. Parasite nuclei were 
isolated by saponin lysis of infected erythrocytes followed by cell rupture by 
homogenisation and separation of parasite nuclei from the external membranes by 
centrifugation (Lanzer et at, 1992). Panels a, c, and e, DAPI stained isolated P. 
falciparum strain 3D7 nuclei from an asynchronous culture. Panel b, the nuclei stained 
panel a, co-stained with FITC labelled pre-immunisation rabbit serum. Panel d, the 
field corresponding to panel c, stained with a FITC labelled mouse antiserum against 
the intra-nuclear chromatin-remodelling complex protein PfSNF2L (Ji & Arnot, 1997). 
Panel e, parasites stained with DAPI in panel f, co-stained with a FITC labelled rabbit 








-I . 	 - 
a 




Figure 3.6 Intra-cellular localisation of PfRCC1 by immuno-fluorescence 
microscopy within different stages of intra-erythrocytic P. falciparum. Panels c, e and 
g. DAPI stained parasite nuclei at the ring, trophozoite/schizont and mature segmented 
schizont stages of development taken from separate synchronous cultures. Panels d, f 
and h, Immuno-fluoresence micrographs of the corresponding parasites with FITC 
labelled polyclonal rabbit antiserum raised against a recombinant fragment of the 
PfRCC 1 protein. Panels a and b, DAPI stained asynchronous parasite nuclei and the 
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ribosylation factors (ARF's). This extremely large, cytosolyic and Golgi-bound GEF, 
the p619 Giant Protein, has two sets of RCC 1-type repeats, the carboxy-terminal one 
interacting with myristylated ARF1 in the Golgi and the amino terminal set stimulating 
guanine nucleotide exchange on ARF1 and Rab but not on the Ran or Ras G proteins 
(Rosa et al, 1996). The alignments of the seven RCC1-type repeats shows that four 
glycine and one proline residues are invariant within the internal seven repeats and in 
between the P. falciparum RCC 1, the human RCC 1 , the S. cerevisiae SRM 1, and the 
two sets of repeats from the p619 protein. Any changes of these residues replaced by a 
charged or large hydrophobic group may cause mutants such as temperature sensitive 
which have already reported by many literatures (Aebi et al, 1990; Matsumoto et al, 
1991; Ohtsubo et al, 1987; Renault et a!, 1998; Sazer & Nurse, 1994). Strikingly, 
three large sequence insertions have been found in repeats I and IV. However, when 
comparing the three-dimensional structures of RCC1 proteins (Renault et a!, 1998), 
none of these sequence insertions is in the -strands which appear to constitute the 
framework of RCC1 architecture. The PfRCC1 is therefore concluded to be a P. 
falciparum homologue of RCC 1. 
What then is the function of RCC1 in P. falciparum? The premature mitotic 
phenotype of the hamster temperature sensitive (ts) BN2 cell line upon temperature 
shift led to the suggestion that RCC1 is part of a cell cycle checkpoint mechanism. 
Loss of RCC 1 disrupts DNA replication from undergoing the normal mitosis pathway 
(Nishitani et a!, 1991; Sazer et a!, 1994). At restrictive temperature tsBN2 cells are 
unable to pass the GUS transition if shifted during GI phase and subject to premature 
chromosome condensation (PCC) and entry into mitosis if shifted during S phase 
(Nishitani et al, 1991). Using DNA-mediated gene transfer to rescue the tsBN2 cell 
line, the human RCC 1 has been shown to regulate mitosis by preventing the activation 
of p34CdC2  histone Hi kinase until DNA replication is complete. No evidence yet 
indicates that PfRCC1 is involved in the regulation of mitosis schizogony. With the 
cloned gene it may be possible to examine this question further e.g. by 'gene knock-
out'. 
In the fission yeast, the temperature sensitive mutant pim shows similar cell 
phenotype to its hamster RCC1tS homologue. The intact nuclear envelope also 
becomes fragmented following mitosis (Demeter et al, 1995). Disruption of nuclear 
architecture may be the initial effect of perturbation of the RanGTPase system. It is 
also possible that a structural component of the nucleolus is the primary target of the 
RanGTPase system and that the abnormal nucleolar structures observed in budding 
and fission yeast pimts mutants influence nuclear structure and function (Forrester et 
al, 1992). Matsumoto and Beach (Matsumoto et al, 199 1) have isolated a S. pombe 
homologue of Ran, termed spil (upressor of 1jm1). Overexpression of the wild-type 
IM 
allele of spil suppresses the pimi mutant phentype, although this will not rescue null 
mutants of pimi, indicating that spil can not completely bypass the requirement for 
pimi and that both proteins are required for normal regulation of the cell cycle with 
respect to completion of DNA replication. From the preliminary results of these 
immunofluorescence experiments, the PfRCC 1 protein has been located in the parasite 
nuclei and translocated between the parasite cytoplasm and nucleus. In some stages of 
malaria life cycle, the PfRCC 1 protein seems be excluded from the nucleus (data not 
shown). The possible functions of the PfRCC1 protein in nuclear structure and nuclear 
transport remain to be determined. 
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CHAPTER 4 
GENE EXPRESSION IN MALARIA PARASITES: CLONING AND 
CHARACTERISATION OF A PLASMODIUM FALCIPARUM 
TRANSCRIPTION FACTOR 
4.1 Introduction 
Plasmodium falciparum has a complex life cycle and the control of its gene 
expression is not understood at even a basic level. A number of preliminary 
observations have been made. Plasmodium mRNA can be translated in vitro and is 
thus inferred to be conventionally capped (Myler et al, 1983; Newbold et al, 1982). 
Three distinct transcripts of a 41 kDa blood stage antigen of P. falciparum have been 
found to be alternative spliced in RNA samples prepared from the schizont stage of 
parasites (Knapp et al, 1991). It therefore appears that malarial parasites, like higher 
eukaryotes, have some capacity to carry out mRNA processing to generate several 
different versions of a protein from a single transcription unit. Promoter 
characterisation in P. falciparum is difficult as the A+T rich base composition of 
intergemc regions (-87%) means that the 5' untranslated regions (UTR5) upstream 
from the initiation codon abound with sequences resembling the TATA motif of most 
eukaryotic transcription promoters (consensus sequence TATAiTA). However, a 
transcriptional start site of proliferating cell nuclear antigen (PCNA) has been mapped 
physically and functionally using a combination of primer extension analysis, 
ribonuclease protection assay and transient transfection analysis with the firefly 
luciferase reporter gene. This functional analysis confirms the general location of the 
mapped transcriptional start site and identifies a region upstream of the start site which 
is required for promoter efficiency (Horrocks & Kilbey, 1996). 
The parasite has a TATA-binding protein and although somewhat divergent 
from other family members, it retains sequences essential for recognition of DNA 
(McAndrew et al, 1993). No other genes encoding transcription factors or proteins 
involved in the transcription process have been characterised to date. Using a pair of 
degenerate primers deduced from amino acid consensus sequences of alignments of the 
GTP binding sites of Ga protein, part of a novel malarial gene related to the SNF2 
(sucrose non-fermenting)-like  family of nuclear ATPases involved in transcription was 
recognised. In order to further characterise the transcriptional process in P. falciparum 
parasites, the whole gene encoding the P. falciparum homologue of the SNF2-like 
protein was cloned for further analysis. 
4.2 Isolation and characterisation of the PfSNF2L gene cDNA clones 
LIM 
The PfSNF2L gene was identified during attempts to clone P. falciparum G-
protein genes. The original PCR reactions were performed by using primers (GP1 and 
GP3) deduced from conserved GTP-binding domains of Ga proteins. A 198 bp 
fragment was amplified and its sequence revealed similarities to the conserved regions 
of the SNF2/SWI2 transcription activation factors when analysed using the BLAST 
search program in the NCBI net service. In attempts to clone members of the G-protein 
gene superfamily, we have amplified several sequences with homologies to ATPase 
domains. Given the importance of SNF2/SWI2 proteins in transcription and our 
interest in developmental gene expression in Plasmodium, the gene was analysed 
further by using the amplified fragment to screen a P. falciparum plasmid cDNA 
library constructed in plasmid vector pJFE14 (see Appendix C) from asexual stage 
mRNA (late rings/early trophozoites) of the P. falciparum clone 1T04. Each positive 
was repeat screened three times (see Figure 4.1 for example). An inverse PCR was 
also launched in order to walk through the poly(A) region in mid of the PJSNF2L gene 
(Figure 4.2). In five rounds of screening, over 65,000 colonies were screened. Ten 
overlapping cDNA clones were isolated and their restriction maps are shown in Figure 
4.2. Each clone was sequenced on both strands using the dye dideoxynucleotide chain 
termination method with the ABI 377 automated sequencer. Sequences derived from 
these overlapping clones were combined to generate a single complete sequence of the 
gene which was named pfSNF2L. 
4.3 The structure of the PfSNF2L gene 
The complete sequence of PfSNF2L has 519 nucleotides of 5'-UTR (86.5% 
A+T) upstream of a putative initiation codon followed by a 4,269 nucleotide open 
reading frame (ORF) (74.1% A+T) and 484 nucleotides of 3'UTR (87% A+T). This 
open reading frame encodes a 1422 amino acid polypeptide with a molecular weight of 
167 kDa (p1 = 6.38). The A/T ratio of the PfSNF2L gene in the sense strand is 1.25; 
nearly all P. falciparum genes analysed to date have values >1.00 of ATF ratio (Weber, 
1987). The exact position of the translation initiation codon is uncertain as there are 
four in-frame methiomne codons in the region 520-595 and alignment with other 
members of the gene family does not resolve this problem since there is heterogeneity 
in the amino terminal sequences of the SNF2-like proteins. The most likely initiation 
site is the first of these in-frame ATG codons since P. falciparum 5' UTR regions as 
a general rule do not maintain in-frame open reading frames. Sequences around this 
codon are not in particularly good agreement with the 'Kozak rules' for eukaryotic 
translation initiation sequences, but P. falciparum genes in general conform poorly to 
this translational initiation consensus which is derived from higher eukaryotic genes 
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Figure 4.1 An autoradiograph showing the results of first, secondary and tertiary 
screening of a positive clone of P. falciparum SNF2L homologue isolated from the 
asexual cDNA library, probed with the PCR product produced by the amplifiction of 
clone gp7. 1. 
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Figure 4.2 	Restriction map of the PJSNF2L gene. The oligonucleotide primers used and 
their locations are underlined with arrowhead. Ten cDNA and PCR clones depicted by 
shaded bar are aligned together in order to indicate their locations. PCR fragments a and b 
depicted by dashed lines were used as the hybridisation probe for cloning and further 
characterisations of PJSNF2L gene. E. Eco RI; H. Hind III; B, Barn HI; C, CIa I; X, Xba I; 
Hp, Hpa I. 
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based on assigning the first in-frame ATG as the initiation codon, is shown in Figure 
4.3. 
The amino acid sequence showed that the highest levels of sequence similarity 
in BLAST searches were with domains conserved between members of the SNF2 and 
SNF2-like (SNF2L) family of transcription factors (Eisen et at, 1995). These proteins 
contain seven conserved regions which constitute the catalytic site of a DNA-dependent 
ATPase which also has a DNA unwinding activity. These seven regions are boxed in 
Figure 4.3. The alignment of the P. fatciparum protein, which we have named 
SNF2L, with the Drosophila (Elfring et al, 1994), human (Okabe et at, 1992), C. 
elegans (unpublished, Genebank ref. P41877) and yeast (unpublished, Genebank 
ref. P31844) SNF2-like proteins is shown in Figure 4.4A. 
Motif I, la and H match the consensus sequence of the bipartite nucleotide 
triphosphate binding motif (A box and B box motifs) found in both ATP and GTP -
binding proteins (Wittinghofer & Pai, 1991) and are required for the transcriptional 
activation of SNF2/SWI2 protein (Laurent et at, 1993). The DNA-dependent ATPase/ 
DNA helicase domain of all the SNF2-like proteins, including P. falciparum sequence, 
is shorter than that of the corresponding domains of SNF2 proteins proper (the human 
and Drosophila brm proteins and the yeast SNF2/SWI2 protein). As in all members of 
the SNF2L subfamily, P. fatciparum SNF2L has the DEAR amino acid motif, 
whereas the SNF2 proteins have a DEGH motif. SNF2L proteins also lack the other 
conserved domains found in brin and SNF2/SWI2, the so-called 'bromodomain', a 
sequence of unknown function postulated to interact with other proteins in the 
transcriptional activation complex. 
In addition to the regions involved in ATPase activity the P. falciparum protein 
also contains a SANT domain which is characteristic of the other SNF2-like proteins, 
but not the SNF proteins (Figure 4.4B). The function of the SANT conserved region 
is unclear but it occurs in several proteins found in transcription complexes such as 
TFIII1B. The domain organisation of the PfSNF2L protein is compared to other SANT 
containing proteins and shown in Figure 4.5. Two regions of the P. falciparum 
SNF2L sequence are not found in other members of the family, although they are 
common in Plasmodium proteins. Eight tandem repeats of a NNHNDD sequence 
occur in the amino terminal domain and between the DNA-dependent ATPase domain 
and the SANT domain, the protein contains a region of 210 lysine rich, basic amino 
acids. Both of these insertions, which make the P. falciparum SNF2L substantially 
bigger than its higher eukaiyotic homologues, are unique. Like most other 
Plasmodium proteins, P. falciparuin SNF2L is an asparagine (12.4%) and lysine 
(11.5%) rich protein. The analysis of secondary structure and hydrophobicity (Figure 
Figure 4.3 The complete sequence of the PfSNF2L gene and its encoded protein. 
The amino acids contained within the solid boxes are those of the conserved ATPase 
domains. The carboxy terminal sequences underlined by the solid bar represent the 
SANT domain characteristic of the SNF2-like proteins. The sequences highlighted 
with dashed line boxes are the asparagine-rich repeated hexapeptides unique to the P. 
falciparum gene. Sequences underlined by dashed lines indicate the position of charged 
residue clusters. The clone contains a single open reading frame of 4269 nucleotides 
encoding a 1,422 amino acid protein with an estimated 167 kDa molecular mass. The 
termination codon is marked by an asterisk and the GenBank accession number is 
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Figure 4.4 A. Alignment of the conserved sequences of the SNF2-like protein 
subfamily. ISWI is the Drosophila protein (Elfring et a!, 1994), HuSNF2L is the 
human protein (Okabe et a!, 1992), CeSNF2L is the C. elegans protein, 
(unpublished, Genebank ref.P4 1877), and ScYB95 is the budding yeast protein, 
(unpublished, Genebank ref. P31844). Regions highlighted in black indicate sequence 
identity, those highlighted in grey indicate conservative amino acid substitutions. The 
overlined position of the seven conserved motifs in the region encoding the framework 
of the DNA-dependent ATPaseIDNA helicase domain is shown. B. The evolutionary 
conservation of the SANT putative DNA binding domain. 
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Domain organisation of SANT proteins 
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Figure 4.5 	The alingment of the SANT-domain proteins and their organisation. MoN-CoR, mouse co- 
repressor; CeYKZ6, ('aenorhabditis elegens predicted protein YKZ6; ScSWI3, Saccharomyces cerevisiae mating 
type switch protein 3; ScADA2, S. cerevisiae transcriptional factor ADA2; ScTFIIIB', S. cerevisiae transcription 
factor III B subunit; PfSNF2L, Plasinodiumfalciparum SNF2 (sucrose non-fermenting)-like protein. Adapted and 
modified from Aasland et al, 1996. 
4.6) shows that the deduced PfSNF2L protein is a very hydrophilic protein except for 
its ATPase/helicase domain and the amino-terminal end sequences. 
GenBank homology searches indicate that P. falcipa rum SNF2L is most 
similar to proteins of the SNF2L subfamily of the SNF2 transcription factors. P. 
falciparum SNF2L proteins are 37.6% identical and 59.8% similar to yeast YB95 
SNF2L protein, 40.6% identical and 63.8% similar to the human SNF2L protein, 
38.1% identical and 61.6% similar to C. elegans SNF2L protein, and 40.4% identical 
and 62.5% similar to Drosophila ISWI protein. Figure 4.7 compares the structure, 
sizes and conserved motifs of these proteins. The primary regions of homology, the 
seven consecutive motifs characteristic of DNA-dependent ATPaseIDNA helicase and 
the C-terminal SANT domain were used to align the five sequences. 
4.4 Phylogenetic analysis of PfSNF2L gene 
Two phylogenetic trees of PfSNF2L were generated depended on the ATPase 
and the SANT domains by using multiple Neighbour-Joining and Parsimony based 
methods in the PAUP computer software package. A tree of SNF2 family was created 
by comparisons of the ATPase regions conserved within the SNF2L subfamily 
members and with the typical representatives of each SNF2 subfamilies (Figure 4.8). 
Less conserved regions (such as the regions flanking the ATPase domain and the 
variable spacer regions) were not used because of problems in obtaining unambiguous 
alignments in these regions and because there is no established method of scoring 
alignment gaps in phylogenetic reconstruction. Bootstrap values for each node are 
shown on the tree. The bootstrap values at the divergent points of the group of SNF2L 
subfamily members with other subfamily members are very high, which indicate a 
high degree of confidence in branch positions. The PfSNF2L is obviously grouped 
with other members of SNF2L subfamily with a high bootstrap value and separated 
from other members of SNF2 families. This indicates that PfSNF2L is truly a member 
of SNF2L subfamily. Another tree of the SANT containing proteins was generated by 
comparison of only the SANT domains conserved among the SANT and MYB 
proteins by Neighbour-Joining method (Figure 4.9). The result also shows that 
PfSNF2L is grouped with the members of SNF2L subfamily and distinguished from 
other SANT containing proteins. 
4.5 	PfSNF2L gene copy number and chromosome localisation 
Genomic DNA was digested with restriction enzymes and analysed by 
Southern blotting (Figure 4. bA). All lanes containing DNA digested with restriction 
enzymes that do not cleave within the probe show hybridisation to a single fragment. 
DNA digested with enzymes which cleave within the probe yield more than one 
MI 
Figure 4.6 The hydrophilicity plot and predicted secondary structure of the 
deduced protein encoded by (A) PfSNF2L and (B) DmISWI. Analyses of 
hydrophilicity and secondary structure prediction were performed using the MacVector 
4.5.1 software. Secondary structure was predicted by Chou-Fasman (CF) and 
Robson-Gamier (RG) methods. The hydrophilicity plot was scaled by the Kyte-
Doolittle method. 
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Figure 4.7 Schematic alignment of the members of the SNF21- 
subfamily. Different shaded boxes represent each different domain 
described above the alignment. Domains are indicated: NNHNDD, 
eight repeated NNHNDD motifs; ATPase domain, DNA-dependant 
ATPase domain; +, highly basic region; SANT, the SANT domain. 
The positions of the bipartite ATP-binding site and other highly 
conserved motifs within the ATPase domain are marked by black 
blocks. The percent identity (ID) of ATPase and SANT domains 
between PfSNF2L and other SNF2L members are marked under 
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Figure 4.8 Phylogenetic tree of ATPase domains of SNF2 families. This is 
rooted tree generated with the program PAUP using maximum parsimony 
method. The bootstrap values are shown at the major points of divergence. 
Hs, Homo sapiens; Mm, Mus musculus; Sc, Saccharomyces cerevisiae, Dm, 
Drosophila mekinogaster; Bc, Bucillus cereus; Lm,, Leishmania major; Ce, 
Caenorhabditis elegens. Accession numbers: Dm_ brahma, M85049; 
Hs_hbrm, X72889; Ce_FO1G4.1, Z68341; Sc_SNF2, M61703; Hs_SNF2L, 
M89907; Dm_ISWI, L27127; Ce_ SNF2L, P41887; Sc_YB95, Z36114; 
Pf_S NF2L, AF003086; Mm_CHD 1, L10410; Mm_Eli-i, X69942; 






































Figure 4.9 Phylogenetic tree of SANT domains and Myb domains. This is an 
unrooted tree generated with the program PAUP using the Neighbour-Joining method. 
The sequences used were (protein, database:identifier): MoNCOR, trn:MM353 12_i; 
HuKG1Q, tr:HSORFKG1Q_1; ScSWI3, sw:SWI3_YEAST; HuMTA1, tm: 
HS 3511310_i; CeYKZ6, sw:YKZ6_CAEEL; ScYCR033, sw:YCS3_YEAST; 
CeCO4A2, tr:CEC04A2_2; ScTFIIIB, trn:SC3 1819_i; CeR151, tr:CER15 1_9; 
ScADA2, sw:ADA2_yeast; HuCMYB, sw:MYB_human (abbreviations : sw: sw 
issprot, tr, and tm: the translated versions of the EMBL and EMBLNEW databases 
Species names are indicated as: Mm, mouse, Hs, human; Ce, C. elegans; Sc, S. 
cerevisiae). Adapted and modified from Aasland et al, 1996. http://www.uib.no/ 
aaslandlniph-tree.html 
Figure 4.10 Copy number and genomic localisation of the PfSNF2L gene. A. 
Southern Blot of P.falciparum (clone 3D7A) DNA cut with the restriction enzymes Bgl 
H, C/a I, Eco RI, Eco RV, Hind III, Hpa I, Mlu II, Nar I, Pst I, Pvu II, Xba I, and 
Xho I (lanes 1-12 respectively) and probed with a labelled fragmentof the cDNA clone 
(as shown in Figure 4.2, probe a). B!. Ethidium stained pulsed field gel separation of 
P.falciparum chromosomes from the Ki and 3D7 lines. B!!. Southern blot of the 
same chromosome separation transferred to nylon membranes and probed with a 












hybridising fragment, whose sizes correspond to the sizes predicted from the 
sequence. No further hybridising bands appeared after longer exposures with high 
stringently washed filters (0.1 x SSC, 0.1% SDS at 560C), this shows that PfSNF2L 
is a single copy sequence without closely related (>80% homology) sequences. The 
same blot was stripped, reprobed and washed under lower stringency (0.4 x SSC, 
0.1% SDS at 52°C) and again a pattern of hybridisation consistant with only a single 
cross-hybridising gene was observed (Data not shown). 
The P. falciparuin chromosomes were resolved on the CHEF gel system and 
the blots were hybridised and washed using the same probe as for Southern blotting. 
The PfSN2L gene was found to be located on chromosome 11 of lines K  and 3137A 
(Figure 4. lOB), according to the definition of chromosome numbers proposed by 
Kemp eta! (Kemp et a!, 1987). Other genes known to reside on chromosome 11 are: 
PfRan, RESA2, pFl 18, pF332, p7-14, Ag840 and pMBA9 (Triglia eta!, 1992). 
4.6 The PfSNF2L intron mapping 
Discrepancies between the size of PCR products derived from genomic DNA 
and eDNA indicated that the gene has at least one intron. Differential splicing in 
Plasmodium Jalciparum has been noted (Knapp et a!, 199 1) and since processing of 
transcription factor mRNA might regulate expression, the introns of this gene were 
cloned, located and sequenced. Using nine pairs of PCR primers and comparing 
genomic DNA, the cDNA clone and the RT-PCR product, the intron-exon boundaries 
of the SNF2L gene were mapped. The intron positions and sequences are shown in 
Figure 4.11. Two introns were 132 and 162 bp in size with 87.1% and 87.6% A+T. 
The splice sites of these introns closely confirmed the mammalian consensus splice 
sites (GT-AG rule). No conservation of branch point sequences was observed in the 
two introns of PJSNF2L which is in agreement with observations made in the Pfexp-1 
gene (Simmons eta!, 1987). 
4.7 PfSNF2L transcription during development 
To determine mRNA size and test for the existence of any precursor or 
processed RNA species, total RNA was isolated from asynchronous asexual stage 
cultures of several P. falciparurn strains and separated on formaldehyde gels for 
Northern blotting. The internal PCR fragment was used as the hybridisation probe. 
The PJSNF2L mRNA can be detected in all three laboratory lines (Dd2, 3D7A and 
HB313) as a single, strong mRNA band of 6-6.5 kb (Figure 4.12A). Faint 
hybridisation to smaller sized fragments varies between RNA preparations and 
probably represents degradation rather than processing. Given that our largest cDNA 
clone is 5.27 kb in size, the primary transcript must be significantly longer than the 
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Figure 4.11 A. PCR fragments (1 to 9) which were designed to locate introns 
shown by solid lines. B. Comparison of the PCR products amplified from genomic 
DNA, RT-PCR product and PJSNF2L cDNA clone of P. falciparurn to map the intron-
exon boundaries. C. The sequence and position of the two carboxy-terminal introns of 
PJSNF2L. Intron 1 is 132 bp and intron 2 is 162 bp. G, genomic DNA; RT, RT-PCR 
product; C, PfSNF2L cDNA clone, M, DNA marker. Hp, Hpa I; E, EcoR I; H, Hind 
III; B, BarnH I; C, Cia I: X, Xba I. 
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Figure 4.12 Message size and steady state mRNA levels throughout the asexual 
cycle. A. Ethidium stained 1.2% formaldehyde/agarose gel separation of total RNA 
from synchronised cultures of 3D7A parasites Northern blotted onto nylon membranes 
and probed with a radio labelled PfSNF2L fragment. R, I and S represent equal 
amounts of total RNA from rings, trophozoites and schizonts respectively. B. Total P. 
falciparum RNA from three parasite clones (1. Dd2, 2. 3D7A, 3. HB3B) and the 
Northern blot of the same gel transferred to nylon membranes and hybridised to a radio 
labelled PfSNF2L probe a (shown in Figure 4.2). 
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coding sequence. 3' RACE (rapid amplification of cDNAends) analysis using a primer 
at the 3' end of the PfSNF2L gene and an oligo dT15 primer indicates that there is a 
longer 3' UTR in the primary transcript (data not shown), and it is likely that this is 
also true at the S end of the mRNA. Low amounts of hybridising message are present 
in gametocytes (data not shown), indicating that the PfSNF2L mRNA is present in all 
erythrocytic stages and in low amounts in the gametocytes (Figure 4.12B). 
4.8 	Discussion 
A P. falciparum homologue of the SNF2L genes which encode chromatin 
remodelling/transcription activation proteins has been identified in this study. The 
protein encoded by this gene may be a component of a Plasmodium chromatin 
remodelling complex. This gene joins the TATA-binding protein gene (McAndrew et 
a!, 1993), the chromatin-associated protein (Birago et a!, 1996), the histone proteins 
(Bennett et al, 1995; Cary et al, 1994) and two high-mobility group protein genes 
(Guntaka et a!, 1992; Kun & Anders, 1995) as characterised loci encoding proteins 
involved in regulating P. falciparum transcription and chromatin remodelling. 
PJSNF2L mRNA is present in low amounts throughout the asexual cycle although it is 
not known whether the protein itself is active in all stages. The P. falciparum SNF2L 
protein is related to the yeast Swilsnf2 protein, the first of this class of proteins to be 
described, but it is more similar to a protein of a Drosophila nucleosome remodelling 
complex, ISWI (Tsukiyama et al, 1995). Interestingly, three different remodelling 
complexes in Drosophila that each contain an ISWI subunit have been found to date. 
The Drosophila nucleosome remodelling factor (NURF) complex appears to be 
involved in chromatin activation yet it is smaller (-500 kDa as opposed to 2MDa), less 
complex (4 as opposed to 11 major polypeptides) and much more abundant (1 05 as 
opposed to 103  copies per cell) than the SWIJSNF complex (Tsukiyama et a!, 1995). 
The chromatin accessibility complex (CHRAC) was identified on the basis of its ability 
to mobilise nucleosomes in a manner that allows enhanced access of a restriction 
enzyme to DNA packaged into chromatin (Varga-Weisz et al, 1997). ATP-dependent 
chromatin assembly and remodelling factor (ACF) was purified as an ATP-utilising 
factor which helps chromatin resembly. Recently, a new, 15-subunit chromatin 
remodelling complex, (RSC - remodel the structure of chromatin ) has been reported 
in yeast. This complex is 10 times as abundant as the SWI/SNF complex and also 
contains a novel DNA dependent ATPase subunit (Cairns et al, 1996). The existence 
of multiple chromatin remodelling complexes may indicate that they regulate different 
promoters and/or control different aspects of DNA metabolism such as repair or 
recombination. It is not known if the PfSNF2L forms part of a multi-protein complex 
or if it is essential for transcription. Unlike yeast and other higher eukaryotic cells 
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which have been found to contain more than one homologue of the SNF2/SWI2 gene, 
the PJSNF2L gene is the only one found in P. falciparurn to date. It is unclear whether 
a more distantly related SNF2/SWI2 homologue exists which may form different 
complexes to regulate distinct cell function manners in malaria cell. The complete 
sequence of P. falciparurn is being carried out at present and this may help resolve 
many of these question relating to the gene repertoire of P. falciparurn. 
Two substantial domains are unique to the P. falciparum SNF21- protein. 
These are the amino terminal tandem repeats of the (NNHNDD)8, and the central 210 
amino acid lysine rich basic domain. The role of neither of these regions is understood, 
although insertions of tandem repeats and basic domains and a consequent marked 
tendency towards larger-than-normal size are common features of Plasmodium 
proteins. The NNHNDD tandem repeat is similar to the common Plasmodium epitope 
(CPE) repeats, such as (X)KND and NKN(X'), which are found in many 
Plasmodium antigens (Cheng et al, 1991). These amino acid repeats are usually 
immunodominant compared to the other parts of the genes. It is interesting that 
asparagine rich repeats, basic domain insertions and the tendency towards increased 
size and complexity are also features of subunits of the P.falciparurn RNA 
polymerases II (Li eta!, 1989) and III (Li et al, 1991). The authors of these studies on 
RNA polymerase proposed that the enlarged variable regions contained regulatory 
domains for transcriptional control during the parasites complex developmental cycle. 
This hypothesis remains tenable and also applicable to the SNF2L protein and its 
unique domains. Lysine rich sequences within nucleoproteins are common and are 
associated with nuclear localisation signals (Gerace, 1995). Residues 895-920 of 
SNF2L have a particularly high similarity to the nuclear targeting consensus sequences 
predicted using the PSORT protein localisation site programme (underlined in dashes 
in Figure 4.3). Several potential casein kinase II phosphorylation sites are also found 
near this region (STDE, 870-873, TDEE,871-874, SGEE, 879-882, TILE 883-886, 
TFLD, 928-931). Such phosphorylation sites are frequently found next to nuclear 
localisation sequences and can enhance the rate of nuclear transport (Rihs et al, 1990). 
In the motif II of the DNA-dependent ATPase domain, all of the members of the 
SNF21- subfamily have the DEAH motif, including PfSNF2L, and are thus different 
from the other subfamilies of the SNF2 family which use the DEGH motif. The 
phylogenetic study of the PfSNF2L protein shows that it is more related to the 
members in SNF21- subfamily than to any other characterised proteins, including other 
members of the SNF2 family. The reason may be that the evolutionary subdivision is 
paralleled by functional subdivision and therefore that particular functions are 
conserved within, but not between, subfamilies (Eisen eta!, 1995). 
liii:] 
The molecular switches which regulate the malaria parasites responses to 
extra-cellular signals and define entry into developmental pathways such as endothelial 
sequestration or gametocytogenesis are not understood. This problem can in principle 
be studied by describing the components of transcriptional activation in P. falciparwn 
and comparing them to better understood systems and then testing hypothetical models 
for Plasmodium developmental mechanisms. The problem with this approach is the 
complexity of gene expression. Thus, for RNA polymerase II (pol II) to transcribe a 
gene requires the recruitment of >20 proteins to a promoter (Buratowski, 1994; Tjian 
& Maniatis, 1994). In addition, assembly of the initiation complex requires the prior 
removal or repositioning of nucleosomes, carried out by multi-protein chromatin 
remodelling complexes, some of which may be promoter specific (another 20-30 
proteins?) (Felsenfeld, 1996; Tsukiyama et a!, 1994). Current models of chromatin 
remodelling complex function are largely based on studies of the yeast, SWIJSNF 
complex. Each protein in this complex is essential for transcriptional control at two sets 
of inducible loci, those involved in mating type switching (the swi mutants) and those 
controlling sugar fermentation (the snf- sucrose non-fermenting mutants). However, 
none of the genes encoding the SWIJSNF complex proteins are essential for asexual 
growth and normal chromatin remodelling and transcription occurs at other promotors 
in swi and snf mutants. 
The lack of mutant selection systems and the fragility of the culture system has 
inhibited progress on complex aspects of the molecular biology of the malaria parasite. 
The genome mapping project (Dame et a!, 1996) and the sequencing of the 
P.falciparum genome could permit much faster identification of conserved core 
components of the parasite's transcription apparatus. With genetic tests for 
functionality such as gene 'knock outs' (Menard et a!, 1997) it may be possible to ask 
whether genes such as P.falciparum SNF2L are essential for survival or involved in 
transcription of inessential' inducible loci such as the metabolic and mating type 
switches activated by the SWIISNF chromatin remodelling complex. We have 
provided Dr. Kirk Deitsch of the National Institutes of Health, Bethesda, with the 
PfSNF2L clones to attempt the 'knock out' transfection of PfSNF2L. Stable 
transfectants with the gene have been obtained and the analysis of selected clones for 
homologous recombinants has started. 
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CHAPTER 5 
THE EXPRESSION OF THE PFSNF2L PROTEIN DURING 
PLASMODIUM FALCIPARUM DEVELOPMENT 
5. 1 Introduction 
Having established that PfSNF2L is a homologue of known eukaryotic 
transcriptional activators, the question arises of what is its role during P. falciparum 
development? The first step towards studying this question is to review what is known 
about the behavior of SNF2/SWI2 and SNF2L proteins in better characterised 
eukaryotic models. In eukaryotes, cell proliferation and differentiation is strictly 
regulated through the process of the cell cycle. During mitosis, the condensation of the 
chromatin into metaphase chromosomes is correlated with a 'global' inhibition of 
transcriptional activity (Johnson & Holland, 1965; Littau et al, 1964). Most 
transcriptional activators are excluded from their normal target sites although they may 
still retain their ability to bind DNA (Martinez-Balbas et a!, 1995). 
The human brahma (hbrm) and brm/S WI-related gene 1 (BRG- 1), two human 
homologues of SNF2/SWI2, are phosphorylated and excluded from the condensed 
chromosomes during mitosis. In addition, hbrm is partially degraded. However, the 
two proteins are located in the nucleus and apparently expressed at approximately 
similar levels throughout interphase. Mitotic phosphorylation of hbrm and BRG- 1 
does not disrupt the association of these proteins with the hSNF5 protein (human 
sucrose non-fermenting gene 5), but does correlate with a decreased affinity of these 
proteins for the nuclear structure before pro-metaphase (Muchardt et al, 1996). 
Phosphorylation triggers the inactivation of the SNF/SWI complexes during cell 
division. Chromosomal exclusion or physical separation of the human SNF/SWI 
complex from the chromosomes at the G2/M transition is therefore thought to be part 
of the mechanism leading to transcriptional arrest during mitosis (Muchardt et a!, 
1996). 
To efficiently arrest cells in the G1 phase of the cell cycle, hbrmIBRG-1 is also 
required to cooperate with the retinoblastoma (RB) protein through a physical 
interaction between RB and hbrm/BRG-1 (Dunaief et al, 1994; Trouche et a!, 1997). 
RB is thus thought to inhibit cell proliferation through its regulation of transcription. 
Repressing expression of RB protein induces cell entry into S phase and may lead to 
malignant transformation (Bartek eta!, 1997). The hbrmIBRG-1 is thus a co-repressor 
for RB and plays a potentially important role in overall cell cycle control (Trouche et a!, 
1997). 
In yeast, the gene NPSJ (nuclear protein of accharomyces), another 
homologue of SNF2/SWI2, is essential for mitotic growth of the S. cerevisiae. The 
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growth of cells carrying the NPSJ null allele and the galactose-inducable NPSJ on the 
plasmid is arrested under NPSJ-repressed conditions. Development halts at the large-
bud stage with a single nucleus that has a DNA content of G2JM phase cell. When the 
arrested cells are further incubated under nps 1-repressed conditions, re-replication of 
DNA occurs in some of the arrested cells without passage through mitosis (Tsuchiya et 
a!, 1992). 
To investigate the links between the activity of the PfSNF2L protein and the 
process of the parasite's intra-erythrocytic cell cycle, immunocytochemical experiments 
were carried out to study the expression and subcellular localisation of PfSNF2L at 
different phases during P. falciparurn development. 
5.2 Expression of recombinant PISNF2L fusion proteins 
The pGEX-4T-1 plasmid (see appendix F) was first chosen to express a 
fragment of PfSNF2L protein as a C-terminal fusion protein with glutathione-S-
transferase (GST), a 26 kDa protein cloned from Schistosoma japonicurn. A 681 bp 
DNA fragment (GST 1) was PCR amplified from cDNA clone Dl.! (nucleotides 4399-
5079) by using a pair of oligonucleotide primers modified to include BamHI restriction 
sites (Figure 5.1). This fragment, which contained the stop codon of PfSNF2L, was 
then inserted into pGEX-4T- I at the BamHI site and introduced into the E. co/i XL- 1 
blue strain by transformation. Positive clones were identified by restriction enzyme 
digestion of the purified plasmids and then confirmed by DNA sequencing. Five 
positive clones were used to transform E. co/i BL2I strain in order to produce the 
predicted 40.3 kDa fusion protein using pGEX-4T- 1 alone as a negative control. The 
proteins were extracted from the BL2 1 cells after IPTG induction at 37°C and 
separated on SDS-PAGE gel. As shown in Figure 5.2, none of the recombinants 
expressed the deduced fusion protein (40.3 kDa), although they all contained a DNA 
insert. However the parental pGEX-4T- 1 could produce the 29 kDa GST fusion 
protein encoded by the pGEX. However, increasing IPTG concentration and induction 
time or reducing the inducing temperature failed to induce any the PfSNF2L fusion 
protein expression (data not shown). The pET-His tag system was therefore tried as an 
alternative to the pGEX system for fusion protein expression. 
Three DNA fragments were PCR amplified from the PfSNF2L cDNA clone 
(Figure 5.1). In order to avoid potential cross-reactions with human SNF2 proteins, 
two unique PfSNF2L-specific regions without homology to the known homologues 
(nucleotides 2787-3163, FF1, and 3378-3766, FF2) were chosen. Another PCR 
fragment (FP3) from nucleotides 4056-4456 was used to express the SANT domain. 
The pET-29 T-vector (see appendix E) is designed for expression of inserts as stable 
fusion proteins with a C-terminal hexa histidine tag transcribed from a T7 RNA 
111 
Figure 5.1 The sequences of the PfSNF2L fragments used to construct fusion 
protein clones for PfSNF2L antibody production. Two oligonucleotide primers, 
underlined by arrowhead lines and contain Bami-Il sites, were used to PCR amplify the 
GST I fragment from the PJSNF2L cDNA clone and subcloned into pGEX-4T- 1 GST 
vector for fusion protein expression. FP 1, FP2 and FP3 were also PCR amplified 
from the PtSNF2L cDNA clone but subcloned into pET29 AT-His6-tag vector in order 
to produce the C-terminal His6-tag fused proteins. The sites of the primers used are 
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Figure 5.2 Comparison of the expression and solubility of the PfSNF2L-
Glutathione-S-transferase (GST) fusion protein clones in pGEX-4T- 1 vector. Proteins 
from an approximately equal number of cells induced with 1 MM IPTG were run on 
each lane of SDS-PAGE gels and stained with Coomassie blue. E. coli BL21 cell 
extracts alone were used as negtive control, whereas pGEX-4T-1 vector alone was 
given a GST protein positive control. Three PfSNF2L-GST fusion protein clones were 
compared. The proteins of soluble and insoluble fractions of total cell extracts and 
whole cell extracts was marked as S, I and W. M and P indicate protein marker and 
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polymerase promoter. The fragments were amplified using three pairs of specially 
designed primers and ligated to the pET-29 T-vector for in-frame expression in the 
pET-29 T-vector. The His6-tag facilitates the purification of PfSNF2L fusion proteins 
by specifically binding to immobilised nickel (Ni 2 ) chelating resins. Positive clones 
from each of these three constructions were identified by restriction enzyme digestion 
of purified plasmid and then further confirmed by DNA sequencing. 
Three positive clones of each recombinant were used to transform E. coli BL2 1 
(DE3) strain in order to produce the predicted fusion protein. The proteins were 
extracted from the BL21 (DE3) cells after 1mM IPTG induction at 37°C and separated 
on SDS-PAGE gel. By this method, the growth of host cells was blocked and the bulk 
of the cell's protein synthesis derives from the fusion protein clones. As shown in 
Figure 5.3, two fusion protein FP1 clones were expressed as a 20.1 kDa soluble 
protein, whereas two FP2 clones were expressed as a 20.5 Wa insoluble protein. The 
fusion protein FP3 clones failed to produce the predicted 21 Wa protein, although a 
lower molecular weight protein is visible in the lane derived from an insoluble protein 
fraction. This clone was therefore abandoned. Solubility of the fusion protein was 
found to dramatically increase when the cell were induced at a lower temperature 
(25 0C). as has previously been reported (Schein & Noteborn, 1988; Schein & 
Noteborn, 1988). However, reducing the induction temperature to 25°C could not 
increase the solubility of FP2 fusion protein (data not shown). 
Before large scale purification of the fusion proteins was carried out, the 
plasmid stability test was carried out to examine whether each recombinant plasmid is 
stable in the BL2 1 (DE3) host. Both recombinant plasmids were transformed into the 
BL21 (DE3) host and then plated on the LB agar plates with or without ampicillin 
selection. As shown in Table 5. 1, both recombinant plasmids are stable in host cells 
even without antibiotics selection. The FP 1 fusion protein was purified under non-
denaturing conditions and the FP2 fusion protein was purified under denaturing 
conditions in 8M urea by using the chromatography on Nickel charged resin in a 
batchwise fashion (as described in Method 2.16). Elution was done by stepwise 
gradient elution with different imidazole concentrations in PBS buffer. The FP  fusion 
protein fractions of 100, 300 and 500 mM irnidazole and the FP2 fractions of 40 and 
60 mM imidazole were collected for further purification. No other bands appeared on 
the gel (see Figure 5.4). The final yield of pure FP  and FP2 fusion proteins was 540 
and 500 jig/ml, respectively. 
5.3 	Raising antibodies against PfSNF2L fusion proteins 
Five MF1 mice were immunised with each PfSNF2L fusion protein. Each 
mouse was bled before the injection of the foreign protein for sera to serve as a control 
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Figure 5.3 Comparison of the expression and solubility of the PfSNF2L-His6-tag 
fusion protein clones in pET29 TA vector. Proteins from an approximately equal 
numbers of cells induced with 1 mM IPTG or uninduced were run on each lanes of 
SDS-PAGE gels and stained by Coomassie blue. E. coli BL21 (DE3) cell extracts 
alone were used as a negtive control. Two or three clones of each PfSNF2L-His6-tag 
fusion protein constructs FP1 and FP2 were compared. The proteins of soluble and 
insoluble fractions of induced total cell extracts and uninduced whole cell extracts are 
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Table 5.1 Plasmid stability test of the recombinants of PfSNF2L fusion proteins 
PfSNF2L fusion proteins 	LB 	LB + 1mM IPTG 	LB + Kan LB + Kan + 1mM IPTG 
FP1-5 5x10 0 4.7x 108 0 
FP1-9 5x108 0 8.2x 108 0 
FP2-1 2x108 0 7.2x 108 0 
FP2-6 3.5 x 108 0 6.3 x 108 0 
FP3-9 2.5 x 108 0 6.3 x 108 0 
FP3-16 7.5 x 108 0 7x 108 0 
FP3-32 4x108 0 6x108 0 
a. CFU/ml culture 
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Figure 5.4 Purification of the PfSNF2L-His6-tag fusion proteins from E. coli 
BL21 (DE3) cells with His-tag affinity chromatography. A. Protein extracts of 
PfSNF2L-His6-tag fusion protein clone FP 1-9 were first sonicated and pelleted. The 
soluble fraction was purified on Nickel resin beads, washed and batchwise eluded in 
imidazole gradients under non-denaturing conditions. Lane: 1 and 2, IPTG uninduced 
and induced whole cell extracts of E. coli BL2 1 (DE3) host cell alone; 3, whole cell 
extract from uninduced FP 1-9 clone: 4, insoluble fraction of total cell extracts from the 
FP1-9 clone induced by 6 hr 1 mM IPTG; 5, flow of soluble fraction of total cell 
extracts from the FP 1-9 clone after passing through affinity chromatography; 6, elude 
of binding buffer wash; 7-13, eludes obtained with 20 mM, 40 mM, 60 MM, 100 MM, 
300 mM, 500 mM and IM imidazole, respectively; 14, elude of strip buffer. B. 
Protein extracts of PfSNF2L-His6-tag fusion protein clone FP2-6 were first sonicated 
and pelleted. The insoluble fractions was purified on Nickel resin beads, washed and 
batchwise eluded in imidazole gradient under a denaturing condition with 8 M urea. 
Lane: 1, whole cell extract from uninduced FP2-6 clone; 2, soluble fraction of total cell 
extracts from the FP2-6 clone induced by 6 hr 1 mM IPTG; 3, flow of resolublised 
insoluble fraction of the FP2-6 clone after passing through affinity chromatography; 4, 
elute of binding buffer wash; 5-9, eludes obtained with 10 MIA, 20 mM, 40 mM, 60 
mM, 100 mM imidazole, respectively; M, protein markers (the molecular weights in 
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to monitor the pre-immunisation response to malaria proteins. Approximately 100 g 
of the FP1 or FP2 fusion protein in 200 il of complete Freund's adjuvant was given to 
each mouse by intraperitoneal injection. The mice were boosted at four weeks, eight 
weeks and sixteen weeks after the initial immunisation with the fusion proteins in 
incomplete Freund's adjuvant. The sera were collected at three weeks, seven weeks, 
fifteen weeks and twenty weeks and tested by Western blotting to check for an 
antibody response (Figure 5.5). 
5.4 Western blotting analysis of the PfSNF2L protein 
After the third boost, each mouse raised a high titre anti-serum against the FP 1 
or the FP2 fusion proteins. The five mouse anti-sera against each FP  or FF2 protein 
were therefore pooled together. Each pooled anti-serum was diluted 1:50, 1:100, 1:200 
and 1:500. Three dilutions of the second antibody (horseradish peroxidase (HRP) 
conjugated anti-mouse IgG) were used at 1:1,000, 1:5,000 and 1:10,000. Results 
showed that 1:200 of each pooled anti-serum and 1:5,000 of the second antibody 
produced minimum background noise on the Western blots of purified FP 1 and FP2 
proteins (data not shown). These were therefore adopted as the optimum dilutions 
required to determine the specificity of the reactions. 
To identify which proteins were recognised by the immune sera, Western blots 
prepared from asexual stage total parasite protein extracts were incubated with the 
pooled anti-sera. Initially, a Western blot of the total protein extracts prepared from the 
-20°C stored 3137A parasites was probed with each pooled anti-sera. Strips of these 
blots were also probed with the pre-immune sera. Multiple bands, all of which were 
smaller than the expected 167 kDa PfSNF2L protein, were detected by both the anti-
FP1 and the FP2 sera (Figure 5.6A, lane 4 and 5). Pre-immune sera did not recognise 
any Plasmodiurn proteins (lane 1), whereas the 50 kDa and 65 Wa proteins were 
detected by a control anti-u-tubulin monoclonal antibody and an anti-PfRap- 1 sera 
(lane 2 and 3). Therefore either the PfSNF2L protein has been degraded during storage 
or the two PfSNF2L antisera may cross-react with some unknown parasite proteins. 
A second Western blot was therefore prepared from freshly harvested parasites 
with a protease inhibitor cocktail added to the preparation to inhibit protein 
degradation. After using this extraction protocol, the predicted approximately 167 kDa 
protein did appear (lane 4 and 6, Figure 5.6B). The multiple lower molecular weight 
bands are however still visible and a few very faint cross-reacting bands are seen in the 
uninfected red blood cell extracts (lane 3 and 5). The same experiment was repeat again 
(Figure 5.7) and this again confirmed that a clear cross-reaction with a 167 Wa bands 
is present (lane 4 and 6). Very faint cross-reacting bands also appear in the lane of the 
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Figure 5.5 Analysis of PfSNF2L mouse sera on the Western blot of the purified 
PfSNF2L fusion proteins. A group of five mice were immunised by each purified 
PfSNF2L fusion protein FPI-9 and FP2-6. Sera were bled from individual mouse 
alter three immunisations and tested on the Western blot of the purified PfSNF2L 
fusion proteins. Lane: 1, purified PfSNF2L fusion protein FPI-9 stained by amido 
black; 2-6, PfSNF2L fusion protein FP1-9 probed by mouse serum A to E; 7, 
PfSNF2L fusion protein FP2-6 stained by amido black; 8-12. PfSNF2L fusion protein 
FP2-6 probed by mouse serum F to J; M, protein markers (the molecular weights in 
kDa are indicated). 
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Figure 5.6 Immunoblot analysis of anti-PfSNF2L mouse sera. A. Immunoblots 
of the total cell extracts were prepared from -20°C frozen stocks of asexual stage P. 
falcipa rum parasites and probed with either anti-PfSNF2L mouse sera FP 1, 1: 300 
dilution (lane 4) or mouse antisera FP2, 1:150 dilution (lane 5). Membrane strips were 
then probed by peroxidase-conjugated rabbit anti-mouse immunoglobulin and detected 
by chemiluminescence. Pre-immunisation sera recognised no parasite protein (lane 1). 
The parasite ct-tubulin and rhoptry proteins were recognised by anti-ct-tubulin 
monoclonal antibody (mAb) TAIl and anti-rhoptry mAb rapi, each used at 1: 500 
dilution (lane 2 and 3). B. Imrriunoblots of the total cell extracts were prepared from 
freshly harvested asexual stage P. falciparum parasites and probed with either mouse 
antisera EP1 (lane 4) or antisera FP2 (lane 6). Blots of RBC extracts alone were 
probed with either mouse antisera FP1 (lane 3) or antisera FP2 (lane 5). Pre-
immunisation sera recognised no parasite proteins (lane 1). The parasite a-tubulin 
were indicated by mAb TAIL (lane 2). The conditions applied here were identical to 




Figure 5.7 Immunoblot analysis of anti-PfSNF2L mouse sera using cell extracts 
prepared from freshly harvested asexual stage P. falciparum parasites, probed with 
either anti-PfSNF2L mouse sera FPI (lane 4) or mouse antisera FP2 (lane 5). E. coli 
BL21 (DE3) cell extract was probed with antisera FP  (lane 1), showing a faint cross-
reaction with bacterial proteins. Blots of purified fusion protein FPI and FP2 were also 
probed with antisera FPI and FP2 (lane 2 and 3). The size of the parasite a-tubulin 
control is indicated by mAb TAT] (lane 6). The conditions applied here were same as 
those described in Figure 5.6. 
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that the original immunisations were not significantly affected by bacterial 
contaminants (Figure 5.7, lane 1). In the above experiments, an anti-trypanosome a-
tubulin mAb which cross-reacts with the Plasmodium protein was used as a positive 
control. Pre-immune mouse sera were the negative control. The anti-a—tubulin mAb 
recognised a band of 50 kDa in size, the P. falciparurn a-tubulin. These results 
indicated that the predicted 167 kDa PfSNF2L protein is present and recognised by this 
polyclonal antiserum in the P. falciparum parasite. It seems that it is easily degraded by 
during the preparation and there may be weak cross-reactions with smaller proteins but 
these do not compromise the use of the antisera in immuno-localisation experiments. 
5.5 Immunolocalisation of PfSNF2L protein 
To localise the PfSNF2L protein in the parasitised red blood cell and to monitor 
its expression throughout the asexual life cycle of the parasite, immunofluorescence 
assays (IFA) were performed on air-dried and acetone fixed thin smears of parasites 
taken from synchronous and asynchronous cultures of P. falciparurn strain 3137A 
infected RB Cs. 
The pooled mouse polyclonal antisera made against the PfSNF2L constructs 
FP  was tested at a dilution of 1:50, 1:100 and 1:200. Antibodies bound to the parasite 
preparation were detected using fluorescein conjugated anti-mouse immunoglobulin G 
(IgG) antibodies at dilutions of 1:50, 1:100 and 1:200. Bound antibodies are thus 
detected by a green fluorescence under UN illumination while the parasite nuclei were 
simutaneously counter-stained with DAPI. Best staining conditions were achieved at 
1:150 dilutions of pooled antisera and 1:100 of the second antibody. 
The FP 1 mouse antisera were first used to examine asynchronous parasite 
blood smears and a series of WA experiments were carried out. These consistently 
gave the same fluorescence patterns. Fluorescence was observed in all stages of the 
intra-erythrocytic parasites from early rings to schizonts (Figure 5.8). A granular 
pattern was seen in the parasitised red blood cell (RBC) cytosol although the exact 
location is unclear. Positive control experiments, using an anti-PfRan rabbit antisera, 
were performed (Figure 5.10 q and r). No fluorescence was detected when mouse pre-
bleed serum (Figure 5.8 a and b) or the fluorescin-conjugated second antibody alone 
were used on the staining of infected or non-infected red blood cells (data not shown). 
When the anti-PfSNF2L antisera were used, although a diffuse pattern was seen over 
the whole parasitised cell throughout all stages of asexual development, an intense 
fluoresein spot was shown to co-localise to the DAPI stained parasite DNA (Figure 
5.8) indicating that most of the PfSNF2L protein is concentrated in the parasite 
nucleus. Figure 5.9 shows the same pattern of spots of fluorescence co-localised with 
the nuclear DAPI stain when the anti-PfSNF2L antisera were used to stain the isolated 
127 
Figure 5.8 Immunofluorescence localisation of PfSNF2L within stages of intra-
erythrocytic P. falciparurn. Panels a, c and e: DAPI stained parasite nuclei taken from 
asynchronously growing asexual stages of P. falciparurn. Panels d and f: Immuno-
fluoresence micrographs of the corresponding parasites with FITC-labelled polyclonal 
mouse antisera (1:150 dilution) raised against the recombinant fragment FP 1 of the 
PfPfSNF2L protein. Panel b: Immuno-fluoresence micrographs of the corresponding 
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Figure 5.9 Staining of isolated P. falciparurn nuclei with antibodies against a 
characterised PfSNF2L. Parasite nuclei were isolated by saponin lysis of infected 
erythrocytes followed by cell rupture by homogenisation and separation of parasite 
nuclei from the external membranes by centrifugation (Lanzer, 1992). Panels a, c, and 
e, DAPI stained isolated P. falciparum strain 3D7 nuclei from an asynchronous 
culture. Panel b, the nuclei stained in panel a, co-stained with FITC labelled pre-
immunisation rabbit serum. Panels d and f, the field corresponding to panels c and e, 
stained with a FITC labelled mouse antiserum against a recombinant fragment FP 1 of 
the PfSNF2L protein. 
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Figure 5.10 Intra-cellular localisation of PfSNF2L by immuno-fluorescence 
microscopy within different stages of intra-erythrocytic P. faiciparurn. Parasite nuclei 
were stained with DAPI at the early ring (c), ring (e), trophozoite (g and i), 
schizontlmerozoite (k), segmenter (m) and gametocyte (o) stages of development taken 
from separate synchronous cultures. Immuno-fluoresence micrographs of the 
corresponding parasites were detected with FITC labelled polyclonal mouse antisera 
raised against a recombinant fragment FP1 of the PfSNF2L protein (d, f, h, j, 1, n and 
p). P. faciparum parasites at segmenter stage were probed with DAPI and FITC-
labelled polyclonal anti-PfRan rabbit sera as a positive control (q and r). Asexual 
stages parasites were also co-stained with DAPI and FITC-labelled mouse pre-immune 
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parasite nuclei. This indicates that the PfSNF2L protein, as would be expected for a 
transcription factor, is located in the parasite nucleus. 
The changing nature of the PfSNF2L expression was further characterised 
throughout the asexual cell cycle of synchronous parasite cultures. PfSNF2L could be 
detected in young rings as a spot of fluorescence which co-localised to the nucleus 
with the DAPI stain (Figure 5.10 c and d). This intra-nuclear concentration then 
changed to more dispersed, a punctate pattern of fluorescence in late rings, although it 
was still predominantly concentrated around a bright spot' of apparently nuclear 
localisation (Figure 5.10 e and f). These extra-nuclear granular spots appear to be 
located within the erythrocyte cytoplasm of the parasitised RBCs rather than just inside 
the parasitophorous vacuole and some cells showed the spots apparently aligned 
directly under the erythrocyte membrane. The punctate spots become bigger in late 
trophozoites but their numbers decrease (Figure 5.10 g to j). Strikingly, the PfSNF2L 
seemed to be excluded from nucleus at this part (Figure 5.10 g to j). As shown in 
Figure 5.10 k and 1, the punctate pattern also disappears during the schizont stages, 
and the bright fluorescein staining appears more concentrated in segmenting schizonts 
and merozoites. In the late schizont or segmenter stage of the parasite, the fluorescence 
appeared to re-localise to the nuclei (Figure 5.10 m and n). The gametocyte gave a 
diffuse pattern of staining with the pattern of fluorescence dispersed throughout the 
parasite cytoplasm and underside of the cell membrane (Figure 5.9 o and p). Positive 
control experiments, using an anti-PfRan rabbit antisera, were performed in Figure 
5.10 q and r. 
5.6 	Discussion 
Genetic and biochemical studies have defined the yeast SNF2/SWI2 and 
Drosophila ISWI proteins as components of a complex machinery that regulates 
transcription by modifying the structure of chromatin. A Plasmodium falcipa rum 
homologue (PfSNF2L) of the ISWI, which encodes a estimated 167 Wa protein, was 
cloned and characterised (Ji & Arnot, 1997). The PfSNF2L mRNA is found to be 
presented in all erythrocytic stages and in low amounts in the gametocytes by Northern 
blot studies. To investigate the expression and localisation of PfSNF2L, two mouse 
sera were raised against two PfSNF2L-His tag fusion proteins FP1 and FP2 (Figure 
5.1). 
These anti-sera were used to detect PfSNF2L protein on a Western blot in 
which total proteins were prepared from frozen stocks of asynchronous parasites. 
However, multiple bands were observed as shown in Figure 5.6A. The sizes of these 
bands are all smaller than 167 kDa. This indicated that either the PfSNF2L was 
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degraded during the protein preparation or that the anti-sera cross-reacted with 
unrelated Plasmodium proteins. However, an approximately 167 kDa protein could be 
detected by both FP1 and FP2 antisera on Western blots which used fresh parasite 
cultures, extracted with an inhibitor cocktail added during the preparation, although 
some smaller bands were still observed. Such protein proteolysis is often seen in other 
malaria proteins (Fonjungo et al, 1998; Holder et a!, 1992; Wiesner et al, 1998). For 
example, during the period of schizont rupture, the 195 Wa merozoite surface protein 
1 (MSP1) protein is primarily broken into four major fragments of 83, 28-30, 38 and 
42 kDa. The 42 Wa fragment is then further processed into 33 and 19 Wa fragment 
after merozoite release (Blackman et a!, 1990; O'Dea et a!, 1995). It is possible that 
PfSNF2L degradation may be the result of protein processing in vivo rather than 
artefactual proteolytic degradation during sample preparation, although no PEST 
sequence is found in PfSNFL protein by the PEST-FIND program. The PEST 
sequences serve as signals for proteolytic degradation of many proteins such as 
transcription factors and cell-cycle regulators through ubiquitin-mediated proteolytic 
pathway (Rechsteiner, 1991). 
It is also possible that the PfSNF2L antisera are cross-reacting to other P. 
falciparum proteins. Many serological cross-reactions between distinct P. falciparum 
antigens have been described, e.g. anti-Pf332 antibodies can recognise the 
'PEEXXEEXX' consensus repeat of Pf 11-1 antigen (Ma et al, 1990; Mattei et al, 
1992; Mattei & Scherf, 1992). The common Plasmodium epitopes such as NKND, 
IKND and KKND can even be recognised by a single monoclonal antibody (mAb) 
M26-32 (Cheng et a!, 1991). Comparison of PfSNF2L protein fragments FP1 and 
FF2 with other Plasmodium proteins by BLAST search of GenBank shows no 
significant homology to any currently known protein. Comparison of 
immunofluorescence assay (WA) results of the MESA (mature erythrocyte surface 
antigen), PfHRP-1 (histidine-rich protein-1) and Pf332 proteins (Coppel et al. 1986; 
Crabb et a!, 1997; Mattei et a!, 1992; Mattei et a!, 1992) indicate that PfSNF2L may 
also be associated with the classically observed structures seen in Giemsa stained 
parasited erythrocytes known as Maurers clefts, a membrane structure located in the 
parasitised erythrocyte. However careful examination of the granular pattern of 
PfSNF2L antibody staining indicates that it is distinct from those described for the 
erythrocyte associated antigens of P. falciparuin such as MESA (Coppel et a!, 1986), 
HRP-1 (Crabb et a!, 1997; Taylor et a!, 1987), and Ff332 antigen (Hinterberg et a!, 
1994; Mattel et a!, 1992). None of these proteins show this developmental switch in 
appearance of the granular pattern. However, the PfSNF2L polyclonal antisera raised 
here cannot conclusively distinguish between several hypothetical models of PfSNF2L 
behavior. A more specific reagent such as an anti-PfSNF2L monoclonal antibody 
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which could immunoprecipitate the pure protein would be very useful for the further 
studies of these questions. 
Based on WA results, PfSNF2L is expressed mainly in the asexual parasite 
with some evidence of its presence in gametocytes. As in other eukaryotic cells, many 
P. falciparum proteins are transported to specific cellular compartments or are secreted. 
The kinetics of PfSNF2L expression showed that it is detectable in the nuclei of young 
rings after merozoite invasion. When the parasite develops to late ring stage, a 
punctate pattern of fluorescence is observed in erythrocyte cytoplasm and under the 
erythrocyte membrane, although most PfSNF2L is still located in the parasite nucleus. 
This seems to indicate that at this stage some PfSN1F2L is exported across the 
parasite's plasma membrane and parasitophorous vacuole membrane into the 
erythrocyte cytosol, although why a transcription-related protein should show this 
behavior is unclear. The differential localisation of PfSNF2L between nucleus and 
cytoplasm at different stages of parasite development suggests that its transport might 
be coupled with the regulation of the parasite cell cycle. However, how and why 
PfSNF2L, a nuclear transcriptional factor, is moved to the cytoplasm of the parasitised 
erythrocyte is not understood. It is possible that the protein is at all times within the 
parasitophorous vacuole membrane and its presence there can be explained by its being 
synthesised on the cytoplasmic ribosomes. Its apparent presence throughout the 
parasitised erythrocyte may then be merely post-fixation leakage. 
In trophozoites, the PfSNF2L seems to be excluded from parasite nuclei and 
its granular pattern becomes more pronounced. As the schizont, segmenter and 
merozoite stages of parasites developed, the PfSNF2L protein is re-located back to the 
parasite nuclei and the punctate pattern is progressively disappears during those stages. 
The hbrm and BRG-1 proteins, two human homologues of SNF2/SWI2, have been 
reported to be phosphorylated and excluded from the condensed chromosomes during 
mitosis (Muchardt et al, 1996). The hbrm protein is further degraded in this phase of 
cell cycle. It has been suggested that chromosomal exclusion of the human SNF/SWI 
complex at the G2IM transition could be part of the mechanism leading to 
transcriptional arrest during mitosis. However, very little is understood about the G2 
and M phases of the Plasmodium life cycle (Arnot & Gull, 1998). There is no clear 
definition to each phase of malaria cell cycle which can be directly compared with 
higher eukaryotic cells and yeast. Thus the PfSNF2L exclusion pattern cannot be 
directly compared to the hbrm and BRG- 1. However there are indications that the 
expression of the PfSNF2L does correlate to the malaria cell cycle in a somewhat 
similar fashion to the way these proteins behave in other eukaryotic cells. Whether the 
PfSNF2L is phosphorylated and how it may be transported between parasite 
cytoplasm and nucleus, and even between parasite and erythrocytic cytoplasm remains 
137 
to be determined. There is also a possibility that the PfSNF2L antisera can recognise 
an unknown parasite protein which can be secreted into the erythrocytic cytoplasm. If 
this is the case, the PfSNF2L punctate pattern and protein exclusion from the nucleus 
may be separated into two independent categories. To made further progress on this 
question could seen to require a monoclonal antibody of defined anti-PfSNF2L 
specificity for electron microscope immunogold localisation studies. 
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CHAPTER 6 
THE INTERPRETATION OF THE CELL CYCLE OF PLASMODIUM 
PALCIPAR UM 
This chapter is concerned with some more general and cell-biologically oriented 
studies of the cell cycle and development of P. falciparum. It involves experiments on 
a) gene expression switches during the parasite's progression through its cell cycle and 
development and b) the question of apoptosis-like symptoms in P. falciparum. 
Apoptosis has not been previously investigated in P. falciparum and some preliminary 
studies of this phenomenon have been carried out. The objective is to link studies of 
transcriptional regulation, signal transduction and nuclear transport and to stimulate 
thought on new directions for further studies. 
6.1 Differential display reverse transcriptase-polymerase chain reaction 
(DDRT-PCR) 
In some sense, changes in gene expression pattern are the developmental 
process of the parasite. Cellular and molecular studies have shown that the 
development of the sexual stages of malaria parasites involves the modification of basic 
cellular components such as ribosomes and the cytoskeleton (Alano & Carter, 1990; 
Sinden, 1982) as well as the expression of numerous, but uncharacterised and 
uncloned sexual stage-specific genes. The technique of differential display of mRNA 
species was therefore assessed to test its potential to identify P. falciparum genes 
whose expression is restricted to the gametocyte relative to the sexual-stage parasites. 
The technique, originally described by Liang and Pardee (Liang & Pardee, 
1992), is based on assumptions that every cell expresses some 15,000 genes and, in 
principle, every individual mRNA molecule can be reverse transcribed and amplified 
by the polymerase chain reaction. In order to display at least 15,000 bands on an 
acrylamide gel, one would therefore need about 100 tracks which could resolve 150 
bands each. Liang and Pardee therefore subdivided the total reverse transcribed cDNA 
into 12 fractions and used a set of arbitrary primers for PCR amplification of each 
cDNA fraction. Denaturing polyacrylamide gel electrophoresis was then used to 
separate each amplified cDNA fraction. 
Figure 6.1 illustrates the general strategy of differential display. An RNA 
sample is reverse transcribed with each of the four sets of degenerate anchored 3' 
oligo(dT) primers (T 11 MN), where M can be G, A or C and N is G, A, T or C. The 
resulting cDNA population is PCR-amplified using the degenerate 5' primer set, an 
arbitrary decamer and radioactive nucleotide. The radioactivity labelled PCR products 
that represent a subpopulation of mRNAs defined by the given primer set are separated 
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Figure 6.1 Schematic representation of Differential display. T 11   MN, degenerate oligo(dT) 
primer: M indicate A,C or G; N can be A,C, G or T; 	: RNA; 	DNA 
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on a denaturing polyacrylaniide gel. By changing primer combinations, most of the 
RNA species in a cell may be represented. Side-by-side comparison of RNA samples 
from different cells then allows the identification and cloning of differentially 
expressed genes. 
To test the potential of differential display PCR in studies of P. falciparum 
differential gene expression, total RNA from asexual or gametocyte stages of parasites 
was reverse transcribed with oligo(dT) primer (T 1 1 GA) and then PCR amplified with a 
decamer (AATGGATGTG). The total RNA from day 9 and day 10 mouse embryo 
were used as a experimental control. The 355-labelled PCR products were separated on 
8M urea-acrylamine sequencing gel and visualised by autoradiography. A 
representative differential display sequencing gel is presented in Figure 6.2. Numerous 
bands reflecting common gene expression can be observed along with bands which are 
apparently specific to in particular parasite stages. 
Putative stage-specific cDNA bands were excised from the dried gel, eluted and 
reamplified using the same primer pair used in differential display. 13 cDNA bands 
were gel purified and re-amplified by PCR from asexual and gametocyte stage parasite 
gel. These reamplified PCR products of cDNAs were then subcloned into pCR2 
vector and sequenced by the automatic DNA sequencer. In analysis of each of the 13 
cDNAs, 12 clones failed to identify any significant similarity to any entries in the 
GenBank database. One clone Pf3-1 shows a high similarity to the yeast Sepi (strand 
exchange protein 1) and mouse Dhm2 (hp1 homologue in mouse protein 2) genes 
(see Appendix B), whose products are involved in many cellular processes including 
meiosis, cellular senescence, and telomere maintenance (Heyer et al, 1995; Shobuike et 
al, 1997). Strikingly, the mouse Dhm2 protein has been suggested to participate in 
gametogenesis in the mouse (Shobuike et al, 1997). If it is true that the Pf3-1 is the 
Sepi and Dhm2 homologue and is involved in malaria gametogenesis it could be 
further determined by cloning the entire gene and characterising its protein. 
The bands shown on the gametocyte lane were less numeruous than those 
present during the the asexual stage, indicating that gametocytes exhibit reduced 
expression of mRNA compared to the sexual stages. The reason is possibly that in the 
sexual stages, gametocytes cease growth and division, keeping a relatively small 
amount of protein synthesis to prolong and maintain their basic metabolism. No similar 
density bands were found between malaria gametocyte and asexual stage parasite lanes 
indicating that such messages are probably being transcribed at very different levels in 
sexual and asexual forms. 
Since DDRT-PCR was first described, RNA fingerprinting has been used 
successfully to isolate differentially expressed genes in a large number of experimental 
systems e.g. mouse and human (McClelland et al, 1995). Although no publications 
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Figure 6.2 Differential display of mRNA from malaria gametocyte versus asexual 
stage parasites, and mouse embryo day 9 versus day 10 using the DDRT-PCR 
technique. The purified total RNA (2 mg) was reverse transcribed with [T11GA]. Then 
the [Ti 1GA] and decamer [AATGGATGTG] were used for the PCR reaction as 
described in text. Lane 1. asexual stage parasites of P. falciparum. Lane 2. gametocyte 
stage parasites of P. falciparum. Lane 3. mouse embryo day 9. Lane 4. mouse embryo 
day 10. Several candidate cDNA tags that appear to be differentially expressed are 








using this technique have been published to date in the malaria field, this experiment 
indicates that it could be used to characterise and isolate some stage-specific genes of 
either asexual or gametocyte stages of P. falciparum from parasites and provide further 
insights into the control of sexual differentiation in malaria parasites. 
6.2 Does apoptosis occur in the P. falciparum parasites? 
Although molecular biology techniques such as DDRT-PCR can provide 
powerful tools for looking at the gene switches during the parasite's development, they 
still cannot resolve some cell biological problems in the malaria cell cycle. For 
instance, even in the so-called synchronous cultures, there is very little information to 
indicate that there is true synchrony in the cell cycle timings of individual cells within 
these culture populations. Malaria schizogony is also imperfectly understood in cell 
biological terms. Another example is the apparent mitotic asynchrony within individual 
parasite cells and variation in the ultimate number of schizonts produced per infected 
erythrocyte which has been observed during the schizogony. In fact, odd numbers of 
nuclei are often seen in schizont formation and there is little evidence for a 1, 2, 4, 8, 
16, 32 type geometric doubling of nuclei during mitosis. Experiments of this chapter 
have been carried out to investigate whether apoptosis may be involved in this process. 
Apoptosis is a form of programmed cell death and is a common feature of 
multicellular organisms. It plays an important role in development and homeotasis of 
metazoan organisms. During apoptosis, a cell activates an intrinsic suicide mechanism 
that systematically destroys the cell. An early marker of apoptosis is the exposure of 
phosphatidylserine (PtdSer) normally concentrated in the luminal layer of the 
cytoplasmic membrane on the cell surface (Martin et al, 1995). Nuclear DNA is 
cleaved between nucleosomes (Wyllie et al, 1980) and the chromatin condenses (Kerr 
et al, 1972). The cell finally breaks into membrane-enclosed fragments, the apoptotic 
bodies (Kerr et al, 1972). The initiation of apoptosis is a highly coordinated and 
regulated process controlled by many apoptotic regulators such as the Bcl-2 family 
proteins, IL-i a-converting enzyme (ICE) proteases (caspases), and p53. 
In mammals, ageing cells are quickly destroyed and removed by apoptotic 
processing. Recently, cell ageing has also been reported in yeast cells to be indicated 
by the accumulation of extra-chromosomal rDNA circles (Guarente, 1997; Simon et al, 
1991; Sinclair & Guarente, 1997; Sinclair et al, 1997), although this has not been 
directly linked with yeast apoptosis. This apoptosis-like phenomenon has however 
been reported in yeast by several research groups (Madeo et al, 1997; Tao et al, 1997; 
Taylor & McKeon, 1997). For example, a Saccharomyces cerevisiae cdc48 cell-cycle 
mutant has been described that exhibits a degree of chromatin condensation and 
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Figure 6.3 The comparison between (A) the necrotic cell death and (B) programmed cell death. Necrotic death: a normal 
cell (a) begins to swell (b) before losing its membrane integrity and lysing (c), spilling its contents into the surrounding 
area. Apoptosis: the normal cell (a) shrinks and the condensed chromatin collapses into crescents around the nuclear 
envolope (b). The membrane then begins to bulge and bleb (c), while the nucleus ultimately collapsed (d). The blebbing 
increases and the cell finally breaks apart into number of apoptotic bodies (e), which lyse in vitro (I) and are phagocytosed 
in vivo (g). (Adapted and modified from Mastrangelo and Betenbaugh, 1998). http://www.uib.no/aasland/SANT.html.  
(Madeo et al, 1997). This protein was not however homologous to any of the apoptotic 
regulators that have been found nor was there evidence of nuclear DNA fragmentation 
in the yeast. A number of observation of apoptosis-like phenomena have also been 
reported in other unicellular and non-metazoan multicellular eukaryotes. The most 
compelling evidence of apoptosis-like cell death programmed in a unicellular organism 
is the developmentally regulated cell death observed in T. cruzi. This exhibits 
membrane blebbing, chromatin condensation and margination strongly reminiscent of 
that seen in apoptosis, and DNA fragmentation (Ameisen et al, 1995). The treatment of 
Trypanosoma cruzi parasites with the antibiotic drug (G418) induces the apoptotic 
death of epimastigotes (Billaut-Mulot et al, 1996). Even in bacteria, self-suicide is also 
thought to be induced when bacteria are treated with physical agents such as heating 
and freeze-thaw, chemical agents such as biocides and biological agents such as 
bacteriophage (Djordjevic et a!, 1997; Dodd et al, 1997). 
During some experiments on malaria transfection by electroporation, it was 
observed that malaria nuclei became condensed and appeared to cleave into dark 
Geimsa stained granules surrounded by cytoplasm approximately 12 hours after 
electric shock (data not shown). Such morphology is more similar to the apoptotic 
phenomenon rather than the necrotic cell death shown in Figure 6.3 (Mastrangelo & 
Betenbaugh, 1998). The phenomenon is similar to the apoptotic cell death described in 
Trypanosoma and yeast cells and is quite different from necrosis, a process resulting in 
cell lysis and release of cytoplasmic material after overwhelming cellular injury. These 
observations suggested that an apoptosis-like mechanism may occur in Plasmodium 
and some further experiments on the phenomenon were carried out. 
Apoptosis-like processes in Plasmodium 
The terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling 
(TUNEL) assay was used to test for P. falciparum apoptosis. The technique is based 
on the ability of terminal deoxynucleotidyl transferase (TdT) to add several fluorescein-
labeled deoxynucleotides at the 3'-OH termini of DNA fragments generated by the 
endonuclease digestion of genomic DNA that occurs during apoptosis. Figure 6.4 
shows 3D7 parasites treated with electric shock, followed by culture for 24 h, then co-
stained with TUNEL and propidium iodide (P1) which stains nuclear DNA. More than 
50% of electric shocked 3D7 parasites showed an intensive green fluorescent staining 
with TUNEL assay (Figure 6.4, panels f & h), whereas all parasite nuclei showed red 
fluorescent stain with P1 (Figure 6.4, panels e & g). Apoptotic-like parasites are 
marked by arrowheads. The parasites showed significant damage by the physical 
injury with morphologic damage and a large decrease in cell numbers. This is similar 
to the apoptotic phenomena that mammalian cells display when treated with known 
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Figure 6.4 DNA fragmentation assay in electric-shock-treated P. faciparum parasites 
using the TUNEL method. Synchronised ring-stage parasites were given electric shock 
treatment (2.25kV, 25m1, 200W) and subsequently grown in parasite culture medium 
for 24 h. Panels f & h: the treated parasites stained with the TUINEL assay. Panel b: a 
TdT-minus negative control. Panel d: the DNase 1-treated positive control. Panels a, c, 
e, & g: IP co-stained parasite nuclei of corresponding negative control, positive control 
and the TUNEL assays. 
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apoptosis-inducers such as dexamethasone (Piqueras et at, 1996). The TUNEL assay 
results indicate that damaged parasites were undergoing DNA fragmentation. 
Interestingly, in some normal schizonts, some nuclei are also shown bright TUNEL 
staining, which indicates that these nuclei may be undergoing the apoptosis while the 
other nuclei in that red blood cell are not (Figure 6.4, panel f). This result might even 
explain why odd numbers of nuclei are often seen in Giemsa stained schizonts. During 
mitosis at the schizont stage, some nuclei could be undergoing apoptosis and are thus 
incapable of further divison. A DNase I treated positive control shows strong TUNEL 
fluorescence in treated parasites (Figure 6.4, panel d). Nothing is observed under the 
same conditions when TdT is omitted from the reaction (Figure 6.4, panel b). 
Analysis of the isolated chromosomal DNA by agarose electrophoresis did not 
show the DNA ladder (Figure 6.5). Such results have also been reported from some 
high eukaryotic cells which undergo apoptosis without the occurrence of a discernable 
DNA ladder (Oberhammer et a!, 1993). 
Much malaria research has gone into examining ways in which parasites may 
be killed using drugs/antibodies etc., but little attention has been directed at examining 
parasite growth limitation/self-regulation. These preliminary results shown here imply 
that certain apoptosis-like phenomenon happen in malaria parasites. The discovery of 
programmed cell death in culture form T. cruzi suggest that the apoptosis-like process 
may also happen in parasitic protozoa, although no similar observations with 
Plasmodium have yet been published by other groups. As in yeast, a database search 
of the Plasmodium genome shows no potential homologues of genes involved in the 
triggering of apoptosis such as the caspases, p53 and bcl-2. Although it is too early to 
say that the apoptotic cell death does exist in P. falciparum parasite, this finding does 
provide a possible direction for the further studies. 
1M2 
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Figure 6.5 Analysis of genomic DNA after treatment of P. falciparum parasites 
without (1) or with electric shock (2). Genomic DNA was analysed in an agarose 
gel (15%). M is a 100-bp DNA ladder marker. 
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CHAPTER 7 
SOME GENERAL OBSERVATIONS ON THE STRUCTURE OF 
PLASMODIUM GENES 
7.1 Introduction 
While carrying out computing analysis of the PfSNF2L, PfRan and PfRCC1 
genes, I found that there was no recent systematic information or general discussion of 
the organisation of the Plasmodium genes. As more and more genes from Plasodium 
and T. gondii have been sequenced, it is likely that a re-evaluation of these early 
observations on protozoan consensus sequences is necessary. Taking advantage of the 
increased number of sequences which now are available from the GenBank database, I 
report here an up-to-date analysis of the nuclear coding sequence, intron/exon 
junctions and the composition of the genome from P. falciparum, other Plasmodium 
and T. gondii and compare differences among them. 
All members of the phylum Apicomplexa are parasitic and have complex, 
multi-stage life cycles. Most are intracellular parasites and some, including 
Plasmodium and Toxoplasma, reproduce sexually in one host and asexually in 
another. Although Toxoplasma gondii is normally non-pathogenic in adults, it can 
cause the emergence of toxoplasmosis as an opportunistic pathogen in AIDS and in 
congenital infection of new-born children (Sibley & Boothroyd, 1992). Because of the 
biomedical interest in T. gondii, many of its genes have been sequenced and it is the 
only other example from the Apicomplexa for which extensive sequence database 
exist. 
The malaria parasite, during most its life cycle, possesses a haploid genome of 
2-4 x107 bp with an extremely high A+T content of about 82% (Pollack et al, 1982). 
Coding regions in malaria parasites are somwhat less A+T-rich than flanking 
noncoding regions and introns (Weber, 1987). Malaria mRNAs are inferred to be 
capped and most of them are also polyadenylated, although some may lack poly(A) 
tails (Levitt, 1993; Weber, 1988). Malarial introns tend to be very short and very A+T-
rich, and the sequences at their donor and acceptor splice junctions seem to closely 
conform to eukaryotic splice consensus sequences (Vinkenoog et al, 1995; Weber, 
1988). The consensus sequences (often termed Kozak sequnce) flanking the 
translational initiation site of nuclear genes which affects the translational efficiency 
have been compiled for many eukaryotes (Kozak, 1996; Yamauchi, 1991). The T. 
gondifs haploid genome contains approximately 8 x 107 bp (Cornelissen et al, 1984) 
and has a G+C content of approximately 55%. Its mRNA usually has a 3'-poly(A) tail 
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(Prince et al, 1985). The translation start sites of Toxoplasma genes also conform 
approximately to Kozak's criteria for initiation codons (Seeber, 1997). 
7.2 Intron sizes and numbers 
Introns are non-coding sequences of DNA inserted into transcribed genes. 
They are usually located in amino acid coding regions within eukaiyotic genes, 
although in some genes introns are present in 5' or 3'-untranslated regions (UTR) as 
well. The P. falciparum histidme-rich protein (HRP) II and III genes, the P. berghei 
nucleosome assembly protein (PbB7) gene and the T. gondii hypoxanthine-xanthine-
guanine phosphoribosyl transferase gene and 65 kDa cyst matrix protein gene each 
have one intron in their 5'- UTR. P. falciparum has a 15 kDa vesicule antigen gene 
which has a intron in its 3'-UTR. The majority of malarial genes have either a few 
introns or no introns at all. 53 of 111 of P. falciparum genes, 19 of 56 of other 
Plasmodium genes and 13 of 28 of T. gondii genes have introns. 40 of 53 of P. 
falciparum genes and 18 of 19 of other Plasmdium genes have introns near the 5' or 3' 
end of the coding region. However, only 3 of 15 of T. gondii genes have introns near 
the 5' or 3' end of the coding region. Simpler (sometimes called primitive) eukaryotes 
tend to have few or no introns, and only the most complex eukaryotes appear to have 
very large numbers of introns (de Souza et al, 1996). Figure 7.1 shows the intron 
numbers in P. falciparum, other Plasmodium, and T. gondii. Figure 7.2 displays the 
intron sizes in P. falciparum, other Plasmodium, and T. gondii. The intron positions 
of a and -tubulin genes in P. falciparum, other Plasmodium, and T. gondii are 
shown in Table 7.1. 
7.3 Consensus splicing signals in Plasmodium 
Table 7.2 gives the percentage of each nucleotide at 5' splicing-site positions - 
10 to +10 and 3' splicing-site positions -15 to +10, for P. falciparum, other 
Plasmodium and T. gondii introns. A total of 100 introns from 53 P. falciparum 
genes, 46 introns from 19 other Plasmodium genes and 60 introns from T. gondii 
genes were collected from GenBank database released at February 3, 1998 (Appendix 
G). A consensus sequence is derived by analysis of the frequency with which 
individual bases occur in particular positions (Long et al, 1997). Thus a certain 
nucleotide should represent at least 40% of the total or exceed 30% and be at least 
twice as frequent as the third highest percentage. The consensus sequences for 
Apicomplean 5' and 3' splicing-sites are listed at the end of each row in Table 7.2. The 









Figure 7.1 Distribution of intron number of protein-coding genes in 
P. falcipa rum, other Plasmodium and T. gondii. Each bar represents 
the percentage of intron number in each number class. The 53 P. 
Jalciparum, 19 other Plasmodium and 13 T. gondii protein-coding 
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Figure 7.2 Size distribution of introns of protein-coding genes in 
P. frilciparum, other Plasmodium and T. gondii. Each bar represents 
the number of introns in each size class. The 100 P. falciparum, 46 
other Plasmodium and 60 T. gondii introns listed in Appendix G 
were used in this survey. 
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Table7.1 The intron locations of a and 3-tubulins 
Species 	 Intron location and sizea 
-tubu1in gene 
P.falciparum 33 (330) 	350 (174) 
T. gondii 	32-33(465) 397 (141) 426-427 (100) 
E.tenella 32-33(541) 
	
397 ( 95) 426-427 ( 94) 
C. parvum 	32-33( 85) 
a-tubulin gene 
P. falciparum 21 (211) 61-62(119) 
T. gondii 
	
21 (511) 61-62(150) 
a: intron located amino acid residue(s) (inserted intron size (bp)) 
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Table 7.2 5 end intron/exon junction 
(i): 	-10 	-9 -8 	-7 	-6 	-5 	-4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 II 12 
Plasmodiumfalciparum (n=100) 
R(i): 	.11 	.02 .06 	.25 	.05 	.22 	.22 .30 .45 .37 1.84 1.76 1.37.82 .35 .49 .34 .29 .46 .85 .65 .65 
Percentages: 
A 	42 33 35 42 	34 38 46 53 60 27 0 1 89 71 33 54 53 48 56 63 62 67 
C 	141822161910918107 0005141069223 
G1720136161215 7755982424088155179 
T 	27 29 30 36 	31 	40 	30 22 23 11 2 97 7 22 26 34 39 31 30 34 29 21 
Consensus 	A 	N N A1F N AfT ATF A A G I 	G I A A G ATF Aft Aft AIr AfT A A 
Other Plasmodia (n46) 
R(i): .01 .02 .00 - .00 .08 .21 .24 .25 .24 1.81 	1.67 	1.14 .53 	.08 - .05 .13 .17 .24 .43 	.23 
Percentages: 
A 24 26 17 32 17 31 48 44 52 35 2 2 85 65 13 30 39 44 43 50 61 	52 
C 28 20 35 20 33 15 28 22 15 9 00241724131711969 
G 33 17 22 24 28 15 9 4 24 45 98 2 9 13 37 17 22 28 33 28 13 	20 
T 15 37 26 24 22 39 15 30 9 11 0 96 4 18 33 29 26 11 13 13 20 	19 
Consensus N N N N NAIT A A A GIG T A A N N N A A A A A 
Toxoplasma gondii (n=60) 
R(i): 	.01 	.02 - .11 - 	 .02 .04 - .131.08 2.00 	2.00 .76 .68 1 .07 .05 - - - - - - 
Percentages: 
A 	20 22 25 8 27 	38 28 30 47 8 0 	0 67 72 8 12 17 20 20 30 32 30 
C 	18 	36 22 29 26 20 34 35 20 5 00313728272220302627 
G 	32 25 20 28 27 20 25 18 18 83 100 	0 27 8 83 25 28 22 27 20 22 18 
T 	30 	17 33 35 20 22 13 17 15 3 0 100 3 7 2 35 28 36 33 20 20 25 
Consensus 	N N N N 	N N NA GIG I AA G N N N NN N N 
Frequencies of nucleotides at 5' splice site locations in P. falciparum, other 
Plasmodium and T. gondii. Percentage of each of the four nucleotides at position -10 to 
+10 at the 5' spice site. The 100 P.falciparum, 46 other Plasmodium and 60 T. gondii 
introns listed in Appendix G were used. R(i) is the quantitive measure of conservation 
at the i'th site, and ranges from zero to two. The deduced 5' consensus sequences are 
given in this Table. N, indicates nucleotide 0, A, T or C. -, indicate R(i) value <0.00. 
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conformed to each other and earlier reports of the P. falciparum consensus (Vinkenoog 
et a!, 1995). Moreover, this 5' Aplicomplexa splicing consensus, AAGIGTAAG, is 
also similar to mammalian consensus, (AIC)AGIGT(A/G)AG, where the bar "I" shows 
the intron/exon junction position (Mount, 1982; Senapathy et at, 1990). Interestingly, 
in Saccharomyces cerevisiae the 5' exon consensus is A47A53ANIG (the numbers 
indicate the percentage at each nucleotide position) are quite similar to the P. falciparum 
consensus (A46A53A60G551G), which is thought to interact with the U5 snRNA (small 
nuclear RNA) to help define 5' splice site (Long et al, 1997). Based on studies using 
constructs with a variety of point mutations, the nucleotides 5 and 6 in the highly 
conserved loop I sequence (GCCUUUUAC) of U5 snRNA pair with bases -2 and -3 
in the 5' exon sequence of pre-mRNA. The -4 exon consensus A is also 
complementary to nucleotide 7 in the loop (Newman & Norman, 1992). This indicates 
that Plasmodium may share a similar 5' splicing mechanism with mammalian and yeast 
sequences. However, this 5' exon consensus is not well conserved in T. gondii. 
Both the Plasmodium and Toxoplasma 3' intron consensus showed the 
expected pyrimidine-rich tract and 3' acceptor consensus sequences (Senapathy et al, 
1990; Vinkenoog et at, 1995). In Plasmodium the pyrimidine tracts are usually poly(T) 
on the mRNA coding strand, whereas in Toxoplasma the pyrimidine tracts are much 
less pronounced. The proposed PyPyPuAPy-branch point sequences have also been 
looked for in the region -10 to -50 of nucleotides upstream of the 3' splicing site. 
However, only 28 out of 100 introns contained this sequence in the expected region in 
P. fatciparum, 8 out of 46 in other Plasmodium and 7 out of 60 in T. gondii. 
Although Smith et at (1993) have demonstrated that the branch point is important for 
the scanning process to identify the first 3' splice-site AG, a long pyrimidine stretch 
was also reported to be important for efficient lariat formation. Whether long the 
pyrimidine stretch often seen in Plasmodium introns plays more a crucial role in 
malaria splicing than the branch point sequence is unclear. The order of 'CAG UAG 
> AAG> GAG' has been suggested for the nucleotide preferences at this position in 3' 
splice sites. Both malaria and Toxoplasma conform to this rule. The fact that there is 
not quite 100% 5'-G and T at the nucleotides +1 and +2 and 3'-A and G at the 
nucleotides -2 and -1 could be caused either by misassignment during database input 
or by certain genes using the non-consensus mRNA splice sites (Jackson, 1991). 
Introns have been classified as group I, II or III (Copertino & Hallick, 1993). 
The eukaryotes have evolved splicing mechanism based on a multi-protein complex, 
the spliceosome, and spliceosome-dependent introns are thought to be evolved from 
group II introns. Members of this complex have introns removal via a two-step trails-
esterification process (Sharp, 1987). It would be interesting to know if the group II 
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Table 7.3 3' end mt ron! exon junction 
(i): 	-15 -14 -13-12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 	-I 	1 	2 	3 4 5 	6 7 	8 9 10 
Plasmodiumfalciparum (n=100) 
R(i): 	.56 	.70 .75 .86 	1.02 .68 .98 .62 .78 .71 1.15 .43 .97 1.44 1.54 .25 .13 .09 .13 .08 .10 .03 .07 .11 	.13 
Percentages: 
A 	26 21 16 1 -7 , It 	24 12 9 20 16 10 33 7 94 3 	35 29 37 39 39 31 27 38 25 	41 
C 	7 	5 9 8 	6 	8 8 23 7 12 7 7 14 0 0 	5 II 14 11 19 13 16 16 19 	10 
G 	5 	5 3 1 	2 	2 I 3 2 2 0 7 I 3 93 	41 18 17 18 14 18 22 17 14 	21 
T 	62 69 72 74 81 	66 79 65 71 70 83 53 78 3 4 	19 42 42 32 28 38 35 29 42 28 
Consensus 	lT TI TT T ITT ITT A GIG TA/TN N TN A TA 
Other Plasmodia (n=46) 
R(i): 	.50 	.19 .32 .77 .51 .28 .70 .36 .48 .32 .70 .08 .31 1.29 1.29 .30 .04 .21 .15 .00 .32 .13 - - .05 
Percentages: 
A 	20 17 II II 11 11 Ii II 7 4 4 20 7 89 4 	37 IS 50 44 30 46 44 28 30 39 
C 	26 35 30 13 30 24 24 26 37 26 20 11 50 5 2 	2 26 11 II 20 2 11 20 24 13 
G 	0 	7 7 2 2 11 0 7 4 18 6 37 II 4 89 37 20 13 15 33 22 17 28 20 22 
T 	54 41 52 74 57 54 65 56 52 52 70 32 32 2 5 	22 39 26 30 17 30 28 24 26 26 
Consensus 	ll IT ITT ITT TN CA GINT A A N AA N N N 
Toxoplasma gondii (n=60) 
R(i): .14 .19 .04 .09 .13 .23 .27 .14 .37 .13 .30 .16 	1.11 2.00 	2.00 .17 .06 .01 	.06 - .03 .01 .09 	.06 	- 
Percentages: 
A 851791267758720 3100 	0 25 20 30 20 25 15 32 33 26 28 
C 29 24 27 28 25 25 18 28 28 35 25 8 83 	0 	0 	18 13 20 32 27 25 20 17 17 24 
G 23 33 18 28 18 22 23 27 13 22 15 30 2 	0 100 47 32 32 20 30 37 30 37 40 20 
T 40 38 38 35 45 47 52 38 54 35 53 42 12 	0 	0 	10 35 18 18 18 23 18 13 17 	28 
Consensus TN N NIT TNT N TI C 	A 	GIG TA/TN N TN A TA 
Frequencies of nucleotides at 3 splice site locations in P. falciparum, other Plasmodium and T. 
gondii. Percentage of each of the four nucleotides at position -10 to +10 at the 3' spice site. The 
100 P. falciparum, 46 other Plasmodium and 60 T. gondii introns listed in Appendix were used. 
R(i) is the quantitive measure of conservation at the i'th site, ranges from zero to two. The 
deduced 3 consensus sequences are given in this Table. N indicates nucleotides G, A, T or C. -, 
indicates R(i) value < 0.00. 
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intron-spliceosome mediated splicing machinery exists in the Aplicomplexa parasites 
and whether they have a similar biological function as in mammalian and yeast. 
In conclusion, I found that the trends of the Plasmodium genes described 
previously with more limited sets of data (Weber, 1988) are still valid. This indicates 
that the 5' and 3' consensus sequences presented here are likely to be true for all 
Plasmodium genes. 
7.4 Kozak rules and promoter sequences in P. falciparum 
The sequence flanking potential ATG start codons has been reported to affect 
the efficiency of initiation of protein translation. A favourable context (often termed the 
Kozak sequence) is important to stop the 40S ribosomal subunit moving forward in the 
3' direction on mRNA and to allow the 60S subunit joining the ribosome to translate 
the first codon into a peptide. Three data sets for Plasmodium falciparum, other 
Plasmodium and Toxoplasma gondii containing gene sequences from genomic or 
complementary DNA sequences were collected and analysed (Appendix G). Sequences 
were compared from position -10 relative to the ATG initiation codon up to position 
+10. Each consensus nucleotide was examined and tested for conformity to the rule 
that it should occur at >50% of all sites or constitute more than twice the frequency of 
the next abundant nucleotide. The second consensus nucleotide may be chosen if it 
exceeds 30% of all sites and is at least two times more frequent than the third highest 
frequency nucleotide. As shown in Table 7.4, three similar consensus sequences were 
obtained as follows: (ATF)AAAAATG(A/G)AN, NANAAAATGAAG and 
GNCAAAATGGNG in Plasmodium falciparum, other Plasmodium and Toxoplasma 
gondii, respectively. These consensus sequences clearly differ from the vertebrate 
consensus, GCCACCATGG. The A-residue is clearly dominant at position -3 in these 
Apicomplexa consensus sequences, whereas the A- or G-residues following the ATG 
codon are dominant at the position +4. The Kozak initiation consensus is derived from 
analysis of vertebrates (Kozak, 1987; Kozak, 1984), plants (Lutcke et al, 1987), 
Drosophila (Cavener, 1987) and yeast (Hamilton et al, 1987) and is taken to suggest 
that the purine residues at positions -3 and +4 play an important role in recognition of 
AUG by the ribosome in all eukaryotic mRNA. Messenger RNA species in which the 
first ATG codon lacks the preferred nucleotide in both of these key flanking positions 
are likely to initiate the translation at the second ATG codon, termed leaky scanning 
(Kozak, 1991; Kozak, 1996). However, several mRNAs such as T. gondii GRA3 
have also been found to produce two versions of the encoded polypeptide from both 
the first and second ATG codon (Bermudes et al, 1994; Lin et al, 1993). Interestingly, 
a P. falciparum gene, PfSNF2L, has four in-frame ATG codons within the first 20 
159 
Table 7.4 Kozak sequences 
-10 -9 -8 -7 -6 -5 -4 -3 -2 -1 	1 	2 	3 4 5 6 7 8 9 10 
Plasmodium falciparum (n=145) 
R(i): 	.35 .41 .40 .35 .20 .36 .31 .77 .43 .56 2.00 2.00 2.00 .44 .12 .24 .18 .14 .09 .07 
Percentages: 
A 34 38 42 40 37 49 52 73 60 63 100 	0 	0 51 44 36 46 42 38 34 
C 767876214116000 315510171714 
G 10 8 7 8 19 11 6 8 8 7 	0 	0 100 34 19 21 25 12 15 20 
T 49 48 45 44 37 34 21 15 21 24 	0100 	0 12 22 38 19 29 30 32 
Consensus AIr All' All' Afr N All' A A A A I A 	T 	G A/G A N A A N N 
Other Plasmodia (n=64) 
R(i): 	.05 .25 .31 	- 	.21 .31 	- .72 .68 .28 2.00 2.00 2.00 1.22 1.04 .34 .15 .11 .02 .00 
Percentages: 
A 28 18 45 35 39 49 22 84 71 56 100 0 0 83 83 28 41 44 30 39 
C 18 16 6 16 12 8 23 8 11 12 	0 0 0 2 5 2 11 20 26 17 
G 16 12 12 27 10 10 22 4 4 17 	0 0100 15 6 47 33 13 22 13 
T 38 54 37 22 39 33 33 4 14 15 	0 100 0 0 6 23 15 23 22 31 
Consensus N T A/T N N A N A A A I A T 0 A A 0 A/G A N N 
Toxoplasma gondii (n=15) 
R(i): 	.02 .29 .28 .28 - 	- .09 1.48 .76 .43 2.00 2.00 2.00 .05 - .02 - .06 .28 .13 
Percentages: 
A 13 7 0 27 20 33 20 93 74 53 100 0 0 33 20 20 20 47 27 13 
C 20 13 40 40 20 20 47 7 13 7 0 0 0 7 20 13 27 27 33 20 
G 20 20 27 0403326013270 0 100 40 33 47 27 13 40 54 
T 47 60 33 33 20 13 70013 0100 02027202613013 
Consensus T T CC G N CA A AlA 1 0 G 	ON AGO 
Frequencies of nucleotides around the translational starting site in the nuclear 
genes from P. falcipa rum, other Plasmodium and T. gondii. Percentage of each 
of the four nucleotides at position -10 to +10 flanking the initiation codon ATG. 
The 145 P. falciparum, 64 other Plasmodium and 15 T. gondii introns listed in 
Appendix were used. R(i) is the quantitive measure of conservation at the i'th 
site, and ranges from zero to two. The deduced translational initiation site 
consensus sequences are given in this Table. N indicates nucleotides G, A, T or 
C. -, indicates R(i) value <0.00. 
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amino acids of the N-terminal. However, none of them perfectly match the 
Plasmodium most favoured context. Therefore, another rule comes into play, in-frame 
context which states that the first ATG is usually the best (Kozak, 1996). The 
description of an Apicomplexan consensus translational initiation sequence reported 
here is a useful tool for the analysis of newly cloned genes or ESTs of Plasmodium 
and T. gondii. 
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CHAPTER 8 
GENERAL DISCUSSION AND FUTURE STUDIES 
8.1 General discussion 
The life cycle of the Plasmodium falciparwn has been known for many years. 
However, very little is known about how parasite integrates the control of its multiple 
cell cycles. To address these tasks, I have looked at G proteins in signalling pathways, 
PfRCC1 in nuclear transport and PfSNF2L in transcriptional regulation, and then tried 
to understand more about their roles in the cell cycle. A number of questions regarding 
the biology and genetics of the parasite have emerged from these investigations. 
Do membrane associated heterotrimeric G proteins exist in Plasmodiumfalciparum? 
An original aim of this thesis was to identify P. falciparum heterotrimenc G 
proteins in order to study their role in the regulation of the cell cycle of the malaria 
parasites. However, no parasite heterotrimeric G-protein gene was successfully cloned 
in the course of studies. Although a total of 95 clones were selected from PCR 
products, and sequenced, only three human G protein genes, G 1 , Gs and Gq, were 
isolated, each approximately 96% identical to published human sequences in their 
nucleotide or amino acid sequences (Appendix B). Although some interesting P. 
falciparum genes were found in the course of this work, none of them was a malaria G 
protein (Appendix B). These 'false' isolations may be due to very low level human 
DNA or RNA contamination from human white blood cells present when the malaria 
RNAs were prepared from parasites growing in human blood cultures. The choice of 
sequence of the 'conserved' primers may also be inappropriate for P. falciparum 
heterotrimeric G protein genes. 
The question also arises, are there 'true' trimeric G-protein genes in malaria 
parasites? All the existing evidence indicates that Ga protein genes in Trypanosoma, 
Toxoplasma and Plasmodium are only just detectable by biochemical assays which use 
human or mammalian antibody reagents (Harnett & Harnett, 1998; Thelu et al, 1994). 
For example, a 46 kDa G oc protein has been shown to cross-reaction with the anti-
human Ga protein monoclonal antibody by Western blotting detection (Thelu et al, 
1994), a result which might also be criticised because of possible human Ga protein 
contamination of the preparations. To date there have been no Ga protein genes cloned 
from any parasitic protozoan. This may indicate that parasitic protozoan possess a 
different signalling pathway to their eukaryotic hosts, or it may simply indicate that 
their structures are not well conserved between distantly related phyla, a situation 
which always makes the identification of homologues more difficult. 
162 
The possible role of Ran and RCC1 in nuclear transport of the P. falciparum parasite 
In eukaryotic cells, various cargoes are delivered between the nucleoplasm and 
cytoplasm through the nuclear pore complex (NPC) gateway. In a recent report 
(Richards et al, 1997), it has been proposed that the RanGTPase controls nuclear 
transport (see Appendix H) and that the RanGlPase is the common factor required for 
the transloction of cargo in both directions. Ran-GTP is the active form for 
translocation. The importin-a and P bind with a nuclear localisation signal (NLS)-
containing protein in the cytoplasm and 'dock' at the nuclear pore complex (Gorlich et 
al, 1995; Gorlich et al, 1995), whereas Ran-GDP binds at or near NLS-cargo docking 
sites (lovine & Wente, 1997). The conversion of Ran-GDP to Ran-GTP by an 
unknown cytoplasmic RanGEF triggers translocation. The Ran switch, therefore, 
performs a general gatekeeping function, determining when NLS cargo is admitted to 
the translocation channel (lovine et al, 1997). 
The P. falciparum homologue of the Ran gene, PfRan, has been cloned and 
characterised (Sultan, 1994). Its protein is localised in both the nucleus and cytoplasm 
of parasite and its mRNA is abundantly transcribed at the trophozoite and schizont 
stages. These results indicated that the PfRan protein also travels between the nucleus 
and the cytoplasm and thus appears to behave in a similar way to the better understood 
Ran proteins of higher eukaryotic cells. However no detailed biochemical work has yet 
been carried out in the P. falciparum system, which is not particularly well suited to 
such biochemical cell biology. 
A Ran-GTP-free docking zone may be important in controlling NLS cargo 
docking (Mahajan et al, 1997; Saitoh et al, 1997). RanBP1 has been thought to shuttle 
between the cytoplasm and the nucleus and link the nuclear and cytoplasmic pool of 
Ran (Lounsbury & Macara, 1997; Mahajan et al, 1997; Saitoh et al, 1997; Zolotukhin 
& Felber, 1997). However, Richards et al have demonstrated that nuclear export 
sequence (NES)-directed export of RanBP1 requires Ran-GTP but not GTP 
hydrolysis, and that NLS-directed import and NES-directed export can be functionally 
uncoupled. Whereas a cytoplasmic RanGAP favors high cytoplasmic Ran-GDP levels, 
an abundant nuclear Ran guanidine exchange factor (RanGEF) such as RCC1 favours 
high nuclear Ran-GTP levels. 
The PfRCC1, a P. falciparum homologue of the RCC1 protein, reported in this 
thesis is localised predominantly in the parasite nucleus. The results of immuno-
fluorescence experiments also indicated that the PfRCC 1 is usually co-localised with 
PfRan in the nucleus and that PfRCC 1 is therefore the candidate nuclear pfRanGEF in 
malaria parasites. It is doubtful that the way forward in this area of malaria research is 
to try to replicate the cell biological work that has already been done in higher 
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eukaryotic cells which are both' free living' and larger and more easily manipulated 
then malaria parasites. 
The PfSNF2L structure and function and chromatin remodelling for transcription in 
malaria 
A P. falciparum homologue of the SNF2-like protein gene, PfSNF2L, has 
been cloned in the course of this study (ii & Arnot, 1997). The predicted protein 
sequence of PfSNF2L is 1422 amino acids long and contains the seven NTP-binding 
motifs of the DNA-dependent ATPase domain found in all the SNF2 superfamily of 
helicase H. Phylogenetic analysis of the PfSNF2L place it within the SNF2-like 
subfamily of these proteins. 
Eukaryotic transcription initiation involves decondensation of DNA from the 
chromatin which is known to inhibit transcription, replication, recombination and 
repair by blocking access to the DNA (Koleske & Young, 1995; Peterson, 1996). Two 
systems that facilitate these nucleosome structure changes are the ATP-dependent 
chromatin remodelling complexes and the enzymatic complexes which control histone 
acetylation and deacetylation (Breeden & Nasmyth, 1987; Laurent et al, 1993; Peterson 
& Herskowitz, 1992; Steger & Workman, 1996; Vettese-Dadely et al, 1996). There 
are five chromatin remodelling complexes which have been described to date: 
SWIJSNF (switching/ sucrose non-fermenting), RSC (remodel the structure of 
chromatin), NURF (nucleosome remodelling factor), CHRAC (chromatin-accessibility 
complex) and ACF (ATP-utilising chromatin assembly and remodelling factor) (Cairns 
et al, 1994; Cairns et al, 1996; Ito et al, 1997; Tsukiyama & Wu, 1995; Varga-Weisz et 
a!, 1997). All are multi-subunit complexes with molecular weights ranging from 2 
MDa to 500 kDa. Strikingly, the Drosophila CHRAC, NURF and ACF all contain 
ISWI (initialswitch) as an ATPase, although each complex appears to remodel 
chromatin structure by different mechanisms. This suggests that ISWI may function in 
a distinct mechanistic manner depending upon the exact protein composition of the 
remodelling complex. PfSNF2L is one of the ISWI homologues. It would be 
interesting to know whether there are more than one PfSNF2L-containing complexes 
in P. falciparum. However, the attempt to clone another P. falciparwn PfSNF2L 
homologue by using PfSNF2L probe at a low stringency condition was unsuccessful 
and whether there is more than one SNF2 homologues in P. falciparum still to be 
found is an open question which again may be resolved by the whole genome 
sequencing project. 
Interestingly, the p55 protein, one subunit of NURF, has also been identified 
as a subunit of Drosophila CAF1 (chromatin assembly factor 1). p55  homologues are 
found associated with histone acetyltransferases (HATs) and deacetylases (HDA5). 
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Many of the genes that show SWIJSNF dependence also demonstrate dependence 
upon the HATs (Pollard & Peterson, 1997) and strains containing mutations affecting 
both SWIJSNF function and HAT activities result in lethality or severe sickness 
(Roberts & Winston, 1997). Thus, many of the diverse chromatin-altering complexes 
may utilise a common subunit. The growth of P. falciparum parasite has been reported 
to be inhibited by low doses of histone deacetylase inhibitors such as HC-toxin and 
apicidin (Brosch et a!, 1995; Darkin-Rattray et al, 1996). A preliminary result, shown 
in Appendix I, also confirmed the HC-toxin finding. This indicates that the HATs and 
HDAs may also exist in P. falciparum and co-operate with PfSNF2L chromatin 
remodelling complex for the regulation of chromatin dynamics. 
The stage specific regulation of PJSNF2L protein 
The human brahma (hbrm) and brm-related gene 1 (BRG-1) proteins are 
phosphorylated and excluded from the condensed chromosomes at the G2IM transition 
(Muchardt et al, 1996). The hbrm and BRG- 1 proteins are also required to co-operate 
with retinoblastoma (RB) protein to arrest cell in the G1 phase (Dunaief et al, 1994; 
Trouche et al, 1997). Repressing expression of RB protein induces cell entry into S 
phase and may cause cell transformation (Bartek et al, 1997). In yeast, mutation in 
STH 1, a yeast SNF2/SWI2 homologue and a subunit of RSC, has been reported to 
cause cell cycle arrest in the G2IM phase of the cell cycle (Cao et a!, 1997). Taken 
together, these results imply a role for hbrm, BRG-1 and STH1 chromatin remodelling 
activity in the progression of the cell cycle. Based on immunofluorescence results, 
PfSNF2L seems to be excluded from parasite nuclei during the trophozoite stage. 
However, it is difficult to compare the malaria cell cycle with the normal mammalian or 
yeast cell cycle. Nothing is known about the phosphorylation of the PfSNF2L protein 
throughout P. falciparum cell cycle. Although it may too early to say that PfSNF2L is 
definitely involved in the cell cycle progression, these observations do provide a new 
angle of attack on the problem of the malaria cell cycle. 
Immuno-localisation of key P. falciparum effector proteins 
In order to carry out further studies on the role of PfRan, PfRCC1 and 
PfSNF2L proteins in the development of the P. falciparum cell cycle, antibodies 
against these proteins have been produced in the course of the studies in this thesis and 
also in a previous study (Sultan, 1994). Although these three protein can all be located 
in the nuclei, some manifestations of their staining patterns are difficult to understand, 
especially the punctate pattern appearing in PfSNF2L immuno-fluorescence stains. 
Immuno-electron microscopy may be an essential tool to resolve this problem. 
However, SNF2 homologues are known to form a very high molecular weight 
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complex which work co-operatively in the chromatin remodelling events. It is 
impossible to only study SNF2 homologues without reference to any other 
components of these large protein complexes. 
A framework to explain the appearance of the punctate fluorescent staining 
might be as follows: 
During the ring/young trophozoite stages no SNF2L protein synthesis is occurring 
and the concentrated intra-nuclear SNF2L protein staining is due to pre-existing protein 
synthesised before merozoite invasion (Chapter 5, Figure 5.9, panel d bottom left). 
As the trophozoite matures, demands on the transcriptional apparatus increase and 
the SNF2L gene is transcribed into RNA which in turn is exported into the cytoplasm 
and translated into SNF2L protein. The IFA pattern observed at this stage (Chapter 5, 
Figure 5.9, panel c, d, e and f) is that of punctate fluorescence - an apparently 
cytoplasmic concentration of SNF2L protein into 3-8 small dots arranged in to a 
roughly circular pattern around the nuclear concentration of SNF2L protein. A possible 
interpretation of this pattern is that the punctate dots are specialised cytoplasmic sites 
for message translation into protein. 
As shizogony is completed, SNF2L fluorescence is present in all the segmenters 
and has apparently been distributed to all the daughter nuclei of the original invading 
merozoite. 
The key question appears to be, that if SNF2L protein is a part of a large multi-
protein transcription activation complex, all the components of which are translated in 
the cytoplasm, then where is this complex assembled, in the cytoplasm or in the 
nucleus? In relatively long-lived eukaryotic cells, it would seem to be obvious 
(although probably as yet uninvestigated) that individual proteins are re-imported 
through nuclear pore complexes for intra-nuclear assembly since the complexes are too 
big to pass through the pores and into the nucleus intact. However, in P. falciparum it 
is possible to speculate that the complex problem of schizogony (1 nucleus - 8-30 
nuclei in 6 hours) might be simplified if chromatin associated multi-protein complexes 
do not have to re-enter the S phase nucleus but are assembled in the cytoplasm and are 
apportioned to daughter nuclei during a phase of nuclear-cytoplasmic fusion 
accompanying the segmentation of replicated chromosomes into daughter merozoites. 
This speculative proposal would imply that the observed staining patterns 
represents local intra-cytoplasmic concentration of SNF2L protein into transcription 
it.1 
initiation complexes which are, or will become, associated with new schizont nuclei 
without passing through nuclear pore complexes. 
Plasmodiumfalciparum: a difficult organism for cell cycle studies 
As in some unicellular eukaryotes, e.g. budding yeast, the nuclear envelop of 
P. falciparum cell does not break down during mitosis and microtubules are nucleated 
by spindle pole bodies rather than by centrosomes, which is different from 
multicellular eukaryotes (Arnot & Gull, 1998; Leete & Rubin, 1996; Read et al, 1993). 
In mammalian cells, the nuclear envelop breaks down during mitosis and microtubules 
are formed from centrosomes (Murray & Hunt, 1993). Moreover, P. falciparum is a 
rather small intracellular parasite and it is not possible to observe the G 1 , S, G2 and M 
phase states in its tiny nucleus by conventional light microscopy. The use of tissue 
culture cell fusion techniques in the studies of cell cycle transitions is also impossible 
in such a cell. Another difficulty for malaria cell cycle study is that there are no 
available techniques to select P. falciparum cell cycle defect mutants for further 
analysis. 
Recently, in budding yeast, chromosome condensation has been directly 
observed by electron microscopy, although the chromosomes did not form a typical 
chromosome structure (Gottschling & Berg, 1998; Guacci et al, 1997; Sutani & 
Yanagida, 1997). Several chromosome associated proteins such as MCD1 (mitotic 
chromosome determinant) have been found to be important for chromsome 
condensation and sister chromatin cohesion, and are essential for successful 
completion of mitosis. However, no homologues of these proteins have been reported 
from P. falciparum to date. It is impossible to understand malaria chromosome 
condensation and sister chromatin cohesion during mitosis without information on the 
behavior of such proteins. 
It seems clear that the central problem in understanding the molecular cell 
biology underlying the replicative phase of malaria parasites-schizogony, remains. The 
best way forward may be to combine malaria genome project data on candidate cell 
cycle and mitotic replication genes and proteins with cell biology and ultra-structural 
studies aimed at understanding the function of such proteins during parasite 
replication. Genetic techniques such as gene knock-outs can also help piece together 
the sequential events of this rather mysterious parasite replicative process. 
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Appendix B 
Sequences similarities of clones isolated from PCR fragments. The sequence smilarities 
of the clones isolated from PCR products during the course of this study which have a 
significant and/or interesting similarity to known proteins are detailed here. DNA 
sequences were searched with BLASTX in six reading frames through the NCBI net 
service (Benson et at, 1998). 
Clone GP1-2 
1 GTGGATTCAG GTm'CCAAG AMTTGTGAA GTAGATGCAG TI'GGCATAGG TGCTAAThAT AATGAGTrTC 
71 TTAMCCATG TTTACGGATT TTAGCTTTA ATTCATCCCA ATCCCAATAT TTGT'rATCAA CTI'TAGCATr 
141 CCACATATCA AATTGTAATA TACCTrGGCT AGCTGGACTT CC'11AACAAG ATCGA 
>> 	(U01323,P50648), RIR1_PLAF4 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE 
LARGE CHAIN (RIBONUCLEOTIDE REDUCTASE), (Ri SUBUNIT), (Plasmodium 
falciparuni], Length = 806 
Score = 307 (140.6 bits), Expect = 1.6e-34, P = 1.6e-34 
Identities = 58/60 (96%), Positives = 58/60 (96%), Frame = -2 
Query: 182 GSPASQGILQFDMWNAKVDNKYWDWDELKAKIRK}{GLRNSLLLAPMPTASTSQILGKPES 3 
GSPASQGILQFDMWNAKVDNKYWDWDELKAKIRKHGLRNSLLLAPMPTASTSQILG ES 
Sbj ct: 557 GSPASQGILQFDNAKVDNKYWDWDELKAKIRKHGLRNSLLIJPMPTASTSQILGNNES 616 
>> 	A49412, Ribonucleoside-diPhOsphate reductase (EC 1.17.4.1) large 
chain, [Plasmodium falciparum], Length = 847 
Score = 307 (140.6 bits), Expect = 1.6e-34, P = 1.6e-34 
Identities = 58/60 (96%), Positives = 58/60 (96%), Frame = -2 
Query: 182 GSPASQGILQFDMWNAKVDNKYWDWDELKAKIRK}{GLRNSLLLAPMPTASTSQILGKPES 3 
GSPASQGILQFDMNAKVDNKYWDwDELKAKIRKHGLRNSLLLAPMPTASTSQILG ES 
Sbj ct: 598 GSPASQGILQFDMWN VDNKYWDWDELKAKIRKHGLRNSLLL,APMPTASTSQILGNNES 657 
Clone GP7-1 
1 CGMTITGTT TAAGAAII'GA TGGATCAACA CCAGGAGATG AAAGACAAGT ACGTATTAAT CAATTTAATG 
71 AACCGAATAG TAAATATTI1 ATI'TCTTAT TATCTACCAG AGCTGGTGGT ATTGGTATTA ACTTAACGAC 
141 TGCTGATATT GTTATCTTAT TTGArCGGA TTATAATCCA CAAATGGATA TACAAGCAAT GGATCCACTT 
>> AB010882, hSNF2h, (Homo sapiens], Length = 1052 
Score = 254 (116.4 bits), Expect = 4.2e-27, P = 4.2e-27 
Identities = 46/64 (71%), Positives = 56/64 (87%), Frame = +1 
Query: 	13 RISTPGDERQVRINQFNEPNSKYFIFLLSTRAGGIGINLDIVILFDSDYNPQIQ 	204 
R+DG TP DERQ IN +NEPNS F+F+LSTRAGG+GINL TAD+VIL+DSD+NPQ+Di-QAND 
Sbj ct: 528 RL1QTPHDERQDSINAYNEPNSTKFVF LSTRAGGLGINLATADVVILYDSDWNPQVDLQAND 591 
>> U64598, similar to helicases of the SNF2/RAD54 family. Does not 
contain the bromodomain. [Caenorhabditie elegans], Length = 1257 
Score = 233 (106.7 bits), Expect = 3.3e-24, P = 3.3e-24 
Identities = 42/65 (64%) , Positives = 54/65 (83%) , Frame = +1 
Query: 	10 LRISTPGDERQVRINQFNEPNSKYFIFLLSTRAGGIGINLADIVILFDSD 	IQAND 204 
LR-i-DGST DER +++ FN PNS+YF+F+LSTRAGG+G+NL TAD VI+FDSD+NP D+QA D 
Sbj ct: 648 LRLDGSTKPDERGALLDKFNAPNSEYFLFMLSTRAGGLGLNLQ"'I'VI IFDSDWNPHQDMQAQD 712 
Clone GP7-3 
1 TCGATmGT rI'AAGAATAA TAATAATAAT GATATI'AATG GTAATAACAA CAATAATAAT AACCACAACA 
71 ATAATAATAA CCACAACAAT AATAATAATA ATAATAATAA TAATGGTI'GC TATAAAATAA TI'AACGAGGG 
141 TACTTTAAAC ATAAATGATG TTATGAAATA TGATGGA GCATCTACAT GPTI'CCAAA TATAAACAAT 
211 GAATCCACT 
SILFKNNNNN DINGNNNNNN NHNNNNNHNN NNNNNNNNGC YKI INEGTLN INDVMKYDGL ASTCFPNINN EST 
Clone GPA11-3 
1 AAGTGGATAC ATTGCTTCAA CGATGTGACT GCCATCATCT TCGTGGTAGC CAGCAGCAGC TACAACATGG 
71 TCATCCGGGA GGACAACCAG ACCAACCGCC TGCAGGAGGC TCTGAACCTC TI'CAAGAGCA TCTGGAACAA 
141 CAGATGGCTG CGCACCATCT CTGTGATCCT GTTCCTCAAT AAGATCGAC 
>> S34421 human GTP-binding regulatory protein GB a chain; (X56009) 
a subunit of GB- GTP binding protein (Homo sapiens], Length = 419 
Score = 315 (144.3 bits), Expect = 1.1e-35, P = 1.1e-35 
Identities = 61/63 (96%), positives = 61/63 (96%), Frame = +1 
Query: 	1 KWIHCFNDVTAI IFWASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNK1D 189 
KWI CFNDVTAI IFVVASSSYNMVIREDNQTNRLQEAII'ILFKSIWNNRWLRTISVILFLNK D 
Sbj ct: 258 KWIQCFNDVTAIIF'VVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNKQD 320 
>> pirIIJHO8l3 GTP-binding regulatory protein GB a chain isoform - 
human (clone pSX4), Length = 335 
Score = 315 (144.3 bits), Expect = 1.1e-35, P = 1.1e-35 
Identities = 61/63 (96%), Positives = 61/63 (96%), Frame = +1 
Query: 	1 KWIHCFNDVTAIIFVVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNKID 189 
KWI CFNDVTAI IFWASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFJNK D 
Sbj ct: 174 KWIQCFNDVTAI IFVVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFJNKQD 236 
Clone Gpall-5 
1 AAGTGGNN'C ACTGCTTTGA GGGAGTGACA GCAATI'ATCT TCTGTGTGGC CCTCAGTGAT TATGACCG 
71 TTCTGGCTGA GGACGAGGAG ATGAACCGAA TGCATGAAAG CATGAAACTG TTTGACAGCA TGTAATAA 
141 CAAATGGTTT ACAGAACTI' CAATCATTCT CTI'CCTI'AAC AAGATCGAC 
> 	P08754, GBAK_HUMAN G PROTEIN G(K), a SUBUNIT (G(I) a-3) pirli 
RGHUI3 GTP-binding regulatory protein Gi a3 chain (adenylate cyclase 
-inhibiting); human (J03005) guanine nucleotide-binding regulatory 
protein a-inhibitory subunit [Homo sapiens]; (M20604) G13 protein a 
subunit; (J03198) G protein a subunit; (M27543) G protein (G) a 
subunit; (J03238) G protein a subunit, Length = 354 
Score = 332 (152.1 bits), Expect = 5.0e-38, P = 5.0e-38 
Identities = 62/63 (98%), Positives = 62/63 (98%), Frame = +1 
Query: 	1 KWIHCFEGVTAI IFCVALSDYDLVLAEDEEMNRESMKLFDSICNNKWFTETSI ILFLNKID 189 
KWIHCFEGVTAI IFCVALSDYDLVLAEDEE NB1'4RES(LFDSICNNKWFTETSI ILFLNK D 
Sbjct: 210 KWIHCFEGVTAIIFCVALSDYDLVLAEDEE FHESMKLFDSICN1KWFTETSIILFLNKKD 272 
>> M17219, G protein ai subunit, (Homo sapiens], Length = 349 
Score = 329 (150.7 bits), Expect = 1.3e-37, P = 1.3e-37 
Identities = 61/63 (96%), Positives = 62/63 (98%), Frame = +1 
Query: 	1 KWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTETSIILFLNKID 189 
KWIHCFEGVTAI IFCVALSDYDLVLAEDEE RHESNKLFDSICNNKWFT+TSI ILFLNK D 
Sbj Ct: 205 KWIHCFEGVTAIIFCVALSDYDLVLAEDEE 	{E 	FDSICN 	TDTSIILFLNKKD 267 
Clone Gpal4-2 
1 AAATGGATAC ACTGCrrrGA AAATGTCACC TCTATCATGT rPCTAGTAGC GCTI'AGTGAA TATGATCGGG 
71 rPCTCGTGGA GTCAGACAAT GAGAACCGAA TGGAGGAAAG CAGGCTCTC ITI'AGTACAA TI'ATCACGTA 
141 TCCCTGGTTC CAGAACTCCT CGGTTAT1'CT G'N'CTTAAAC AAAATCGAC 
M. 
>> AF011497, G protein all subunit, [Homo sapiens], Length = 359 
Score = 311 (142.5 bits), Expect = 3.9e-35, P = 3.9e-35 
Identities = 60/63 (95%), Positives = 61/63 (96%), Frame = +1 
Query: 	1 KWIHCFENVTSINFLVALSEYDRVLVESDNENRMEESKALFSTI ITYPWFQNSSVILFLNKID 189 
KWIHCFENVTSIMFLVALSEYD+VLVESDNENPMEESKALF TI ITYPWFQNSSVILFLNK D 
Sbj Ct: 215 KWIHCFENVTSIMFLVALSEYDQVLVESDNENRMEESKALFRTI ITYPWFQNSSVILFLNKKD 277 
>> AF011496, G protein ug [Homo sapiens], Length = 359 
Score = 311 (142.5 bits), Expect = 3.9e-35, P = 3.9e-35 
Identities = 60/63 (95%), Positives = 61/63 (96%), Frame = +1 
Query: 	1 KWIHCFENVTSIMFLVALSEYDRVLVESDNENPNEESKALFSTI ITYPWFQNSSVILFLNKID 189 
KWIHCFENVTSIMFLVALSEYD+VLVESDNENRMEESKALF TI ITYPWFQNSSVILFLNK D 
Sbj Ct: 215 KWIHCFENVTSINFLVALSEYVLVESDNENNEESKALFRTI ITYPWFQNSSVILFLNKKD 277 
Clone Pf3-1 
>> 1458367 strand exchange protein 1 [Saccharomyces cerevisiae], 
(M36725) DNA etrandtransferase 0, (M90097) 5 1 -3 exoribonuclease 
(X84705) DNA strand transferase, exoribonuc lease, (Z72695) ORF 
YGL173c, Length = 1528 
Score = 126 (57.7 bits), Expect = 6.4e-10, P = 6.4e-10 
Identities = 25/44 (56%), Positives = 30/44 (68%), Frame = +2 
Query: 	5 DMAGEGEHKILKFIRENCKNDSNFK WN}{CIYGLDADLIMLSLA 136 
++ GEGEHKI+ FIR 	+N HCIYGLDADLIML L+ 
Sbj Ct: 172 EVPGEGEHKIMFIRHLKSQKDFNQNTR}{CIYGLDDLIMLS 215 
>> D88026 Dhm2 protein [Mus musculus], Length = 1687 
Score = 126 (57.7 bits), Expect = 6.4e-10, P = 6.4e-10 
Identities = 24/40 (60%) , Positives = 28/40 (70%) , Frame = +2 
Query: 	14 GEGEHKILKFIRNCKNDSNFKNWNHCIYGLDLIMISL 133 
GEGEHKI++FIR 	+ N HC+YGLDDLIML L 
Sbj Ct: 175 GEGEHKINEFIRSEKAKPDHDPNTRHCLYGLD?DLIMLGL 214 
>> 	X91617 5 1 -3 exonuclease [Mus musculus], Length = 1719 
Score = 126 (57.7 bits), Expect = 6.4e-10, P = 6.4e-10 
Identities = 24/40 (60%), Positives = 28/40 (70%), Frame = +2 
Query: 	14 GEGEHKILKFIRENCK DSNF} NHCIYGLDADLIMLSL 133 
GEGEHKI++FIR 	+ N HC+YGLDADLIML L 
Sbj Ct: 175 GEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDLIMGL 214 
>> P40848 DHP1_SCHPO DHP1 PROTEIN, S43891 dhpl protein - fission 
yeast (SchizosaccharOmYCes pombe], (D17752 and Z69240) Dhpl protein, 
Length = 991 
Score = 118 (54.1 bits), Expect = 8.1e-09, P = 8.le-09 
Identities = 24/41 (58%), Positives = 28/41 (68%), Frame = +2 
Query: 	14 GEGEHKILKFIRENCK DSNF} WNHCIYGLDADLINLSLJ' 136 
GEGEI-iKI++FIR 	 N +H +YGLDADLIML LA 
Sbj ct: 204 GEGEHKIMEFIRSQRVKPEYDPH VYGLDADLIMLGLA 244 
IM 
>> 	149635 mouse Dhml protein - mouse, (D38517) DhIU1 protein (Mug 
musculus), Length = 947 
Score = 112 (51.3 bits), Expect = 5.5e-08, P = 5.5e-08 
Identities = 22/41 (53%), Positives = 27/41 (65%), Frame = +2 
Query: 	14 GEGEHKILKFIRENCKNDSNFKNWNHCIYGLDADLIMLSU 136 
GEGEI-iKI+ +IR 	+ N +HC+ G DADLIML LA 
Sbjct: 202 GEGEHKIMDYIRRQRAQPNQDPNTHHCLCGADADLINLGLA 242 
Appendix C 
The restriction map of the pJFE14 plasmid vector (Elliot et al, 1990) which was 
used to clone the P. falciparum asexual cDNA library for the study of this thesis. 
The RNA was prepared from ring and trophozoite stages of line 1T04 parasites. 
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Sequence of the polylinker from pJFE14 plasmid vector: 
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5 TCTAGAGATCCCTCGACCTCGAGATCCATTGTGCTGGC.. .3 60bp a tu f fer.. . GCCAGCACAATGG 
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Target sequence requirements for in-frame expression of insert and C-terminal flis•Tag' in the pET-29 T-'Ie.ctor. The underlined sequence 
is the insert containing single 3 dA overhangs. Note that the EcoR V site in the vector is destroyed. The 5' primer should be designed so 
that the first nucleotide completes the codon TTX. The 3 primer should be designed so that the first (51 nucleotide completes the triplet 
XAA on the opposite strand (do not use an A in this position unless a stop codon is desired). 















Schematic diagram of pGEX-4T- 1 vector. 
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5' 	splice 	sites 3' 	splice 	sites 
z31584 P.falciparum gene for hydroxymethyl-dihydropterin pyrophosphokinase and dihydropteroate synthetase. 
aaatatttaggtaagaaaaaag atatacatatcactctttgattctatatatttttatttttcactttgtaggaaaaattat 
aatatatgtggtgtgtttaaaa aatataaataatatatattcatgtatatgtatttatgtatttcttttcaggtggattagC 
X69769 P.falciparum GBPH2 gene. 
ggccttattggtatgccgaaat acatatctatatatatataatttttttttttttgtattatttaattttagaatgtttata 
U94594 Plasmodium falciparum heat shock protein 60 hsp60 gene, nuclear gene encoding mitochondrial protein, 
atgcttacaggttaatattata tatatttatttatttattattatattttatttattaattcataaatataggttgcaataa 





tJ69552 Plasmodium falciparum histidine-rich protein III 	(HRP III) gene, complete cds. 
aaaattcaaggtataaaataat tatatatatatatatatttttttattatttctttttttatattaatacagttattttaaa 
gttagataacgtaagtatttta atatatatatgtacatttttacatttttaaatgatttttcatttttatagaataactccg 
U69551 Plasmodium falciparum histidine-rich protein II (HRP II) gene, 	complete cds. 
ataattaaaagtatagaacaat acaattatatttatacatttttgttattatttctttttctatttatatagttatttaata 
gttagataacgtaagcatttta gtatatatataaattttttcatttttaaatgcttttttatttttatatagaataattccg 
L46348 Plasmodium falciparum clone HB3 d-aminolevulinic acid synthetase gene, complete cds. 
ccgttccaatgtaaaaaaataa tatatatatatatatatatatttatttatttattatttttttttttataggggaatggaa 
























ccaacattaagtaataatt taa gaaacatgatagtgtacatttatatatatatatatattattCctttaCagaattattaag 
aattctcatagtattaataaag tttattattatatcttaatatttttttttttttttttttttcCaCCttagttgaagCgga 
aaaaagaaacgtaatatatata tctttctctatacaaaattttcttctttacttttttttttttttttataggattgaatga 
X71765 S63253 	P. falciparum gene for Ca2+ - ATPase. 
acagcactaggtaataacaata ttgtcttatacatcctattcatcaattatctttttttttaatttttttagggttCaatCc tatataaagaatggaagagg 
aaaaattaaggtaataaatata atgtatatatttatatatattcatttatttatatatttttttatttttaggCaagcacct 
X93462 	P.falciparum GR2 gene. 
gggcagcaaggttatatgaaaa tgtgtgtgtgtgctttatattttttgtccatttctttctttttattgtaggcataaCgCa aaacgcaaatatggtttacg 
tcctaaaaaagtaataccattt gtataatttttatttatttatttttttttatttttattttttttgtCCagattatgttCa 
Z68200 	P.falciparurn glutathione peroxidase gene. 
aggattggaggtatacataata atatatatatatatatgtataattatttatttattattcccttgCtttagatCttagCtt tataaaaaatatgttcttCt 
ttgtgattcggttagtaaaaaa tattattttttttccaaataaattatttcatatatttcatttttttcCagatgcatgatg 
M91672 	Plasmodium falciparum RESA-2 gene, complete cds. 
cattttaaatgtaagttttatt tgtgtagttatttaatttaatatatattaaatttttttttctttttttagtataatttta ttgaataagtatgaaaCaaC 
U27338 	Plasmodium falciparum erythrocyte membrane protein 1, Malayan Camp variant 1 (MCvar-1 PfEMP1) gene, complete cds. 
atttttgaaggtaatatatata catacatatacacacctacatatacatacatacctcttttattattttagaaaaaaaCCa tgtcgatacaatggggggag 
X83707 	P.falciparum P1<1 gene. 
tggtcaataggtgtgttcaaag atatattcatattcatttacttatatattatcattacatttttaccttaggatgCgttat gattttcttcatgatggaCt 
L40609 Plasmodium falciparum (strain FCR3) variant-specific surface protein (var-2, var-3) genes, complete cds's. 
atttttgaaggtaatatatata atacctacacatacatatacacatatacatatatgttcctttttttttagaaaaaaacca gaatacaaaaatggcacctg 
ttatctaaaggtaaatggaagt atacctaaatacatatatacatacacatatatgttcatttttttttttagaaaaaaaCca aataacgaaaatggtgctcc 
L40608 Plasmodium falciparum (strain Dd2) variant-specific surface protein (var-l) gene, complete cds. 
ttatctaaaggtaaatggaagt atacctaaatacatatatacatacacatatatgttcatttttttttttagaaaaaaacCa acataatgtaatggtggagt 
X73954 P.falciparum gene for ras-related nuclear protein. 
aaaatatatagtaagtgaaaag tatatttttgtatttatttattttattataatttttttttttttttttaggctactcttg aatttaaaaaatggattcaC 
M94732 	Plasmodium falciparum 15 kDa vesicular-like antigen gene, exons 1 through 4. 
catcaaaatggtaagaggaaaa tattttgtttcatttcatttaatttttttttatttttgatacctttatagagtaatgtta tgtcatcaaaatgagtaatg 
gtcaggaaaagtaattattttt ttatttatttattttattttttttttttcccaatcatattaacacaaaagatgtggcaag 
aatatgaactgttcaggcaaaa tatataatatatttatgtttatatatatatatatatttttatttttgtagacaaaaaaaa 
L01655 M98341 Plasmodium falciparum T9/106 triosephosphate isomerase (tpi) gene. 
agcaaattaggtatatatcaaa atatatgttcaaatttgtaaaatatatatttgtatgtttttattccctagacgttgttgt tttttacaaaatggctagaa 
L34028 Plasmodium falciparum (clone H33) heat shock protein 86 gene, complete cds. 
tcgtacaaaggtaaaaagaaga ttactttttaccttttactttatattttttacttttaattttttttttagatcaccgaat ttcgaataaaatgtcaacgg 
L34027 Plasmodium falciparum (clone Dd2) heat shock protein 86 gene, complete cds. 
tcgtacaaaggtaaaaagaaga ttactttttaccttttactttatattttttacttttaattttttttttagatcaccgaat ttcgaataaaatgtcaacgg 
Z26314 P.falciparum gene for STARP antigen. 
ttctaataaagtaagataaaaa taatatataattatttatattttttttttttttttaatattactttttagaatttaaaat acaaaaaataatgatacata 
X05074 Plasmodium falciparurn exp-1 gene for malaria protein exp-l. 
aaaaataaaagtaagtcatttt tgatatatatgtgtatgatatataatattttattttctttttgttaatagaaggatcagg tatattcaaaatgaaaatct 
tacaccagaggtatgatttttt tgtgtatccaaatgtctatatatttattttatttttctttatttttatagCaaCCaCaag 
U07706 Plasmodium falciparum NF7 dihydropteroate synthetase gene, complete cds. 
aaatatttaggtaagaaaaaag atatacatatcactctttgattctatatatttttatttttcactttgtaggaaaaattat tatatataatatggaaaCta 
X75420 P.falciparum (FCR3) cpn60 gene. 
aataaaagtggtacgttaaaaa ctataagagctccatcatttggtgatagaagaaaagactatctaaaagatttatgtattg ttttttttttatgagaatga 
X61921 P.falciparum pfc2 gene for p34cdc2 protein kinase. 




J04000 Plasmodium falciparurn serine-repeat antigen protein gene (SERA), complete cds. 
ttcatattgtgtaagaatgaaa aatataatatttttacgcatacacaaacatttgtcattatttttttttaggtgttatatt atatatcaaaatgaagtCat 
actactgaaagtataaaaaata attatttatattattattatttattatttatttatttattttttttttagataacaaagt 
gacattccaggtaaataacaat tatatatatatatatacatattatatatttttttaatttttttgttttagaaaaatgtga 
M22718 J03988 P.falciparurn actin II gene, complete cds. 
agaacaacaggtatagaatgaa gatttaattttatctgattttatttcttggtcctaaatggttccctgtaggtatCgttct ttttctttagatgtctgaag 
L22057 Plasmodium falciparum ribonucleotide reductase RI subunit gene, complete cds. 
tattgatcaggtaaaattaaaa ttttgttcatacatttatattcatatatattttttttcctttttttatagtcccaatcat tatacaaacaatgtatgtgt 
Z28975 	P.falciparum (Kl) Ag15 gene. 
atggtaagaggaaaa attttgtttcatttcatttaatttttttttatttttgatacctttatagagtaatgttaa atggtaatgt 
gtcaggaaaagtaattattttt ttatttatttatttttttttttttttttcccaatcatattaacacaaaagatgtggcaag 
tgaccttaaggtaaaaaattga ttttcctttttgttgttatatattaactattaataatataaaatatttttgtagaCaaaa 
L11172 Plasmodium falciparum RNA polymerase I gene, complete cds. 
gacccatacaggtataatcaaa atatatatatgtatgtatttattttttttttttttttttttttCCCtttaggtgatttga atgtacgata 
aattcaattggtaagggaaaaa tatatttttatatgtgtatatatataatatttctatttttttttttgtagattaCttatC 
L18785 Plasmodium falciparurn DNA polymerase alpha (Pol alpha) gene. 
aaaacgatgagtgagtagataa ttttttatattttcttatattttattttttatattttattttcttctcagattcgatttg ttatatatatatgtatatat 
M99442 Plasmodium falciparum calmodulin gene, complete cds. 
ggagatggaagtaaatcataaa tattttatattatattatattatattatatttttttatttttctcattagCtataacaac aaatatatcaatggcagaca 
A00661 P.falciparum RESA gene for ring-infected erythrocyte surfaceantigen. 
cattttaaatgtaagttttttt tatctttgttattatatataattttttttttttttttttttttttcatagggtaatcttg ctaaataattatgagacctt 
X01469 Plasmodium gene fragment for histidine-rich protein. 
ttcaggaagcgtaagataaagc ataaaaaaaaagaaaaatctttaacatttaattttttatttatattatagaattcatgta gaaaggaagtatgtttactt 
X16075 Plasmodium falciparum beta-tubulin gene. 
aatagatccagtaagtttaaaa tttatatatttatttatttattttttttttttttattttattttttttagagtggtacct ttattaaagaatgagagaaa 
acaacacaaagtaagaaggaac attttttttttttctttttcttttttttttttttttgtttttttctttagatcaagtgtt 
X15979 	Plasmodium falciparum alpha-tubulin I gene. 
atgcttgctggtaaaacgataa aatacatcttttctttattctttttataaataatttgttgaattttttagggaattgttt taaataaaaaatgagagaag 
aggaaaacatgtaagaaataat tatatacatatatatatatatatatatttt ttttttttttttccttttaggtaccacgtt 
Y00060 P. falciparum SD17 gene for knob-associated histidine-rich protein. 
ctctaataacgtaagttcataa aattttattttattttattttaatttaattttattttttttttcatatagtgcaataatg ttattagagaatgaaaagtt 
L02822 L02823 Plasmodium falciparum heat-shock protein gene, complete cds. 
gactcaaacagtaagtattata gtaatatgtgtatatataaaaaatttgaatcttttattttaattttttagttgagggacc taattcaaaaatgaaccaaa 
X67288 P.falciparum cpk gene. 




M73770 M37820 P.falciparum RNA polymerase III largest subunit gene, complete cds. 




M69183 Plasmodium falcipanim (MESA) mRNA exons 1-2, complete cds. 
ttttttattagtaagttgctaa aaatgaaaaaaaaagtatatttattatcaccgtaatatatttttttataggatatCtata aaataatatgatggaaaatg 
M19881 P.falciparum knop protein (KP) gene, complete cds. 
ctctaataacgtaagttcataa atttttttattttattttaatttaatttttattttttttttcatata-gtgcaataatg ttattagagaatgaaaagtt 
J03998 P.falciparurn glutarnic acid-rich protein gnen, complete cds. 
ttctactaaggtaacaaaaata atttacatatatatttacatatttataatatatatgtattttttttttagtgcttttcca tttttaaaaaatgaatgtgc 
M93397 Plasmodium falciparum erythrocyte binding protein gene, complete cds. 
gctttttcaagtatgatattca taaaaaaaattaatttctcattaattttttttttctttttttctttttaggtatgccata tgtgcatacaatgaaatgta 
aatatcaaaggttagaaaaaat tatatatatatatatatatatatattgtattatatattttttttttatagttctgaagga 
tccaatatgtgtaatacaaata ttatattatcctataatatttatttttattttatgttttttttttttcagtcaatcaaca 
M59770 	P.falcipanim calmodulin gene, complete cds. 
ggagatggaagtaaatcataaa gttcttattttatattatattatattatatttttttatttttctcattagctataacaac aaatatatcaatggcagaca 
M31205 P.falciparum beta-tubulin gene (bTub), 	complete cds. 
tagatccaaggtagtttaaaaa tattattattatatattattattattattttttttttatttattttttagtggtacctat ttattaaagaatgagagaaa 
acaacacaaagtaagaaggaac tttttttctttttcttttttttttttttttttgttttttttttcttttagatcaagtgtt 
M34390 P.falciparum alpha-tubulin II gene, complete cds. 
atgcttgctggtaaaaaaaaaa taattaaaaatatacatatatatatatatatatatattttttttttatagggaattgttt tttacgaacgatgagagaag 
tggaaaacatgtaataataaae tatttatttacttatacatgtgtgcttctttttgtcgttactcattttaggtaccacgtt 
M28881 P.falciparum aldolase gene, complete cds. 
tttgaaaatggtaagaatataa attatatattttccttttttcttatttttatatttttatattttttttaggctcattgca tattttgaaaatggctcatt 
AF031144 	Plasmodium falciparum aspartate transcarbamoylase (ATCase) gene, complete cds. 
tccatcaaaggtaagaaaataa gcatatatatatatatatatatatttttatttatttattttcctttttagaaaaatgtcg atgttttata 
cgacacaaaggtaataatgtta ttaatgcatgtaaaatatatacatacatatatatatttatatatttatagatacttcaCc 
U89025 	Plasmodium falciparum protein phosphatase-beta gene, complete cds. 
ttccatatcggtatatttttat tatatatatatatatatttttctgttttttttttttttttttttttttaggaggtttacc aaagggaaggatgaaaaatt 
U40232 	Plasmodium falciparurn exported serine/threonine protein kinase (FEST) gene, complete cds. 
aaaataaaatgtataatataaa tatatatatatatatatatttatgtattttattttattttttttttataggtgttcgcat ggcaaaagctatgaataata 
U08113 	Plasmodium falciparurn serine repeat antigen (SERA3) gene, complete cds. 
ttcatattgtgtaagaatgaaa aatataatatttttacgcatacacaaacatttgtcattatttttttttaggtgttatatt atatatcaaaatgaagtcat 
actactgaaagtataaaaaata attatttatattattattatttattatttatttatttattttttttttagataacaaagt 
gacattccaggtaaataacaat tatatatatatatatacatattatatatttttttaatttttttgttttagaaaaatgtga 
M65160 P.falciparum glycophorin binding protein homology (GBPH) gene, complete cds. 
agccttattggtatgataat 	tatatatttatatatatatatttttttctgtttgcatcatttatttttagggtgtttata 	ctaagtaaaaatgCgtattt 
AF027825 Plasmodium falciparum glutathione reductase (GR3) mRNA, complete cds. 	 aaacgcaaatatggtttacg 
AF017139 Plasmodium falciparum casein kinase 1 (CK1) mRNA, complete cds. 	 aatttaaaaaatggaaatta 
D85686 	Plasmodium falciparum DNA for Pfjl, complete cds. 	 tgattatataatgttagctt 
U84403 Plasmodium falciparum adenylosuccinate lyase gene, complete cds. 	 attttttattatggatgtac 
AF012551 Plasmodium falciparum ornithine decarboxylase (ODC) mPNA, complete cds. 	 tggaaagtatatgttcatga 
U57371 	Plasmodium falciparum ADP-ribosylation factor-like protein (p1ARL) gene, complete cds. 	 atgggattga 
U57370 Plasmodium falciparum ADP-ribosyiation factor (p1ARF) mRNA, complete cds. 	 atgggtttat 
AF008549 Plasmodium falciparum chorismate synthase (AroC) mRNA, complete cds. 	 aaaaaacat tatgagcacat 
U38963 	Plasmodium falciparum 60 kDa heat-shock protein PfHsp60 mRNA, complete cds. 	 tgtagaaacaatgatatcaa 
M77834 Plasmodium falciparum membrane-associated calcum-binding protein(Pfs40) gene, complete cd 
	
tttttacaaaatgatgaaaa 
U85963 	Plasmodium falciparum asparigine-rich protein gene, complete cds. 	 atgaataata 
1)70366 Plasmodium falciparum rab6 (Pfrab6) mRNA, complete cds. 	 ttagatatatatgtatatac 
1)78753 	Plasmodium faiciparum ribosomal P2 phosphoprotein (P2) gene, complete cds. 	 tatataaaaaatggctatga 
1)65407 Plasmodium falciparurn apical membrane antigen 1 (AMA-1) gene, complete cds. atgagaaaat 
1)78291 	Plasmodium falciparuin cAMP-dependent protein kinase catalytic subunit (PfPKA) mRNA. 	acttctcgctatgcagttta 
1356663 Plasmodium falciparum acidic ribosomal phosphoprotein P0 (PFPO) mRNA, complete cds. atggcgaaat 
1)65959 	Plasmodium gallinaceum circumsporozoite protein (CSP) gene, complete cds. 	 gtact tcaaaatgaagaaat 
1)73195 Plasmodium falciparum M015-related protein kinase Pfmrk (Pfmrk) gene, complete cds. 	ttatgttctcatggaaaata 
1)67764 	Plasmodium falciparum thrombospondin related adhesion protein (PfTRAP) gene, complete cds 
	aaaataatgaatcatc 
1)31083 Plasmodium falciparum erythrocyte membrane protein 1 (PfEt4P1) gene, complete cds. 	 acaaacaaaaatggcgcctc 
D86574 	Plasmodium falciparum DNA for iron-sulfur subunit of succinate dehydrogenase, complete cd • 	aataagaaaaatgttaaaaa 
D86573 Plasmodium falciparum DNA for flavoprotein subunit of succinate dehydrogenase, complete c S. 	 cataagatttatgcaatcaa 
1)36377 	Plasmodium falciparurn mitogen-activated protein kinase-related protein gene, complete cds aaaaaaaaaaatgcctaaag 
1349381 Plasmodium falciparum phosphate carrier (PfMPC) mRNA, nuclear gene encoding mitochondrial protein ttttttcataatgatgaaaa 
1337225 	Plasmodium falciparum elongation factor 3 related protein (pfgcn20) gene, complete cds. 	 gaaaaaatatatgatggaag 
1)16995 Plasmodium falciparum ATPase gene, complete cds. 	 atcaatagttatgagttctc 
1)18984 	Plasmodium falciparum putative phosphatidylethanolamine-binding protein gene, complete cd • 	gttggatataatgacaatac 
1354642 Plasmodium falciparum phosphoribosylpyrophosphate synthetase (prs) gene, complete cds. 	 atggaaaatg 
L04161 	Plasmodium falciparum (clone Pfg377 [PfsXLX]) DNA sequence, complete cds. 	 ttttttccaaatgaagttgc 
1351645 Plasmodium falciparum cytidine triphosphate synthëtase gene, complete cds. atggatagtg 
1)41269 	Plasmodium falciparum Rabl protein (PfRabl) gene, complete cds. 	 gaaagaaaaaatgactgaga 
1)10322 Plasmodium falciparum H33 cyclophilin (cyppfl) gene, complete cds. aatcgagaatatgaaaaata 
1)15994 	Plasmodium falciparum histone H3 mRNA, complete cds. 	 aacaagcaaaatggcaagaa 
1)34363 Plasmodium falciparum CTRP gene, complete cds. 	 caaataacaaatgaagaaag 
L42636 	Plasmodium falciparum variant-specific surface protein (var-7) mRNA, complete cds. 	 gcatacaaaaatggagccag 
L31630 Plasmodium falciparum (clone: DlO) high mobility group protein, complete cds. 	 caacgctagaatgaagaata 
M14632 	Plasmodium falciparum GP185 mRNA encoding antigenically diverse glycoprotein, complete cd 
	
taattcaataatgaagatca 
1)14735 Plasmodium falciparum histone H3 mRNA, complete cds. 	 aacaagcaaaatggaaagaa 
1)14734 	Plasmodium falciparum histone H23 rnRNA, complete cds. atattgcaaaatggtatcaa 
U14189 	Plasmodium faiciparum MCP1 mRNA, complete cds. 
U25814 Plasmodium falciparum chromodomain protein mRNA, complete cds. 
U16955 	Plasmodium falciparum ATPase 2 gene, complete cds. 
M80655 Plasmodium falciparum glucose-6-phosphate dehydrogenase (PFG6PD) mPNA, complete cds. 
L07944 	Plasmodium falciparum secreted polymorphic antigen gene, complete cds. 
L28825 Plasmodium falciparum polymorphic antigen, complete cds. 
U20969 	Plasmodium falciparum circuinsporozoite protein (CS) gene, complete cds. 
U20985 Plasmodium falciparum rhoptry associated protein (RAP-1) gene, complete cds. 
L13381 	Plasmodium falciparum HB3\W2 transport protein (mdr2) gene, complete cds. 
J03772 Plasmodium falciparum (clone HB3) dihydrofolate reductase/thymidylate synthase (DHFR-TS) g 
L04162 	Plasmodium falciparum (clone sY) s230 mRNA, complete cds. 
U04335 Plasmodium falciparum adenine nucleotide translocase mRNA, complete cds. 
M59706 	P.falciparum glutamate rich protein (glurp) gene, complete cds. 
U08851 Plasmodium, falciparum isolate 1<1 polymorphic antigen gene, complete cds. 
U01323 	Plasmodium falciparum Dd2 ribonucleotide reductase large subunit (RNR1) mRNA, complete cds 
U01322 Plasmodium falciparum Dd2 ribonucleotide reductase small subunit (RNR2) mRNA, complete cds 
L15631 	Plasmodium falciparum (NF54) circumsporozoite-related antigen (Ag 5.1)mRNA, complete cds. 
U04640 Plasmodium falciparum multi-drug resistance homolog 2 (pfmdr2) gene, complete cds. 
U07365 	Plasmodium falciparum S-adenosylhomocysteine hydrolase mRNA, complete cds. 
M97214 Plasmodium falciparum S-antigen gene, complete cds. 
L01654 	Plasmodium falciparum triosephosphate isomerase (tpi) mRNA, complete cds. 
U00152 Plasmodium falciparum enolase gene complete cds. 
L32150 	Plasmodium falciparum carbamoyl phosphate synthetase II gene, complete cds. 
J03993 P.falciparum serine-repeat antigen mRNA, complete cds. 
J03084 	P.falciparum aldolase (P41) gene, complete cds. 
J03828 P.falciparum integral membrane protein mRNA, complete cds. 
J05544 	Plasmodium falciparum glucosephosphate isomerase (ggi.Rl) gene, complete cds. 
M12897 Plasmodium falciparum glycophorin binding protein (GBP-130) gene, complete cds. 
J03028 	P.falciparum dihydrofolate reductase-thymidylate synthase gene, complete cds. 
K02194 Plasmodium falciparum circumsporozoite (CS) protein gene, complete cds. 
M11145 	Plasmodium falciparum circumsporozoite-protein related antigen(CRA) mRNA, complete cds. 
M22719 J03988 Plasmodium falciparum actin I gene, complete cds. 
J03902 	Plasmodium falciparum p101/acidic basic repeat antigen (ABRA) DNA, complete cds. 
304656 Plasmodium falciparum 41-2 protein antigen gene, complete cds. 
L15426 	Plasmodium falciparum ornithine aminotransferase (OAT) mRNA, complete cds. 
L22058 Plasmodium falciparum ribonucleotide reductase R2 gene, complete cds. 
L15446 	Plasmodium falciparum dihydroorotate dehydrogenase homologue gene, complete cds. 
L08135 Plasmodium falciparum transmission blocking target antigen (Ps230) mPNA, complete cds. 
M80807 	P.falciparum Pr86 rhoptiy precursor protein (P82) gene, complete cds. 
M19753 Plasmodium falciparum heat shock protein (HSP70) homologue mRNA, complete cds. 
M93720 	Plasmodium falciparum L-lactate dehydrogenase (LDH-P) roRNA, complete cds. 











































M92054 	Plasmodium falciparum hexokinase gene, complete cds. 
M64705 Plasmodium falciparum protein antigen mRNA, complete cds. 
M94013 	Plasmodium falciparum sporozoite surface protein 2 gene, complete cds. 
M32853 P.falciparum rhoptry associated protein 1 (ropl) gene, complete cds. 
M59249 	P.falciparum 3-phosphoglycerate kinase gene, complete cds. 
M28261 P.falciparum p75 mRNA, complete cds. 
M28890 	P.falciparum membrane protein Pf 7 gene, complete cds. 
M29154 M24322 P.falciparum multidrug resistance (MDR) gene, complete cds. 
M86518 	Plasmodium falciparum high mobility group-like protein (PS16) gene, complete cds. 
M37213 P.falciparum major merozoite surface antigen (gp195) gene, complete cds. 
M64715 	Plasmodium falciparum DNA polymerase-delta gene, complete cds. 
M81341 M80590 Plasmodium falciparurn cysteine proteinase gene, complete cds. 
M64107 	P.falciparum 17 kD sexual stage protein mRNA, complete cds. 















U51723 Plasmodium vivax Serine Repeat 
V-SERA 2 tgggccatgtgtaaggagagag 
ccatcggacagtaatagaaa 
gacattccaagttagcacgcac 
V-SERA 4 ttcatactaagtaagaggggaa 
ccatcggacagtaatggaaaag 






V-SERA 5 tcttgatattgtgtaaggatga 
ggggagacaagtaagaggaaat 
caaattccaggtaggtttacgg 
X84734 P.vivax GAM1 gene. 
cgctgtatggtaaggtggatga 




























M88097 Plasmodium vivax retyculocyte 
aactatttaggtaacacacatg 
X55197 P.yoelii YEL6 gene for ATPase. 
















U43538 Plasmodium yoelii hepatocyte erythrocyte protein 17 kDa gene, complete cds. 
gttattaagagtaagttgattt tttatttattatttatttattatttactcactttttaataatttgtttagaacacggaga 
L27591 Plasmodium chabaudi adarni erythrocyte membrane antigen 1 gene, complete cds. 
cacgggttgcgtaatatacgaa aaattaacataacaatatttgatatatttttaattttgttatttttttagtttggatgct 
L27590 Plasmodium chabaudi chabaudi erythrocyte membrane antigen 1 gene, complete cds. 
cacgggttgcgtaatatacgga taataaattaacaatatttgatatgtttttaattttgttattttgtttagtttggattcc 
tatataataagtaataataaat taataaataataaataaatatatatatacatatatatatttttaatgcagatgtgttatt 





































U51724 	Plasmodium vivax serine repeat antigen-related (V-SERA 5) mRNA, complete cds. 	 gaggaacaaaatgaagtctc 
M60807 	Plasmodium vivax merozoite surface antigen 1 (MSA1), complete cds. 
L26362 Plasmodium vivax cysteine proteinase mPNA, complete cds. 
009737 	Plasmodium vivax Gabon clone G24 circumsporozoite protein gene, complete cds 
M11926 J04090 M20671 Plasmodium vivax circumsporozoite protein gene, complete cds. 
009766 	Plasmodium malariae China-1 CDC circumsporozoite protein gene, complete cds. 
DEFINITION Plasmodium malariae (clone 255A) circumsporozoite protein (CSP) gene, complete cds. 
067763 	Plasmodium berghei thrombospondin related adhesion protein (PbTRAP) gene, complete cds. 
D88664 Plasmodium berghei DNA for ookinete surface protein, complete cds. 
043521 	Plasmodium berghei rnerozoite surface protein-1 gene, complete cds. 
L04508 Plasmodium berghei heat shock related protein gene, complete cds. 
045969 	Plasmodium berghei apical membrane antigen-1 gene, complete cds. 
1346549 Plasmodium berghei heat shock protein ClpB mPNA, complete cds. 
012275 	Plasmodium berghei ANKA dihydrofolate reductase thymidylate synthase (DHFR/TS) gene 
M81793 Plasmodium berghei fructosebisphosphate aldolase (ALDO-2) gene, complete cds. 
M28887 	Plasmodium berghei (clone 236L) circumsporozoite protein (CSP) gene, complete cds. 
L19784 Plasmodium chahaudi adami integral membrane protein mRNA, complete cds. 
L22982 	Plasmodium chabaudi chabaudi merozoite surface protein-1 gene, complete cds. 
M30834 P.chabaudi dihydrofolate reductase/thymidylate synthase (DHFR-TS) gene, complete cds. 
080896 	Plasmodium chabaudi 93 kDa protein mRNA, complete cds. 
049743 Plasmodium chabaudi DS apical membrane antigen 1 (AMA-1) gene, complete cds. 
M25248 	Plasmodium chabaudi apical membrane antigen I (AMA-1) gene, complete cds. 
043145 Plasmodium chabaudi repeat organellar protein gene, complete cds. 
M34947 	P.chabaudi major merozoite surface antigen mRNA, complete cds. 
M95789 Plasmodium chabaudi acidic phosphoprotein mRNA, complete cds. 
D89082 	Plasmodium yoelii mRNA for 28 kDa ookinete surface protein, complete cds. 
D89081 Plasmodium yoelii mRNA for 21 kDa ookinete surface protein, complete cds. 
045971 	Plasmodium yoelii apical membrane antigen-1 gene, complete cds. 
L27838 Plasmodium yoelii rhoptry protein, complete cds. 
J04668 	P.yoelii major merozoite surface antigen gene (PNMSA), complete cds. 
J02695 Plasmodium yoelii circumsporozoite protein (CSP) gene, complete cds. 
M84732 	Plasmodium yoelii sporozoite surface protein 2 gene , complete cds. 
L33882 Plasmodium reichenowi surface antigen (Prs48/45) gene, complete cds. 
020986 	Plasmodium reichenowi rhoptry associated protein 1 (RAP-1) gene, complete cds. 
M75444 X61376 Plasmodium reichenowi sporozoite antigen gene, complete cds. 




































K00822 	Plasmodium knowlesi circumsporozoite protein gene, complete cds, and 5' and 3' flanking regions. caagaacaagatgaagaact 
M61097 M37854 P.knowlesi 66-kDa protein (PK66) gene, complete cds. 	 acaacacaatatgaataaaa 
M11031 	Plasmodium knowlesi circumsporozoite antigen (CS) gene, complete cds. 	 caagaacaagatgaagaact 
ttttttggatatgaattttt 
L05069 	Plasmodium simium circumsporozoite protein type 2 (CS) gene, complete cds. 	 atgaagaact 
009765 Plasmodium simiovale circumsporozoite protein gene, complete cds. 	 atgaagaact 
M96886 	Plasmodium gallinaceum ookinete stage-specific surface antigen (pgs28) gene, complete cds. atttaaaaaaatgaaaattc 
M90978 	Plasmodium cynomolgi heat shock protein 70 (hsp70) gene, complete cds. 	 agttttcaaaatggccagcg 
M15102 P.cynomolgi (strains Mulligan and NIH) circumsporozoite (CS) gene, complete cds. 	 caagaacaagatgaagaact 
M29898 	P.fragile apical membrane antigen 1 (AMA1/AG352) gene, complete cds. 	 acaacacaatatgaataaaa 
L42007 Toxoplasma goridii protein serine/threonine kinase (PK1) gene, complete cds. 





tgggcacttggtaaggtacagt gcaaaataccgcttctact ttgtgtatt tctgagccgtcgtttgctacaggagtgattct 
gttcagcggcgtgaggcgtcct tgccgccattttcttgaatagcaatttctttttggggttttggtggacaggtgcgaacga 
ggcagactaggtggctgttcat aggagaaagtaccacatggtagaagtagatccttttttgtgtcttcacagtgtcaggtac 
AJO01085 Toxoplasma gondii crk2 gene. 





U62660 Toxoplasma gondii micronemal protein MIC2, complete cds. 
gatacttcaggtaaggtgacga cccatgttgtcgctgttctttgtgggatatgtgtgtgctcgttcctgaaggcgttgaaga tgttttcacaatgagactcc 
gcttgtggaggtaaggcacttg gacagtgtggttaatcgaccttttgctttttgtgtgtggattgttgccagcttcctgcac 
actatttgaggtaaggttatca ttagtatccgacacgatgagcctccgggtgtctgtttatctgctcttcagctccagtgtc 
1381497 Toxoplasma gondii hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase (pppk-dhps) gene, complete cds. 
agcggactgggtaagcctagcg ggcttattaccttgtagcgagcgtgagctgaggcatcccgctgccctcaggtgaacgacc cctccagaagatgagggaag 




Z71786 T.gondii MIC1 gene. 
tatggagaaggtacgtttccag cagcgacgacacgtgaactggctctctcgattctgtcggtgttttttcagcgtcgcattc atttgcaaagatgggccagg 
ttacgagaaggtgaggaagaac ggaaggaatgttaggttggcattgtttgctgtcgtcgaatagctgtttaggccagcttgc 
ggacgacgaggtaagttggaaa cgatggctcatccgttccccgttttcttgccggcaccccgttacctgcagggacgtCgac 
Z48750 T.gondii hsp30/bagl gene. 
ctctcaacaggtacagttgaaa tcttgcggtaaacaccgatggaaattgcgatttgatgcgtggatatgcagctagactatt ttcaaaaaagatggcgccgt 
ccctcccccggtaagactgaca cgccttgagtaggagggatggt cgtcccacagatgtgtgcatctgtgcagttttggggtg 
cgt tatcaaaggtaaatcgtct tttttttcgtgcatgacgacggaatcgcgttgctccgtgctgccctggcaggagagaaga 
Y09782 T.gondii H4 gene. 











Toxoplasma gondii dihydrofolate reductase-thymidylate synthase gene, complete cds and complete genomic sequence. 
cctcttccctgtgagcacacac 	acctccgttacgctttttttctggctttcttcttcgtctctgtttatcagcaaagaagaa 	gtctgggaagatgcagaaac 
tttgtcgtgggtatgttgtcct gtccagactatgtcgcctgtttccccacccttctcggcttgtgctttcaggaggagcggg 









Toxoplasma gondii 65 kDa cyst matrix protein gene, complete cds. 
atcacaccgggtaaggtcacga 	actcgtattcactgaagtgatcgctattttgtttgcgttactgtgcacagcaacatggat 	caccggcaacatggattgcc 
tgagccaaaggtgagtcaagcg ttgttggtaagtgttttgcaaggcgttgtgttggcacaactggcgtgcagggtgccagag 
Toxoplasma gondii antigen p28 gene, complete cds. 
gagcagttgggtaagttggcaa tgtagtgtcttgagactcggtgccatgtagaattttgtgtctgcctgcagaggaaaaggt 






Toxoplasma gondii RH uracil phosphoribosyl transferase gene, complete cds. 
tcatcacgaggtaatccttcaa tcggaaaagttcattgtgaacgttccccttgcgtgtcatgactttatcaggtttccCaat 










T.gondii alpha-tubulin gene, complete cds. 
acgcctgctggtaagcggacac ccagttcgctgtaaccattgtcttttgtgtgttttctctccttcttttagggagCtCttc 
tggcaagcacgtgagtattgtt ggttgtctcttgtattttgtcaaacgtgttgactgcgtacgctgactcaggtgccccgat 








L07954 Eirneria tenella horñologue of E.coli transhydrogenase (7B2) gene,complete cds. 
acattcttgggtatgtcgtttt 	atacgtgccttgcgcgaccatttcgatactcattggctttttaaCagtCttgtgggC 
M21088 E.tenella major sporozoite surface antigen gene, exons 1 to 4, complete cds. 
ccaacagcaggtgggcttttcc 	aaaacgaggtgcattcaccttttgcatgttgtgtgcggaaattttatCagttacgctgga 
agtcttaggagtaagccgtcca gaacaaggaactacactgtccttgaatttttaatCt tttgttacgtacagggcggaaggt 
aaccattcgagtgagagtcagc 	agcgcaatcttctaatacttgtttgtaatgtttgtaatgtttgcgtgcagCgacgagcaa 








Y12615 C.parvum beta tubulin gene. 
gatcgaccctgtaagttttgaa 	aataattgactttttttttttctttttttttctttgaaatatgaatttagactggtaCtg 










gtcctcaattgtaagt 	 atttactgtttaatatcacattttaggtaccaaagC 
U40703 Theileria par-va sporozoite surface protein p67 gene, complete cds. 
agagaattaggtttg 	 tttttttgagtatatgggttttaggtaatagggc 	acactgaacgatgcaaataa 
M67476 Theileria par-va cathepsin L-like cysteine protease gene, partial cds and p67 and ORF1 genes, complete cds. 
agagaatcaggtttgttttttt 	 gagtatatgggttttaggcaatagggc 	acactgaacgatgcaaataa 
M37791 Theileria par-va cysteine protease gene, complete cds. 
gaacaaaagggttagtt 	 acacacacttaatattattttataggtgatgaaCc tgtattaaccatggttagtt 
U70130 Babesia bovis iron-dependent superoxide dismutase (Fe-SOD) gene, complete cds. 
aaactaaacagtaagtatta 	 ttacccatgaatataatggttcaggtctcatcaa 
	tgtatctacaatggccttca 
actatcgaaggttgttatag gattccatgttatccatgatgccacagagttgatact 
tacattaacagtaggttgta 	 tagctcctaaatatactccacaggctggtggaa 
U34076 Babesia bovis ribosomal protein L35 (bL35) gene, complete cds, and nucleoside monophosphate kinase (bNMK) gene, nuclear gene 
encoding putative mitochondrial protein, complete cds. 
tgattttctcctgtacgtaacgt 	taataacgtaaaaaacaaacaaataaaaacgcaaagaagatatacttaccatttttaaa 
gtttcatcaggttcgttt 	 tgtgcattggttgttttacgcggtattaaggtgatatact 
	atctgttgatgattagca 
gtatagtcaggtaccatt agtagccatcctgttctatatgctacagcgctgagttg 
aggccgaagggtgtgttt 	 ccatttgccactttaattttttatagcactgtgctc 
cttgctgaaggtttgtct accagcaaccaccatgacttcgtttcagtgcaacggtt 
tctagaaggtgttagttt 	 tttcttagacgatttagacttaatagataccaacga 
Appendix H 
The Ran GTPase cycle. 
A Proposed role of Ran in the import of nuclear localisation sequence (NLS) tagged 
NLS cargo to nucleus. (1) The targeting complex forms when the NLS receptor a binds 
NLS cargo and docking factor b. (2) Docking occurs at the filamentous sites that 
protrude from the pore complex. Ran-GDP, presumably initially bound to the small 
Ran-GDP binding factor NTF2, docks independently. (3) Transfer to the translocation 
channel is triggered when an unidentified RanGEF converts Ran-GDP to Ran-GTP. (4) 
The nuclear pore complex catalyzes translocation of targeting complex. (5) Ran-GTP is 
recycled to Ran-GDP by docked ubiquitin-RanGAP. (6) Ran-GTP disrupts the 
targeting complex by binding to a site on b that overlaps with a binding site. (7) NLS 
cargo dissociates from a, and Ran-GTP may dissociate from b. (8) a and b factors are 
recycled to the cytoplam. 
B The Ran translocation switch is off in the cytoplasm and on in the nucleus. Ran-
GTP promotes NLS- and NES-directed translocation. Cytoplasmic Ran is enriched in 
Ran-GDP (OFF) by an active RanGAP and nuclear pools are in Ran-GTP (ON) by an 
active RanGEF. RanBP1 promotes the contrary activities of these two factors. Direct 
linkage of nuclear and cytoplasmic pools of Ran occurs through the nuclear pore 
complex by an unknown shuttling mechanism. NLS, nuclear localisation signal; NES, 
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Appendix I 
Survival of P. faciparum parasites in different cytotoxic drugs. 
0 	12 	24 	36 	48 	60 	72 
Hour 
On the vertical axis are plotted the parasitaemia (%) treated with 2.5 pg/m1 of 
aphidicolin, 0.1 pg/ml of coichicine, 2.5 nglml of pyrimethamine, 100 ng/ml of 
HC toxin, 30 iM of verapmil and without any treatment. The drugs were given 
in the culture from ring stage of P. falciparum parasites for 72 hr contineously. 
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Appendix J 
Two publications produced from the course of this PhD study: 
Ji and Arnot, 1997. Mol. Biochem. Parasitol. 88, 151-162. 
Ji et a!, 1998. Mol. Biochem. Parasitol. In press. 
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A Plasmodium falciarum homologue of the ATPase subunit of 
a multi-protein complex involved in chromatin remodelling for 
transcription' 
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Abstract 
A Plasmodium falciparurn homologue of one of the components of a chromatin-remodelling complex .which 
controls binding of transcription factors to nucleosome core particles has been cloned and characterised. The gene 
encodes 1422 amino acids with an estimated molecular mass of 167 kDa. The protein, SNF2L, shares 60%  amino acid 
identity in its conserved DNA-dependent ATPase domain with yeast transcription factors originally identified by 
characterising mating type switch mutants. It also contains sequences related to the so-called SWI3, ADA2, N-CoR 
and TFIIIB B" or SANT DNA binding domains which are characteristic of these transcriptional activation factors. 
The SNF2L gene has two short introns in the 3' region of the coding sequence of the gene and is transcribed into a 
single 6.5 kb messenger RNA species which is present throughout the asexual stages of the cell cycle. Southern 
blotting and pulsed field' gel electrophoresis experiments show that SNF2L is a single copy gene, located on P. 
Jalciparum chromosome 11. © 1997 Elsevier Science B.V. 
Keywords: Pfalciparum ATPase; Chromatin remodelling; Transcription factors; SNF2L; SWI/SNF 
1. Introduction 
Abbreviations: CRC, chromatin remodelling complex; SNF, 
sucrose non-fermenting; SWI, mating type switch; UTR, un-
translated region. 
* Corresponding author. Tel.: + 44 131 6508655; fax: + 44 
131 6508655; e-mail: dea@holyrood.ed.ac.uk  
Note: Nucleotide sequence data reported in this paper are 
available in the EMBL, GenBankTM  and DDJB databases 
under the accession number AF003086. 
Plasmodium falciparum gene expression is not 
understood although a number of interesting ob-
servations have been made. Plasmodium mRNA 
can be translated in vitro and is thus inferred to 
be conventionally capped [1,2]. These mRNAs 
frequently possess long, A + T rich, 5' UTR's 
0166-6851/97/$17.00 © 1997 Elsevier Science B.V. All rights reserved. 
P1150166-6851(97)00089-3 
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whose function is unclear [3-5]. Transcript map-
ping has indicated heterogeneous initiation at 
the 5' ends of some P. falciparum messages [3,6] 
although other studies have detected single start 
sites in other genes [7,8]. Features characteristic 
of protozoan promotors such as repeated se-
quences upstream of the start codon have been 
reported for a gene transcribed during gameto-
cytogenesis [9]. The 3' UTR's of P. falciparum 
mRNAs are also A + T rich and multiple poten-
tial polyadenylation sites occur downstream of 
the stop codon [8, 10,11]. As more genes are se-
quenced it has become clear that introns are not 
uncommon and probably occur in a majority of 
loci, although they are usually small (< 150 bp) 
and tend to occur near the 5' or 3' ends of a 
gene, leaving the central transcribed region unin-
terrupted. A similar size, frequency and distribu-
tion of introns has previously been noted in 
yeast [12]. Trans-spliced leader sequences have 
not been found although differential splicing has 
been detected in one P. faiciparum gene with 
eight introns [13]. 
Promotor characterisation in P. falciparum is 
difficult as the A+ T rich base composition of 
intergenic regions (' 87%) means that the 5' 
UTRs abound with sequences resembling the 
TATA motif of most eukaryotic transcription 
promoters (consensus sequence TATA/TA). 
However, the parasite has a TATA-binding 
protein and although it is somewhat divergent 
from other family members, it retains sequences 
essential for recognition of DNA [14]. 
Eukaryotic transcription initiation involves de-
condensation of DNA from chromatin which in-
hibits transcription, replication, recombination 
and repair by blocking access to the DNA 
[15,16]. Two types of enzymes are known to re-
arrange nucleosomes. Type A historic acetyl-
transferases increase the affinity of transcription 
factors for nucleosomal DNA sites by altering 
DNA binding via increasing the level of lysine 
acetylation in histone proteins [17]. The second 
class of known chromatin remodellers/transcrip-
tional activators, are the SWI/SNF proteins, 
which catalyse ATP hydrolysis in a DNA de-
pendent fashion [18-21]. We have identified a 
novel member of this important family of gene 
expression regulators in P. falciparum and char- 
acterised its structure and expression pattern. 
2. Materials and methods 
2. 1. Parasites. 
P. falciparuin lines 3137A and KI were grown 
under standard conditions [22]. Synchronised 
cultures were obtained using the method of 
Lambros and Vanderberg [23] and gametocyte 
enriched cultures were prepared following the 
methods described by Carteret al. [24]. 
2.2. PCR cloning of the amplified fragments and 
eDNA library screening 
Two stretches of amino acids (KWIHCF and 
FLNKID) that encode GTP binding residues and 
are conserved among members of the Goc protein 
family were used to design primers biased towards 
P. falciparuin codon usage [25]. The primers 
were named as GPI (5'AA(A/G)TGGAT(A/C/T) 
CA(C/T)TG(C/T)TT-3') and GP3 (5'(A/G)TC(A/ 
G/T)AT(C/T)TT(A/G)TT(T/C)AA(A/G)AA-3'). 
A total of SOng of total asexual RNA was reverse 
transcribed in 40 ,ul of a solution containing 50 
mM Tris—HC1, pH 8.3, 75 mM KCI, 10 mM 
dithiothreitol, 3 mM MgCl2 1 mM dNTPs, 20 U 
RNasin (Promega), 2.5 pM of oligo dT 15 primer, 
200 U M-MLV reverse transcriptase (BRL) at 
37°C for 2 h. A total of 40 cycles of PCR were 
carried out with 2 jil of the cDNA product and 
the GPI and GP3 primers in 50 jil of 10 mM 
Tris—HCI, pH 8.3, 50 mM KC1, 10 mM dithio-
threitol, 2.5 mM MgCl,, 75 pM dNTPs, I pM 
primer GPI, 1 pM primer GP3, 2 U Taq poly-
merase (Perkin-Elmer). PCR cycling was at 94°C 
for 1 mm, 40°C for 2 mm, 72°C for 1 mm, with a 
final 72°C extension for 10 mm. The 198 bp 
fragment obtained was gel-purified and subcloned 
into the pCRII (Invitrogen) vector for sequencing. 
The PCR fragment was radiolabelled and used to 
screen a P. falciparum asexual stage cDNA library 
constructed in the plasmid vector pJFE14. Ten 
positive clones were selected from a screening of 
50000 colonies. 
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2.3. DNA isolation and southern blotting 
Genomic DNA was purified from saponin-lysed 
cultures as described [5]. For Southern blots, ge-
nomic DNA was digested and fractionated on 
0.8% agarose gels then transferred to Hybond N 
nylon membranes (Amersham). Membranes were 
prehybridised for 4 h at 65°C in 1%  sodium 
dodecyl sulphate/i M NaC1/10% dextran sulfate/ 
5 x Denhardt's solution/100 mg ml -' denatured 
salmon sperm DNA. Hybridisation was carried 
out in the same buffer with radiolabelled probe at 
56°C overnight. Following hybridisation, the blot 
was washed under conditions of increasing strin-
gency, ending with 0.1 x SSC at room tempera-
ture. 
2.4. Pulsed field gel electrophoresis 
P. falciparum chromosomal DNA blocks were 
prepared as described [26]. Pulsed field gel elec-
trophoresis (PFGE) was carried out using a Bio-
RadTM CHEF DRII apparatus and 1% agarose 
gels. The chamber buffer was 0.5 x TBE circu-
lated at 14°C. Gels were ramped from 90300 s 
pulse times at a constant 95 V for 20 h then 
switched to a ramp from 300-720 s pulse time at 
a constant 90 V for 30 h. 
25. RNA isolation, Northern blots and intro/i 
detection 
Total RNA was prepared from cultures using 
an RNA Isolator Kit (Genosys) after removing 
haemoglobin by saponin lysis of erythrocytes. For 
Northern blotting, 2.5 jig of total RNA was 
separated in 1.2% agarose gels containing 0.74% 
formaldehyde and transferred to Hybond N + 
membranes (Amersham) by alkaline transfer. In-
tron-exon detection was performed by PCR and 
RT-PCR amplification from genomic DNA, 
cDNA and the SNF2L clone [27]. PCR and RT-
PCR was carried out as described above except 
that Taq polymerase was added to a 'hot-start' 
reaction at 68°C.  
2.6. Computing analysis 
Sequence analysis was performed using the 
GCG software package [28] or through World 
Wide Web browsers. The eDNA sequences and 
translated amino acid sequences of the SNF2L 
gene were compared with the EMBL and Gen-
Bank database using the BLAST algorithm [29] as 
implemented in the GCG package. Local align-
ments of multiple sequences were constructed us-
ing these algorithms under varying parameters on 
individual sequence pairs, followed by manual 
optimisation of the alignments. The RNASPL [30] 
and POLYAH [31] programs were used to predict 
intron-exon junctions and potential poly(A) sites. 
PSORT version 6.3 (WWW) was used to do the 
prediction of protein localisation sites from 
cDNA sequences. Statistical analysis of protein 
sequences was carried out using the SAPS pro-
gram [31]. 
3. Results 
3.1. Isolation and characterisation of the SNF2L 
gene cDNA clones 
The SNF2L gene was identified during attempts 
to clone P. falciparum G-protein genes. The origi-
nal PCR reactions were performed by using 
primers (GPI and GP3) deduced from conserved 
GTP-binding domains of Goc proteins. A 198 bp 
fragment was amplified and its sequence revealed 
similarities to the conserved regions of the SNF2/ 
SWI2 transcription activation factors. In attempts 
to clone members of the G-protein gene super-
family, we have amplified several sequences with 
homologies to ATPase domains. Given the impor-
tance of SNF2/SWI2 proteins in transcription and 
our interest in gene expression in Plasmodium, we 
analysed the gene further by using the amplified 
fragment to screen a P. falciparum plasmid cDNA 
library. Ten overlapping cDNA clones were iso-
lated. 
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3.2. The structure of the SNF2L gene 
The largest cDNA clone, SNF2L-3, has 519 
nucleotides of 5'-UTR (86.5% A + T) upstream of 
a putative initiation codon followed by a 4,269 
nucleotide open reading frame and 469 nucle-
otides of 3'UTR (87% A + T). The exact position 
of the translation initiation codon is uncertain as 
there are four in-frame methionine codons in the 
region 520-595. Alignment with other members 
of the gene family does not resolve this problem 
since there is heterogeneity in the amino terminal 
sequences of the SNF2-like proteins. The most 
likely initiation site is the first of these in-frame 
ATG codons since P. falciparuin 5' UTR regions 
do not maintain in-frame open reading frames. 
Sequences around this codon are not in particu-
larly good agreement with the 'Kozak rules' for 
eukaryotic translation initiation sequences, but P. 
ftilciparum genes in general conform poorly to this 
translational initiation consensus which is derived 
from higher eukaryotic genes [32]. The nucleotide 
and translated amino acid sequence of this 
protein, based on assigning the first in-frame 
ATG as the initiation codon, is shown in Fig. IA. 
The amino acid sequence showed that the 
highest levels of sequence similarity in BLAST 
searches were with domains conserved between 
members of the SNF2 and SNF2-like (SNF2L) 
family of transcription factors [33]. These proteins 
contain seven conserved regions which constitute 
the catalytic site of a DNA-dependent ATPase 
which also has a DNA unwinding activity. These 
seven regions are boxed in Fig. 1. The alignment 
of the P. falciparum protein, which we have 
named SNF2L, with the Drosophila [34], human 
[35], C. elegans (unpublished, GeneBank ref. 
P41877) and yeast (unpublished, GeneBank ref. 
P31844) SNF2-like proteins is shown in Fig. 2A. 
Motif I, la and II match the consensus se-
quence of the bipartite nucleotide triphosphate 
binding motif found in both ATP and GTP-bind-
ing proteins [36]. The DNA-dependent ATPase/ 
DNA helicase domain of all the SNF2-like 
proteins, including P. falciparuni sequence, is 
shorter than that of the corresponding domains of 
SNF2 proteins proper (the human and Drosophila  
brm proteins and the yeast SNF2/SWI2 protein). 
As in all members of the SNF2L subfamily, P. 
falciparum SNF2L has the DEAH amino acid 
motif, whereas the SNF2 proteins have a DEGH 
motif. SNF2L proteins also lack the other con-
served domains found in brin and SNF2/SWI2, 
the so-called 'bromodomain', a sequence of un-
known function postulated to interact with other 
proteins in the transcriptional activation complex. 
In addition to the regions involved in ATPase 
activity the P. falciparum protein also contains a 
SANT domain which is also characteristic of the 
other SNF2-like proteins, but not the SNF 
proteins (Fig. 213). Again, the function of the 
SANT conserved sequence is unclear but it occurs 
in several proteins found in transcription com-
plexes such as TFIIIB. Two regions of the P. 
ftilciparum SNF2L sequence are not found in 
other members of the family, although they are 
common in Plasmodium proteins. Eight tandem 
repeats of a NNHNDD sequence occur in the 
amino terminal domain and between the DNA-
dependent ATPase domain and the SANT do-
main, the protein contains a region of 210 lysine 
rich, basic amino acids. Both of these insertions, 
which make the P. falciparum SNF2L substan-
tially bigger than its higher eukaryotic homo-
logues, are unique. Like most other Plasmodiun, 
genes, P. falciparum SNF2L is an asparagine 
(12.4%) and lysine (11.5%) rich protein. 
GenBank homology searches further indicate 
that P. falciparuni SNF2L is most similar to 
proteins of the SNF2L subfamily of the SNF2 
transcription factors. P. falciparwn SNF2I. 
proteins are 37.6% identical and 59.8% similar to 
yeast YB95 SNF2L protein, 40.6% identical and 
63.8% similar to the human SNF2L protein, 
38 . 1% identical and 61.6% similar to C. elegans 
SNF2L protein and 40.4 0/0 identical and 62.5% 
similar to Drosophila ISWI protein. Fig. 2 com-
pares the structure, sizes and conserved motifs of 
these proteins. The primary regions of homology, 
the seven consecutive motifs characteristic of 
DNA-dependent ATPase/DNA helicase and the 
C-terminal SANT domain were used to align the 
five sequences. 
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Fig. I. (A) The complete sequence of the PfSN F2L eDNA clone and its encoded protein. The amino acids contained within the solid 
boxes are those of the conserved ATPase domains. The ca - box terminal sequences underlined by the solid bar represent the SANT 
domain characteristic of the SNF2-like proteins. The sequences highlighted with dashed line boxes are the asparagine-rich repeated 
hexapeptides unique to the P. falcipariini gene. Sequences underlined h dashed lines indicate the position of charged residue 
clusters. The clone contanis it single an open reading frame of 4269 nucleotides encoding a 1422 ammo acid protein with an 
estimated 167 k Do molecular mass, The termination codon is marked h an asterisk and the GenBank accession number is 
A H)03056. (B) The sequence and position of the t\6 0 earbox terminal introns of .SVF2L. Intron I is 132 bp and tntron is 162 op. 
3.3. Gc,uniie localisation aiuf 11)/ron inapnng 	 sequence without closely related ( > 80s homol- 
ogy) sequences. Southern blotting of pulsed field 
	
Genomic DNA was digested with restriction 	gel separations of two cloned lines of P. t0/el- 
enzymes and analysed by Southern blotting Fig. pwwli maps the gene onto chromosome Ii (Fig. 
3A). This shows that SNF2L is a single copy 	313). Discrepancies between the size of PCR prod- 
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1 - ig. 2. (A) Alignment 01 the conserved sequences ot the SNE 2-like protein subfamily. ISWI is the Tho,iop/u/a protein [341. I IuSN 1-2L is the human protein I 9.J. ( eSNI-2L 
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ucts derived from genomic DNA and cDNA in-
dicated that the gene has at least one intron. 
Differential splicing in Plasn,odiun, has been 
noted [13] and since processing of transcription 
factor mRNA might regulate expression. the in-
trons of this gene were located and sequenced. 
Using nine pairs of PCR primers and comparing 
genomic DNA. the cDNA clone and the RI-
PCR product, the intron-exon boundaries of the 
SNF2L gene were mapped. The intron positions 
and sequences are shown in Fig. 1B. 
3.4. SNF2L transcription during deuelopineiit 
To determine mRNA size and the existence of 
any precursor or processed RNA species. total 
RNA was isolated from asynchronous asexual 
stage cultures of several P. fa/cipwuni strains 
and separated on formaldehyde gels for North-
ern blotting. The internal PCR fragment was 
used as the hybridisation probe. The SN F2L 
mRNA can be detected in all three laboratory 
lines as a single. strong niRNA hand of 6 -6.5 
kb (Fig. 4). Faint hybridisation to smaller sized 
fragments varies between RNA preparations and 
probably represents degradation rather than pro-
cessing. Given that our largest cDNA clone is 
5.27 kb in size, the primary transcript must be 
significantly longer than the coding sequence. 3' 
RACE (rapid amplification of cDNA ends) 
analysis using a primer at the 3 end of the 
SNF2L gene and an oligo dT 1 primer indicates 
that there is it longer 3' UTR in the primary 
transcript (data not shown) and it is likely 
that this is also true at the 5' end of the 
mRNA. Low amounts of hybridising message 
are present in gametocytes (data not shown), in-
dicating that the SNF2L mRNA is present in all 
ervthrocytic stages and in low amounts in the 
gametocytcs. 
4. Discussion 
We have identified it P. talci/)arunl homologue 
of the S.VF2L genes which encode chromatin 
remodelling transcription activation proteins. 
The protein encoded by this gene may be a 
component of a Plasnwdium chromatin remod-
elling complex. This gene joins the TATA-bind-
ing protein gene [14] and two high-mobility 
group protein genes [37.38] as characterised loci 
encoding proteins involved in regulating P. ta/cl-
parun? transcription. SNF2L mRNA is present 
in low amounts throughout the asexual cycle al-
though it is not known whether the protein it-
self is active in all stages. The P. fthiparuin 
SNF2L protein is related to the yeast SWI 
SNF21? protein, the first of this class of proteins 
to be described, but it is more similar to a 
protein of a Drosophila nucleosome remodelling 
complex, ISWI [39]. Other higher eukaryotic 
genes of less well characterised function also fall 
in this group. These proteins form it distinct 
subfamily, the 'SNF2-like' proteins which lack 
the bromodornain motif of SNF2 proteins and 
instead possess a SANT type domain character-
istic of several proteins involved in DNA bind-
ing and transcriptional regulation [40]. The 
Drosophila n ucleosoni e remodelling factor 
(NURF) complex appears to be involved in 
chromatin activation, yet it is smaller ( 500 
kDa as opposed to 2 MDa), less complex (four 
as opposed to II major polypeptides) and much 
more abundant OW as opposed to 1()3  copies 
per cell) than the SWI SNF complex [39]. Re-
cently, a new. 15-subunit chromatin remodelling 
complex (RSC, remodel the structure of chro-
matin) has been reported in yeast. This complex 
is ten times as abundant as the SWI:SNF com-
plex and also contains a novel DNA dependent 
ATPase subunit [41]. The existence of multiple 
chromatin remodelling complexes may indicate 
that they regulate different promotors and or 
control different as-pects of DNA metabolism 
such as repair or recombination. We do not 
know if the P. falciparw?I SN F2L forms part of 
it multi-protein complex or if it is essential for 
transcriptio n. 
Two substantial domains are unique to the P. 
/ilciparuni SN F2 L protein. These are the amino 
terminal tandem repeats of the (8 x NNHNDD) 
and the central 210 amino acid lysine rich basic 
domain. The role of neither of these regions is 
li-I). ii. I). E1rniii 	l!o/eeeeIir and Bualeenju a! Pi,rani /'e SX (1997) 1 5 1 162 
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Fig. ). Cops number and genomic localisation of the PISN F2L gene. (A) Southern Blot of P. la/cipaneni (clone 3D7A) DNA CLIt 
with the restriction enzymes kg/11.  (lot. Eco RI. E'o RV. Hind Ill. Hpa I, tJ/,, II, Var I. fi, I. Pju II .\ia I and lien I (lanes I 12 
respectively) and probed with a labelled fragment of the eDNA clone. (BI) Ethidium stained pulsed field gel separation of P. 
/akiparuin chromosomes from the K I and 3D7 lines. (BI 1) Southern blot of the same chromosome separation transferred to nylon 
membranes and probed with a labelled fragment of the eDNA clone. 
understood, although insertions of tandem repeats 
and basic domains and a consequent marked ten-
dency towards larger-than-normal size are com-
mon features of P/asmoc/,u,n proteins. It is 
interesting that asparagine rich repeats, basic do-
main insertions and the tendency towards in-
creased size and complexity are also features of 
subunits of the P. /a/ciparwn RNA polymerases 11 
[421 and Ill [43]. The authors of these studies 
proposed that the enlarged variable regions con-
tained regulatory domains for transcriptional con-
trol during the parasite's complex developmental 
cycle. This hypothesis remains tenable and also 
applicable to the SNF2L protein and its unique 
domains. Lysine rich sequences within nucle-
oproteins are common and are associated with 
nuclear localisation signals [44]. Residues 895-
92() of SNF2L have a particularly high match to 
the nuclear targeting consensus sequences pre-
dicted using the PSORT protein localisation site 
programme (underlined in dashes in Fig. 1). Sev-
eral potential casein kinase II phosphorylation 
sites are also found near this region (STDE. 870-
873; TDEE. 871 -874; SGEE, 879-882: TILE 
883-886; TFLD, 928-931). Such phosphoryla-
tion sites are frequently found next to nuclear 
localisation sequences and can enhance the rate of 
nuclear transport [45]. 
The molecular switches which regulate the 
malaria parasite's responses to extra-cellular sig-
nals and define entry into developmental path-
ways such as endothelial sequestration or 
gametocytogenesis are not understood. This prob-
lem can in principle be studied by describing the 
components of transcriptional activation in P. 
/aIcipaiu,i and comparing them to better under-
stood systems and then testing hypothetical mod-
els for Plas,nodiu,n developmental mechanisms. 
The problem with this approach is the complexity 
of gene expression. Thus, for RNA polymerase 11 
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I io 4. \l 	age site and ,ad) stale mR NA IC\e11 throughout the asexual ccIe. A) Ethidium stained 1.2"— fonnaldehvde a Lit rose 
itI separation of total RNA from synchronied cultures of 3D7A parasites Northern blotted onto nylon membranes and probed 
\ki th a radiolabelled S.VF2L fragment. R. T and S represent equal amounts of' total RNA from rings, tropliozoite and schizonts 
respectis el (B) Total P. /olcipariun RNA front three clonal parasite lines (I. Dd2 2 .3D7A 3. HB313) and the Northern blot of 
the same gel translèrred to nlon membranes and hshridised to a radiolahelled .S.VF21. probe. 
(p01 II) to transcribe a gene requires the recruit-
ment of > 20 proteins to a promotor [46.47]. In 
addition, assembly of the initiation complex re-
quires the prior removal or repositioning of flu-
cleosornes. carried out by multi-protein chromatin 
remodelling complexes, some of which may be 
promotor specific (another 2() -30 proteins?) 
[48.49]. Current models of chromatin remodelling 
complex function are largely based on studies of 
the yeast SW! SNF complex. Each protein in this 
complex is essential for transcriptional control at 
two sets of inducible loci, those involved in mating 
type switching (the siti mutants) and those con-
trolling sugar fermentation (the sn/-sucrose non-
fermenting mutants). However, none of the genes 
encoding the SWI SNF complex proteins are es-
sential for asexual growth and normal chromatin 
remodelling and transcription occurs at other pro-
motors in sit! and .vn/ mutants. 
The lack of' mutant selection systems and the 
fragility of the culture system has inhibited pro-
gress oil complex aspects of' the molecular biology 
of the malaria parasite. The genome mapping  
project [50] and the sequencing of the P. talC//Ia/U/fl 
genome could permit much faster identification of 
conserved core components of the parasite's tran-
scription apparatus. With genetic tests f'or func-
tionality such as gene 'knock outs' [51] it may he 
possible to ask whether genes such as P. falciparIII  
SNF21- are essential for survival or involved in 
transcription of 'inessential' inducible loci such as 
the metabolic and mating type switches activated 
by the SWI SNF chromatin remodelling complex. 
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Ran, a small GTPase found in the cytoplasm 
and the cell nucleus [1,2], is abundantly expressed 
in the dividing blood stages of Plasmodium falci-
parum [3,4]. It plays an essential role in protein 
import into the nucleus [5] and its GTP loading 
and hydrolysis cycle may be the major energy 
source for nuclear localisation signal mediated 
translocation through nuclear pore complexes [6]. 
The guanidine nucleotide exchange factor for Ran 
is known as RCC1 (for regulator of chromosome 
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condensation [7]), a chromatin protein which 
stimulates guanine nucleotide loading and thus 
generates Ran GTP within the nucleus. Ran 
GTP—Ran GDP hydrolysis is catalysed by the 
GTPase activating protein Ran GAP1, which is 
located exclusively in the cell cytoplasm [8]. 
A cytoplasmic activator of GTP hydrolysis sep-
arated by the nuclear membrane from a nuclear 
GTP generator regulate nuclear protein import by 
the Ran cycle. Ran GDP-associated nuclear local-
isation signal marked protein complexes destined 
for nuclear import form in the cytoplasm and 
dissociate in the nucleus along a steep trans-mem-
brane Ran GTP gradient [6]. Exchange of GDP 
for GTP on intra-nuclear RCCl/Ran complexes 
causes dissociation of the complex and Ran GTP 
export to the cytoplasm. There, Ran-GAP 1 
catalyses re-conversion to Ran GDP which can 
then once more bind and chaperone nuclear local-
isation sequence tagged proteins to nuclear pore 
complexes and the nucleus. 
0166-6851/98/519.00 © 1998 Elsevier Science B.V. All rights reserved. 
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If a Ran-mediated nuclear import cycle func-
tions in intra-erythrocytic malaria parasites then a 
protein homologous to the Ran guanidine ex-
change factor RCCI must exist. In all organisms 
from which this guanidine exchange factor has 
been characterised, RCC1 is a 600-700 amino 
acid protein with a central region of seven 50-60 
amino acid repeats each of which contains con-
served sequence motifs within otherwise divergent 
sequences [7,9-13]. The seven RCC1-type repeats 
have also been found in one other protein which 
also appears to act as a guanidine exchange fac-
tor, but in this case for the small G protein 
ADP-ribosylation factors (ARF's) for trimeric G 
protein i chains. An extremely large, cytôsolyic 
and Golgi-bound protein, the p619 Giant Protein, 
has two sets of RCCI-type repeats, the carboxy-
terminal one interacting with myristylated ARFI 
in the Golgi and the amino terminal set stimulat-
ing guanine nucleotide exchange on ARFI and 
Rab but not on the Ran or Ras G proteins [14]. 
Two degenerate oligonucleotides were synthe-
sised based on the conserved repeat sequences to 
try to PCR amplify a P. falciparum RCCI gene 
fragment and characterise this protein and its role 
in the parasite nuclear import cycle. A 380 base 
pairs (bp) fragment was amplified in this way 
from parasite genomic DNA and this sequence 
encoded a reading frame with homology to the 
conserved motifs of the human RCCI protein. 
The fragment was used to screen an asexual ery-
throcytic stage cDNA library from which a 3 kb 
cross hybridising clone was isolated, sequenced 
and used to isolate three more cDNA clones 
which extended the sequence further on the 5' and 
3' sides. A total of 4161 bp of cDNA have been 
sequenced, encoding a single contiguous reading 
frame without stop codons which has been primed 
from a short dA-rich 3' end sequence. Restriction 
mapping and Southern blotting experiments indi-
cate that this is a single copy gene co-localising to 
chromosome 5 with the P. falciparum reference 
marker gene Mdr-1 on pulsed field gel blots. 
Northern blotting experiments with RNA from 
synchronised cultures indicate that low-level tran-
scription of a single 8 kb RNA occurs in the 
trophozoites and to a lesser extent in the schizonts 
but that the gene is inactive in the young ring  
stages. This clone was named RCCI and its size 
and structure compared with other RCC1 motif 
proteins are shown in Fig. I. 
The Swissprot data base was used to compare 
the putative P.falciparum RCCI homologue with 
other RCCI proteins and the p619 Giant Protein. 
The alignments of the seven RCC1-type repeats 
from the human RCCI protein, the Saccha-
romyces cerevisiae RCC1 homologue (SRM1), 
and the two sets of repeats from the p619 protein 
confirm that the P.falciparum RCCI is a member 
of this family of guanidine exchange factor 
proteins. Internal homology of the repeats to each 
other is low in all of these proteins. Outside the 
repeat blocks there is no sequence conservation. 
Sequence insertions, a common feature of P.falci-
parum proteins, occur in two of the seven repeats 
and in repeat IV the insertion is 140 amino acids 
Iona. Amino acid identity between each sequence 
in the seven RCC1 repeats is only between 11 and 
15% although similarity in the short sequence 
motifs themselves rises to 60%. The single 
longest block of amino acid identity between the 
P. falciparum sequence and any other is a se-
quence around the third tandem repeat where 
11/18 amino acids (61%) are shared with the p619 
giant protein. This, together with the large size of 
the parasite RCC1 and its slightly higher homol-
ogy with p619 raises the possibility that the P. 
falciparum sequence is actually a homologue of 
this cytoplasmic guanidine exchange factor rather 
than of the intra-nuclear RCC1 proteins. Arguing 
against this possibility is the fact the extensive 
partial sequence obtained does not appear to 
leave coding space in the 8 kb mRNA for the 
additional set of seven RCCI repeats that occur 
in p619 (encoded by a 15 kb mRNA molecule 
[14]). Low stringency Southern blotting experi-
ments also detect only one copy of the RCC1 type 
repeats in the P. falciparum genome. 
To establish the intra-cellular location of RCCI 
in parasitised erythrocytes, a DNA fragment en-
coding 139 amino acids (comprising the whole of 
the first and most of the second RCCI repeat) 
was cloned into the pET29b bacterial expression 
vector. The hexahistidine-tagged fusion protein 
was expressed in Escherichia coli and purified by 
affinity chromatography [15]. The purified protein 
I I 
P619 377 .BN8SflO LflDNNQ8TUt. . 
P619.2 4002 .IA9)IH IAGRN.V . FV1 0AN I T 
1. 	RDTfl SDVY 
QflNODDLHVTVX . 
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........... 
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x NRCFjLT X. LVSW
LNIIULVDAEWWA 	DO 
ACC1 179 SaHDLVW 	AEiD 	 ÀY 	FIHEI1.&YG LB 
AWl 	228 PXDflILF DEZWV QQNQERK ..........VW:FRL.XTLDPRPFQLR.HVAYIA.. lct0 	"
PfRCC1 	344 FCFNflLA 	 INDNDBDDDLI YILLY 	II8DF8VFLLRSOAYT 	YN 
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.......................... ........... 
IyIcCnLnNsmLrL. 
Consensus: 	TSWG ......G.LG.G .......... .... .............. G ............Hs$. .DG. .VW 
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Fig. I. Alignment of the conserved sequence motifs in the RCCI-type repeats. p619 is the human p619 giant protein [141, RCCI is the human RCCI protein [71 and 
SRMI is the yeast homologue of RCCI [121. Regions highlighted in black indicate sequence identity, those in grey indicate conservative amino acid substitutions. The 
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was injected into rabbits with Titremax adjuvant 
to raise a specific antiserum against the recombi-
nant protein. Fig. 2 shows immunofluoresence 
micrographs comparing the localisation of anti-
bodies to RCCI in isolated P. falciparum nuclei, 
with nuclear staining using the DNA binding dye 
diamino-2-phenylinodle (DAPI) Plates 1, 3, and 5, 
show isolated parasite nuclei from mechanically 
disrupted parasitised erythrocytes stained with 
DAPI. Plates 2 shows the corresponding parasite 
nuclei stained with fluorescein isothiocyanate 
(FITC) labelled antisera from the rabbit before 
immunisation with recombinant RCCI protein. 
Plates 4, and 6 show fluorescent staining with 
FITC-labelled mouse antiserum raised against the 
P. falciparum homologue of the SNF2L chro-
matin remodelling ATPase [16] and the rabbit 
anti-RCCI antiserum respectively. While the pre-
immune sera does not react with the isolated 
nuclei, antibodies raised against SNF2L, a chro-
matin associated helicase, and antibodies against 
RCCI both react with the isolated nuclei. This 
indicates that the proteins recognised by both 
these antisera are located within the parasite 
nucleus. 
To locate RCC1 in developing intra-erythro-
cytic parasites, immuno-fluorescence microscopy 
using the FITC labelled anti-RCCI antisera with 
the ring, trophozoite and segmenting schizont 
stages of sorbitol synchronised cultures are shown 
in Fig. 2, plates 7-12. Although the resolution of 
internal structures within the erythrocytic parasite 
is at the limits of that obtainable with fluorescence 
microscopy, it is clear that the labelled antibody 
co-localises with segmented schizont nuclei 
stained with DAPI (plates 11 and 12 and also 
with the small DAPI stained nuclei of the early 
ring stages (plates 7 and 8) and the larger, proba-
bly dividing nuclei present in the late trophozoite/  
early schizont stages (plates 9 and 10). 
The conclusion drawn from these experiments 
is that we have identified a P. falciparum RCC1-
type guanidine exchange factor and that antibody 
localisation studies indicate that it is located in 
the parasite nucleus. It is therefore likely that this 
gene encodes the intra-nuclear guanidine ex-
change factor involved in the Ran mediated nu-
clear protein import cycle. 
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